data_2hgo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hgo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.882 0.373 . . . . 55.119999999999997 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -134.1 139.57 46.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.030000000000001 110.925 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -109.67 172.19 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.416 . . . . 71.519999999999996 111.222 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 m -56.79 -62.94 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.120000000000005 110.996 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.8 m -147.17 132.5 18.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.316 -0.402 . . . . 72.120000000000005 111.238 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -116.22 121.29 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.703 -0.48 . . . . 72.319999999999993 109.703 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.13 146.62 33.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 54.340000000000003 111.713 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -141.71 128.09 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.539 -0.755 . . . . 63.130000000000003 110.322 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 17.28 51.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 44.030000000000001 112.685 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.38 47.78 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 73.340000000000003 110.939 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.04 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.571 -0.823 . . . . 75.349999999999994 112.891 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.39 155.61 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 73.310000000000002 111.091 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.36 161.89 22.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 61.109999999999999 110.988 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.68 150.99 21.75 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.898 -0.667 . . . . 32.789999999999999 112.141 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -83.8 -9.6 58.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.697 0.285 . . . . 71.540000000000006 110.991 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 75.75 5.41 3.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.361 -0.381 . . . . 62.530000000000001 110.81 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.98 -7.21 10.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.501 -0.318 . . . . 52.049999999999997 110.903 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 11.77 2.7 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.75 -0.738 . . . . 71.439999999999998 113.17 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -109.18 146.11 34.69 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.963 0.411 . . . . 72.409999999999997 111.304 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.22 139.24 33.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.864 -0.607 . . . . 72.319999999999993 110.396 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -161.0 149.38 16.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.529 -0.305 . . . . 71.319999999999993 111.368 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.48 130.16 43.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 73.420000000000002 110.344 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.6 p -140.14 165.41 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 75.329999999999998 111.914 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -106.1 -20.5 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.502 -0.772 . . . . 44.240000000000002 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.69 97.03 0.47 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.993 -0.622 . . . . 33.229999999999997 112.485 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.889 . . . . 54.329999999999998 110.93 179.895 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.855 0.359 . . . . 61.119999999999997 110.762 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -139.84 144.28 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 33.439999999999998 110.899 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.7 m -112.33 172.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 73.140000000000001 111.177 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.83 -62.82 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 63.25 110.921 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -147.14 135.16 21.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 72.329999999999998 111.224 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.74 121.33 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.664 -0.495 . . . . 54.409999999999997 109.664 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.2 t-20 -78.81 147.24 33.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 64.129999999999995 111.789 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.9 m-85 -142.12 127.58 18.91 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.49 -0.777 . . . . 61.32 110.332 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.35 51.01 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 73.219999999999999 112.671 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.56 47.52 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 110.905 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.46 -37.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.654 -0.784 . . . . 61.539999999999999 112.926 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -106.35 155.74 19.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 74.109999999999999 111.094 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.39 162.21 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.44 . . . . 55.420000000000002 110.947 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.27 150.84 21.85 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.776 -0.647 . . . . 51.109999999999999 112.114 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -83.07 -9.42 59.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.769 0.319 . . . . 74.219999999999999 111.047 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.45 4.79 3.59 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.333 -0.394 . . . . 74.239999999999995 110.86 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.66 -7.89 10.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.497 -0.32 . . . . 60.219999999999999 110.906 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.88 9.11 2.87 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.759 -0.734 . . . . 64.129999999999995 113.262 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -106.34 146.25 30.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.027 0.442 . . . . 64.129999999999995 111.315 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -141.2 139.88 33.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 64.420000000000002 110.356 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -161.64 149.35 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.328 . . . . 54.219999999999999 111.325 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.31 129.96 42.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 65.510000000000005 110.354 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.13 165.36 27.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 73.340000000000003 111.926 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 p -106.06 -19.62 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 51.030000000000001 110.332 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.92 96.84 0.5 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.009 -0.615 . . . . 63.420000000000002 112.522 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.252 -0.88 . . . . 55.329999999999998 110.95 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.827 0.346 . . . . 54.420000000000002 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.5 m -116.14 144.73 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.911 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -111.37 172.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.419 . . . . 72.510000000000005 111.215 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 p -57.14 -62.69 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 74.349999999999994 111.002 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -148.74 131.54 16.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 52.149999999999999 111.236 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.53 121.35 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.767 -0.457 . . . . 73.219999999999999 109.767 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.1 t-20 -78.93 146.58 33.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.184 0.516 . . . . 64.219999999999999 111.734 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -141.58 128.36 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.466 -0.788 . . . . 74.439999999999998 110.328 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.64 16.55 51.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.818 -0.706 . . . . 74.319999999999993 112.687 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 57.28 49.15 13.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 71.319999999999993 110.817 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.59 -36.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.486 -0.864 . . . . 71.530000000000001 112.876 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.34 155.71 19.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 75.519999999999996 111.061 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.49 160.51 25.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 55.32 111.0 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.75 150.13 20.98 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.946 -0.645 . . . . 71.129999999999995 112.11 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -83.39 -9.76 58.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.711 0.291 . . . . 75.409999999999997 110.969 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 76.21 4.76 3.71 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.326 -0.397 . . . . 72.140000000000001 110.86 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.09 -8.29 10.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.456 -0.338 . . . . 45.229999999999997 110.845 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.9 11.66 2.56 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.724 -0.751 . . . . 64.239999999999995 113.075 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -108.62 146.35 33.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.999 0.428 . . . . 44.450000000000003 111.309 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.17 139.58 33.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.848 -0.615 . . . . 65.140000000000001 110.303 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -160.91 149.46 16.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.45 -0.341 . . . . 73.140000000000001 111.43 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.09 129.75 41.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 74.230000000000004 110.251 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.16 165.39 27.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.118 0.485 . . . . 63.549999999999997 111.867 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.51 17.01 14.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 63.420000000000002 110.338 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.84 97.73 2.45 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.958 -0.639 . . . . 42.520000000000003 112.607 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.325 -0.845 . . . . 71.109999999999999 110.884 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.868 0.366 . . . . 63.32 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -132.18 127.52 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 110.977 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.47 172.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 53.340000000000003 111.353 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 t -60.64 -61.87 2.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 73.150000000000006 111.052 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.7 m -149.24 134.28 18.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 61.329999999999998 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.41 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 2.8 m -120.04 121.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 40.039999999999999 109.798 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -77.57 146.28 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.112 0.482 . . . . 75.409999999999997 111.762 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CZ ' HG21 ' A' ' 7' ' ' VAL . 25.9 m-85 -140.89 128.52 21.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.557 -0.747 . . . . 60.32 110.309 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.69 50.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.617 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 57.55 49.19 13.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.866 0.365 . . . . 74.540000000000006 110.861 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.62 -36.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.475 -0.869 . . . . 65.219999999999999 113.013 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -106.43 155.76 19.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.912 0.387 . . . . 52.140000000000001 111.171 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -121.19 158.07 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 60.219999999999999 110.923 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.84 149.53 20.24 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.806 -0.634 . . . . 72.329999999999998 112.091 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -85.73 -11.59 53.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 74.349999999999994 110.987 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.34 7.33 4.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 52.439999999999998 110.602 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.53 -6.1 10.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.316 -0.402 . . . . 60.450000000000003 110.767 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.69 17.94 2.51 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.903 -0.665 . . . . 43.140000000000001 112.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.401 ' OD1' ' CE3' ' A' ' 22' ' ' TRP . 5.3 t-20 -116.17 145.29 43.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.993 0.425 . . . . 74.540000000000006 111.371 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 p -141.07 137.09 32.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.601 . . . . 54.229999999999997 110.276 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.401 ' CE3' ' OD1' ' A' ' 20' ' ' ASN . 37.4 p90 -158.61 149.28 20.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.799 0.333 . . . . 74.209999999999994 111.471 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.29 129.3 39.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.156 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.1 165.41 27.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.197 0.522 . . . . 64.209999999999994 111.934 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.33 16.28 14.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 62.43 110.319 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.09 96.45 2.46 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.036 -0.602 . . . . 75.209999999999994 112.494 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.274 -0.869 . . . . 62.140000000000001 110.923 179.891 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.6 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.778 0.323 . . . . 72.329999999999998 110.89 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -129.68 138.3 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.2 172.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.120000000000005 111.195 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -56.76 -62.94 1.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 75.209999999999994 110.924 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.9 m -147.91 131.69 16.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.247 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.33 121.31 66.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.759 -0.46 . . . . 63.130000000000003 109.759 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.32 146.21 33.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.471 . . . . 73.310000000000002 111.768 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.3 m-85 -141.43 128.43 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.563 -0.744 . . . . 74.209999999999994 110.349 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.0 51.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.319999999999993 112.644 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 56.38 47.49 18.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 75.150000000000006 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.72 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.572 -0.823 . . . . 74.450000000000003 112.916 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.38 155.65 19.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 111.102 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.51 160.75 24.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 54.119999999999997 110.983 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.88 150.61 20.96 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.747 -0.66 . . . . 55.219999999999999 112.108 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -84.0 -10.29 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.702 0.287 . . . . 73.519999999999996 111.0 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 75.25 6.2 4.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.368 -0.378 . . . . 72.140000000000001 110.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.17 -6.64 9.91 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.461 -0.336 . . . . 61.420000000000002 111.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.85 15.69 2.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.744 -0.741 . . . . 55.340000000000003 113.166 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.37 146.31 39.68 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.972 0.415 . . . . 72.430000000000007 111.375 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.16 138.41 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 55.329999999999998 110.3 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -160.67 149.46 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.81 0.338 . . . . 75.530000000000001 111.344 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 130.56 44.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.274 -0.421 . . . . 64.540000000000006 110.244 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.12 165.39 27.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.144 0.497 . . . . 64.409999999999997 111.932 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -117.9 15.96 14.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.51 -0.768 . . . . 65.150000000000006 110.38 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.37 98.4 2.51 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.984 -0.627 . . . . 40.340000000000003 112.559 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.225 -0.893 . . . . 72.230000000000004 110.917 179.923 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.814 0.34 . . . . 51.409999999999997 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -116.13 145.33 43.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.866 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.33 172.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 71.340000000000003 111.227 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.93 -62.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 60.219999999999999 111.023 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.1 m -147.82 133.81 19.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.419 . . . . 55.009999999999998 111.265 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.408 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 3.1 m -117.27 121.27 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.764 -0.458 . . . . 53.109999999999999 109.764 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.4 t-20 -78.56 147.4 33.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.742 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.408 ' CZ ' HG21 ' A' ' 7' ' ' VAL . 26.8 m-85 -142.15 127.26 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.764 . . . . 71.329999999999998 110.356 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.16 17.17 51.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.732 -0.747 . . . . 72.519999999999996 112.707 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.66 47.94 17.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 74.319999999999993 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.99 -37.43 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.545 -0.836 . . . . 42.020000000000003 112.878 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.41 155.7 19.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 61.210000000000001 110.999 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.15 161.81 22.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 110.975 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.92 150.21 21.32 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.93 -0.653 . . . . 71.329999999999998 112.118 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -82.45 -9.56 59.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 72.109999999999999 111.007 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.3 4.91 3.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.318 -0.401 . . . . 62.509999999999998 110.866 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.58 -8.04 10.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.427 -0.351 . . . . 72.310000000000002 110.967 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.52 10.2 2.71 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 113.19 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -107.52 146.57 31.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.041 0.448 . . . . 74.420000000000002 111.282 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -141.2 140.57 34.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.825 -0.625 . . . . 72.430000000000007 110.342 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -161.76 149.43 14.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.317 . . . . 71.109999999999999 111.373 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 129.66 41.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 64.540000000000006 110.265 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.11 165.41 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.201 0.524 . . . . 61.130000000000003 111.887 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -117.24 16.39 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.541 -0.754 . . . . 63.210000000000001 110.313 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.01 97.99 2.47 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.061 -0.59 . . . . 65.420000000000002 112.54 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.266 -0.873 . . . . 72.150000000000006 110.933 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.767 0.318 . . . . 65.310000000000002 110.894 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -116.16 138.6 51.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 71.109999999999999 110.817 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -108.55 172.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.248 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -57.48 -62.75 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 43.240000000000002 110.944 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.52 130.07 15.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 111.232 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.93 121.33 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.738 -0.467 . . . . 65.209999999999994 109.738 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.71 146.51 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.081 0.467 . . . . 63.25 111.66 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -141.53 128.17 20.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.608 -0.724 . . . . 72.540000000000006 110.4 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.22 17.12 51.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.219999999999999 112.678 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 m120 56.39 47.36 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.354 . . . . 73.239999999999995 110.93 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 64.420000000000002 112.879 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -106.44 155.69 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 62.229999999999997 111.06 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.21 161.56 23.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 74.540000000000006 110.947 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.03 150.78 21.42 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.76 -0.654 . . . . 72.319999999999993 112.173 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -84.04 -10.49 57.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.639 0.257 . . . . 60.119999999999997 110.931 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 75.5 5.89 4.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.37 -0.377 . . . . 75.140000000000001 110.762 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -119.8 -6.84 10.08 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.416 -0.356 . . . . 62.450000000000003 110.873 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 16.06 2.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.82 -0.705 . . . . 52.219999999999999 113.07 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.74 145.7 40.97 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.0 0.429 . . . . 74.310000000000002 111.312 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 p -141.03 138.52 33.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 63.229999999999997 110.316 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.4 149.53 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 74.420000000000002 111.376 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 130.19 43.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.32 -0.4 . . . . 63.340000000000003 110.31 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.9 p -140.17 165.35 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.508 . . . . 72.430000000000007 111.834 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.09 -19.83 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.474 -0.784 . . . . 73.519999999999996 110.316 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 97.56 0.53 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.01 -0.614 . . . . 71.219999999999999 112.514 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.212 -0.899 . . . . 51.049999999999997 110.962 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.766 0.317 . . . . 65.109999999999999 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.4 m -132.09 147.16 52.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 33.43 110.843 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.7 m -115.95 172.2 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 63.119999999999997 111.202 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.6 -62.79 1.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 51.439999999999998 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.2 m -147.75 133.22 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 52.020000000000003 111.319 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 2.8 m -117.21 121.31 67.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.584 -0.525 . . . . 61.149999999999999 109.584 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.0 t-20 -78.5 147.07 34.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 74.209999999999994 111.798 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -142.03 127.24 18.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 64.430000000000007 110.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.39 17.18 52.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.712 -0.756 . . . . 32.25 112.653 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.53 47.81 17.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 53.229999999999997 110.945 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.87 -37.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.515 -0.85 . . . . 41.149999999999999 112.867 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -106.44 155.64 19.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.843 0.354 . . . . 64.510000000000005 111.084 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.01 161.8 22.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 73.209999999999994 110.964 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.94 150.95 21.81 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.15 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -83.87 -9.83 58.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.675 0.274 . . . . 63.439999999999998 111.003 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 76.29 4.96 3.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.337 -0.392 . . . . 62.520000000000003 110.837 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.31 -7.81 10.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.544 -0.298 . . . . 71.409999999999997 110.912 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.75 2.78 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.73 -0.747 . . . . 72.349999999999994 113.134 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -107.95 146.04 32.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 72.519999999999996 111.339 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.16 139.06 33.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 72.430000000000007 110.327 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -160.49 149.36 16.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.348 . . . . 73.439999999999998 111.337 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.62 129.78 41.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 54.149999999999999 110.302 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.18 165.3 27.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.192 0.52 . . . . 55.32 111.863 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 p -105.35 -21.08 13.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.522 -0.763 . . . . 73.409999999999997 110.282 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.32 96.4 0.42 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.913 -0.66 . . . . 52.310000000000002 112.502 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.225 -0.893 . . . . 74.510000000000005 110.937 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.1 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.785 0.326 . . . . 63.409999999999997 110.889 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.97 138.34 51.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.25 172.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 54.310000000000002 111.197 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -62.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.939 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -148.81 130.02 14.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 64.239999999999995 111.227 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 m -113.81 121.35 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.763 -0.458 . . . . 62.25 109.763 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.86 145.21 32.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 65.129999999999995 111.739 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.8 m-85 -141.0 129.19 22.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.541 -0.754 . . . . 73.420000000000002 110.362 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.98 51.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.575 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.0 46.59 21.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.874 0.369 . . . . 54.520000000000003 110.891 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -37.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 34.509999999999998 112.982 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -106.48 155.67 19.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 64.239999999999995 110.997 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.6 159.84 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 52.350000000000001 110.939 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.8 150.3 20.3 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.865 -0.684 . . . . 73.530000000000001 112.084 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -84.14 -10.86 57.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.713 0.292 . . . . 52.43 111.003 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 75.25 6.12 4.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 74.329999999999998 110.685 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.38 -6.21 9.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.492 -0.322 . . . . 72.129999999999995 111.027 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.52 18.53 2.21 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.806 -0.712 . . . . 40.039999999999999 113.054 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -116.53 146.47 42.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 72.310000000000002 111.312 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 p -141.17 138.66 33.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 71.219999999999999 110.241 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.62 149.63 16.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 74.140000000000001 111.417 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 130.84 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 63.219999999999999 110.207 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.13 165.38 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 73.439999999999998 111.966 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.5 t -118.61 16.38 13.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.519 -0.764 . . . . 62.32 110.324 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.19 97.6 2.46 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.034 -0.603 . . . . 74.319999999999993 112.529 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.177 -0.916 . . . . 74.140000000000001 111.008 179.819 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.743 0.306 . . . . 62.32 110.939 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.91 138.95 50.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 62.350000000000001 110.867 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -106.6 172.15 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.245 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -57.29 -63.07 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 73.510000000000005 110.935 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.0 m -148.87 131.16 15.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 63.43 111.282 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -113.98 121.37 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.761 -0.459 . . . . 65.219999999999999 109.761 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.93 146.12 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.121 0.486 . . . . 45.210000000000001 111.721 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.7 m-85 -141.66 128.15 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.521 -0.763 . . . . 71.140000000000001 110.337 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.18 51.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 73.310000000000002 112.6 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.09 46.94 20.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 60.420000000000002 110.902 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -38.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.583 -0.817 . . . . 44.039999999999999 112.937 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -106.46 155.69 19.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 111.045 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.5 161.27 23.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.978 0.418 . . . . 61.350000000000001 111.021 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.78 150.92 20.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.792 -0.64 . . . . 54.030000000000001 112.106 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -84.35 -11.08 56.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.79 0.329 . . . . 73.109999999999999 111.067 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 76.05 5.28 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.322 -0.399 . . . . 62.43 110.724 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.21 -6.97 10.35 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.445 -0.343 . . . . 43.240000000000002 110.933 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 17.75 2.15 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.758 -0.734 . . . . 74.239999999999995 112.995 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -115.3 146.6 41.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.971 0.415 . . . . 75.340000000000003 111.288 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.17 138.44 33.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.868 -0.605 . . . . 40.119999999999997 110.284 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -160.58 149.48 16.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 63.539999999999999 111.355 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.24 130.9 46.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.388 . . . . 75.140000000000001 110.239 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.13 165.4 27.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.128 0.489 . . . . 73.329999999999998 111.894 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.63 16.18 14.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.537 -0.756 . . . . 44.329999999999998 110.386 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.45 97.42 2.42 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.955 -0.64 . . . . 75.409999999999997 112.569 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 74.219999999999999 110.908 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.836 0.351 . . . . 52.049999999999997 110.956 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -124.23 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 53.109999999999999 110.956 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.81 172.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 111.234 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -62.89 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 111.053 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.3 m -147.29 132.41 18.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 54.32 111.318 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.63 121.34 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.732 -0.47 . . . . 74.439999999999998 109.732 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.82 146.2 33.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.749 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.1 m-85 -141.51 128.22 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.533 -0.758 . . . . 55.020000000000003 110.31 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.77 52.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.747 -0.74 . . . . 61.130000000000003 112.57 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.75 48.18 16.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.845 0.355 . . . . 74.319999999999993 110.843 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.87 -36.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.536 -0.84 . . . . 72.25 112.895 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -106.36 155.76 19.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.847 0.356 . . . . 63.219999999999999 111.165 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -121.91 160.95 23.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 110.878 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.06 150.63 21.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.917 -0.658 . . . . 44.409999999999997 112.227 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -83.83 -10.09 58.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.689 0.28 . . . . 54.009999999999998 110.989 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 74.95 6.57 4.31 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.342 -0.39 . . . . 60.329999999999998 110.765 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.13 -6.62 9.93 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.381 -0.372 . . . . 60.350000000000001 110.89 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.45 13.4 2.58 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.824 -0.703 . . . . 51.409999999999997 113.167 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -111.61 146.0 38.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.969 0.414 . . . . 62.210000000000001 111.325 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -141.24 139.3 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.783 -0.644 . . . . 71.310000000000002 110.209 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -160.87 149.38 16.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.326 . . . . 75.219999999999999 111.423 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.99 129.93 42.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 45.210000000000001 110.263 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.39 27.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.506 . . . . 63.43 111.908 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -117.19 16.85 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 75.310000000000002 110.388 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.56 98.0 2.46 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.978 -0.629 . . . . 53.149999999999999 112.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.184 -0.912 . . . . 61.310000000000002 111.017 179.803 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.83 0.348 . . . . 61.450000000000003 110.853 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -122.56 139.0 54.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.239999999999995 110.866 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.3 172.19 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 71.340000000000003 111.215 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.32 -62.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.340000000000003 110.965 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 74.530000000000001 111.232 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.1 121.41 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.692 -0.484 . . . . 62.439999999999998 109.692 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.5 t-20 -79.43 146.43 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 71.209999999999994 111.698 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -141.66 128.01 19.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 110.439 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.13 17.24 51.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.686 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.26 47.02 20.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 52.219999999999999 110.891 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.95 -37.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 63.219999999999999 112.887 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.36 155.63 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.781 0.324 . . . . 43.530000000000001 111.087 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.41 161.37 23.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 64.310000000000002 110.987 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.33 150.22 20.9 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.743 -0.662 . . . . 54.350000000000001 112.057 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -83.61 -10.39 58.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.697 0.284 . . . . 54.020000000000003 110.983 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 75.51 5.72 4.04 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.329 -0.396 . . . . 74.329999999999998 110.815 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.67 -7.1 10.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.43 -0.35 . . . . 72.319999999999993 110.95 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.18 16.09 2.19 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.809 -0.71 . . . . 51.149999999999999 113.06 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -113.92 146.03 40.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.04 0.448 . . . . 74.230000000000004 111.261 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.1 138.74 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.848 -0.615 . . . . 53.539999999999999 110.295 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.77 149.56 16.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.516 -0.311 . . . . 55.439999999999998 111.419 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 130.38 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 62.32 110.199 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.17 165.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 73.140000000000001 111.87 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 p -117.82 16.63 14.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.533 -0.758 . . . . 53.219999999999999 110.339 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 97.82 2.43 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.987 -0.625 . . . . 51.020000000000003 112.513 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 74.439999999999998 110.89 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.867 0.365 . . . . 62.310000000000002 110.888 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -125.3 138.87 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.310000000000002 110.902 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.11 172.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 44.219999999999999 111.253 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 m -56.78 -62.58 1.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 52.43 111.031 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.6 m -147.46 129.23 15.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.394 . . . . 65.109999999999999 111.235 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.413 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 m -112.8 121.43 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.694 -0.484 . . . . 72.430000000000007 109.694 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.48 147.37 33.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 71.230000000000004 111.738 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.413 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 26.7 m-85 -142.04 127.33 18.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 72.409999999999997 110.349 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.92 17.32 50.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.737 -0.744 . . . . 54.229999999999997 112.674 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 56.61 47.67 18.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.862 0.363 . . . . 73.129999999999995 110.911 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.48 -37.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.542 -0.837 . . . . 72.129999999999995 112.838 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -106.38 155.64 19.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.846 0.355 . . . . 74.310000000000002 111.099 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.96 161.96 21.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 32.530000000000001 110.918 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.36 150.24 21.46 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.931 -0.652 . . . . 61.210000000000001 112.081 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -82.89 -9.36 59.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.707 0.289 . . . . 73.109999999999999 110.901 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 75.41 5.78 4.09 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.312 -0.403 . . . . 43.340000000000003 110.787 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.63 -6.87 10.16 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.497 -0.32 . . . . 62.119999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.25 2.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.648 -0.787 . . . . 31.52 113.125 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -108.51 146.03 33.84 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.068 0.434 . . . . 72.439999999999998 111.346 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 t -141.12 140.47 34.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 62.530000000000001 110.316 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -161.79 149.38 14.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 71.219999999999999 111.383 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 129.73 41.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.36 -0.382 . . . . 74.129999999999995 110.238 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.36 27.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.125 0.488 . . . . 65.519999999999996 111.948 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.19 16.59 14.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.557 -0.747 . . . . 71.150000000000006 110.325 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.39 97.89 2.44 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.035 -0.602 . . . . 75.239999999999995 112.527 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.197 -0.906 . . . . 61.240000000000002 110.968 179.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.8 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.78 0.324 . . . . 43.210000000000001 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -129.26 126.98 40.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 40.020000000000003 110.992 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -97.84 172.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 54.240000000000002 111.242 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 t -58.52 -62.58 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 45.520000000000003 110.97 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.5 m -148.02 133.14 18.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 75.230000000000004 111.244 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.83 121.32 67.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.755 -0.461 . . . . 71.530000000000001 109.755 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.6 t-20 -78.89 146.08 33.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 62.109999999999999 111.721 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.0 m-85 -141.27 128.79 21.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.5 -0.773 . . . . 75.120000000000005 110.3 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.15 51.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.764 -0.731 . . . . 43.329999999999998 112.621 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.6 m120 56.53 47.53 18.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.816 0.341 . . . . 74.120000000000005 110.943 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.92 -37.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.485 -0.864 . . . . 74.120000000000005 112.923 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 54.9 m-85 -106.34 155.56 19.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 72.409999999999997 111.192 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.49 160.42 24.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 110.948 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.46 150.83 21.25 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.86 -0.686 . . . . 44.25 112.16 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -85.36 -10.05 56.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.312 . . . . 52.140000000000001 110.952 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 72.83 7.79 5.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.33 -0.395 . . . . 75.120000000000005 110.679 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.71 -6.8 10.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 72.420000000000002 110.739 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 15.87 2.43 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.821 -0.704 . . . . 60.43 112.953 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -114.54 145.84 41.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.956 0.408 . . . . 74.310000000000002 111.356 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -141.12 137.22 32.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 61.140000000000001 110.227 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -159.37 149.29 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.412 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.404 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . . . -64.15 130.55 44.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 73.109999999999999 110.348 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -140.1 165.44 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.224 0.535 . . . . 71.430000000000007 111.885 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -105.78 -19.65 13.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 62.310000000000002 110.256 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 96.92 0.49 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.057 -0.592 . . . . 74.319999999999993 112.5 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.208 -0.901 . . . . 51.119999999999997 110.977 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.843 0.354 . . . . 61.409999999999997 110.792 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -137.2 128.1 27.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 75.109999999999999 110.964 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 m -100.14 172.17 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 43.140000000000001 111.276 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.5 p -58.62 -62.7 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.938 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.7 m -146.85 137.36 23.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 111.155 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -120.87 121.31 64.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.772 -0.455 . . . . 75.409999999999997 109.772 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -78.71 147.12 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.093 0.473 . . . . 63.509999999999998 111.801 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -142.09 128.17 19.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 73.219999999999999 110.392 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.34 17.69 47.54 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.737 -0.744 . . . . 30.91 112.65 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 56.23 46.7 20.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.794 0.33 . . . . 73.25 110.932 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.03 -38.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.512 -0.852 . . . . 63.240000000000002 112.908 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -106.42 155.77 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 73.129999999999995 111.072 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.23 162.84 20.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 61.520000000000003 111.029 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.51 150.43 21.63 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.902 -0.666 . . . . 71.120000000000005 112.067 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -82.27 -9.59 59.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.744 0.307 . . . . 73.219999999999999 110.98 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 75.24 6.63 4.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.309 -0.405 . . . . 60.409999999999997 110.723 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -119.79 -6.8 10.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.329 -0.396 . . . . 72.329999999999998 110.929 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.26 10.29 3.08 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.743 -0.741 . . . . 42.539999999999999 113.13 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -108.84 146.97 32.82 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.055 0.455 . . . . 74.519999999999996 111.426 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.2 140.77 34.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.66 . . . . 42.409999999999997 110.249 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -162.53 148.96 12.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.486 -0.325 . . . . 73.329999999999998 111.302 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.75 130.71 46.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 64.420000000000002 110.231 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.4 p -140.1 165.36 27.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 71.430000000000007 111.936 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.3 p -106.58 -18.37 13.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.239999999999995 110.234 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.84 97.63 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.0 -0.619 . . . . 60.210000000000001 112.493 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.204 -0.903 . . . . 72.319999999999993 110.9 179.827 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.802 0.334 . . . . 72.209999999999994 110.936 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -120.82 127.24 51.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.934 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.17 172.18 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 111.211 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 t -55.65 -62.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.082 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -149.09 127.86 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 52.329999999999998 111.271 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.411 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 2.9 m -111.03 121.29 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.756 -0.461 . . . . 55.210000000000001 109.756 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -78.27 146.41 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.139 0.495 . . . . 64.340000000000003 111.73 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.411 ' CZ ' HG21 ' A' ' 7' ' ' VAL . 26.0 m-85 -141.18 128.41 20.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.563 -0.744 . . . . 71.340000000000003 110.333 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.78 50.47 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.74 -0.743 . . . . 71.510000000000005 112.703 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 m120 57.21 48.52 15.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 74.420000000000002 110.818 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.44 -36.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.506 -0.854 . . . . 52.039999999999999 112.987 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.44 155.7 19.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.943 0.401 . . . . 72.329999999999998 111.11 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.69 159.52 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 64.230000000000004 110.73 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.85 149.54 20.46 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.814 -0.708 . . . . 64.140000000000001 112.285 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -86.26 -7.95 58.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.673 0.273 . . . . 74.450000000000003 111.024 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 68.76 10.17 7.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.342 -0.39 . . . . 61.25 110.745 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 m -121.17 -5.5 9.46 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.335 -0.393 . . . . 36.270000000000003 110.736 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.96 16.86 2.87 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.949 -0.643 . . . . 60.340000000000003 112.832 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -116.42 145.74 43.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.998 0.428 . . . . 75.230000000000004 111.398 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -141.14 136.93 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 64.109999999999999 110.145 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.21 149.17 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.521 -0.308 . . . . 74.340000000000003 111.53 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.15 129.96 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 73.549999999999997 110.321 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.14 165.34 27.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 111.843 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.7 m -116.56 17.67 15.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.572 -0.74 . . . . 55.329999999999998 110.327 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.14 97.23 2.4 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.923 -0.656 . . . . 64.109999999999999 112.567 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.198 -0.905 . . . . 73.340000000000003 110.978 179.85 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.849 0.357 . . . . 71.319999999999993 110.817 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 m -140.49 141.43 35.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.963 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.4 m -112.22 172.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 111.183 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.87 -62.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 110.974 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -146.52 134.01 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 31.129999999999999 111.221 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.41 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 m -117.74 121.24 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.622 -0.51 . . . . 63.420000000000002 109.622 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -77.96 147.32 34.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.18 0.515 . . . . 74.430000000000007 111.747 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CZ ' HG22 ' A' ' 7' ' ' VAL . 26.6 m-85 -142.22 126.84 17.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 73.150000000000006 110.319 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.06 17.38 51.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 31.199999999999999 112.661 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 56.41 47.19 19.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.896 0.379 . . . . 62.450000000000003 110.981 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.59 -38.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.587 -0.816 . . . . 55.009999999999998 112.871 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -106.43 155.71 19.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 74.519999999999996 111.02 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.17 162.27 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 75.510000000000005 110.884 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.49 150.84 21.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.916 -0.659 . . . . 44.240000000000002 112.196 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -82.5 -9.33 59.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 42.520000000000003 110.874 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 76.25 5.07 3.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.298 -0.41 . . . . 73.25 110.876 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.93 -7.56 10.4 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.479 -0.328 . . . . 71.430000000000007 111.0 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.29 7.29 3.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.669 -0.777 . . . . 72.439999999999998 113.264 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -105.22 146.28 29.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 111.309 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.27 140.9 33.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 71.430000000000007 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -162.19 149.28 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 73.340000000000003 111.384 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 129.91 42.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 73.219999999999999 110.284 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.2 p -140.16 165.44 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.131 0.491 . . . . 62.130000000000003 111.898 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.1 p -116.89 16.22 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.543 -0.753 . . . . 71.209999999999994 110.389 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.53 97.5 2.43 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.895 -0.669 . . . . 72.340000000000003 112.484 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.252 -0.88 . . . . 62.130000000000003 110.907 179.817 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.4 p . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.789 0.328 . . . . 65.340000000000003 110.885 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 m -132.61 127.47 35.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.938 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.4 m -102.37 172.23 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 54.409999999999997 111.106 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.9 p -55.46 -62.91 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 45.039999999999999 111.085 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.0 m -149.05 129.97 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 60.130000000000003 111.286 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -113.26 121.37 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.36 146.13 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.123 0.487 . . . . 51.409999999999997 111.706 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.03 128.5 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 72.239999999999995 110.269 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.4 16.79 51.08 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.754 -0.736 . . . . 32.530000000000001 112.643 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.1 48.65 15.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 74.140000000000001 110.808 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.53 -36.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.48 -0.866 . . . . 42.32 113.033 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -106.39 155.64 19.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 73.140000000000001 111.177 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.74 159.32 25.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 61.32 110.762 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.43 149.28 20.25 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.92 -0.657 . . . . 63.219999999999999 112.296 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -85.95 -7.47 58.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 32.409999999999997 111.128 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 68.26 10.85 8.09 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.257 -0.429 . . . . 54.43 110.634 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -122.09 -5.02 8.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.441 -0.345 . . . . 74.439999999999998 110.79 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.47 16.74 3.05 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.827 -0.701 . . . . 74.230000000000004 112.85 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -116.53 145.98 42.94 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.992 0.425 . . . . 63.539999999999999 111.341 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 p -141.17 136.97 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 61.240000000000002 110.146 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.22 149.2 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 63.210000000000001 111.49 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 129.91 41.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 62.350000000000001 110.317 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.12 165.4 27.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.232 0.539 . . . . 73.510000000000005 111.81 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -116.71 17.25 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.501 -0.772 . . . . 71.450000000000003 110.36 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.87 97.56 2.44 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.973 -0.632 . . . . 65.430000000000007 112.559 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.249 -0.882 . . . . 73.150000000000006 110.97 179.865 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.0 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.774 0.321 . . . . 54.520000000000003 110.92 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 m -132.86 127.01 33.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 110.961 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -101.41 172.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 111.221 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.06 -62.91 1.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 60.310000000000002 111.005 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.4 m -147.7 130.33 15.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.3 -0.409 . . . . 45.210000000000001 111.255 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.412 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 m -113.96 121.28 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 61.229999999999997 109.709 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -78.73 146.34 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.184 0.516 . . . . 74.140000000000001 111.709 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CZ ' HG21 ' A' ' 7' ' ' VAL . 26.2 m-85 -140.93 128.11 20.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 75.109999999999999 110.316 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.89 51.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.765 -0.731 . . . . 63.420000000000002 112.626 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.04 48.5 15.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.84 0.353 . . . . 62.450000000000003 110.91 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.27 -36.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.559 -0.829 . . . . 74.420000000000002 112.987 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.41 155.66 19.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 74.340000000000003 111.149 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.82 160.15 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.219999999999999 110.83 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.93 150.26 21.1 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.864 -0.684 . . . . 71.540000000000006 112.21 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -86.26 -7.19 58.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.762 0.315 . . . . 63.32 111.095 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 68.49 10.34 7.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.277 -0.42 . . . . 73.310000000000002 110.759 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -121.85 -5.63 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.387 -0.37 . . . . 72.420000000000002 110.788 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.88 15.88 2.81 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.862 -0.685 . . . . 53.219999999999999 112.985 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -115.12 145.38 42.41 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.948 0.404 . . . . 62.530000000000001 111.402 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -141.15 136.32 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 71.409999999999997 110.202 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -158.27 149.22 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 73.209999999999994 111.383 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.97 41.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.355 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.16 165.34 27.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 60.240000000000002 111.895 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.87 -19.43 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.576 -0.738 . . . . 35.789999999999999 110.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.33 0.52 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.974 -0.631 . . . . 73.120000000000005 112.525 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.215 -0.897 . . . . 73.510000000000005 111.008 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.842 0.353 . . . . 73.409999999999997 110.799 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -127.03 128.75 46.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 52.329999999999998 110.912 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.0 m -88.58 172.19 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 72.310000000000002 111.308 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -59.41 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 34.409999999999997 110.891 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -146.0 131.54 18.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.388 -0.369 . . . . 63.229999999999997 111.253 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.85 121.29 67.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.722 -0.473 . . . . 73.430000000000007 109.722 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.48 144.92 35.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.167 0.508 . . . . 64.319999999999993 111.733 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.4 m-85 -140.84 129.28 22.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 64.409999999999997 110.27 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.2 17.04 51.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.733 -0.746 . . . . 62.329999999999998 112.678 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 56.18 46.93 20.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 60.310000000000002 110.874 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.02 -37.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.517 -0.849 . . . . 64.140000000000001 112.939 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -106.45 155.68 19.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 74.230000000000004 111.134 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.8 158.79 28.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 110.817 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.89 151.76 20.8 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 73.219999999999999 112.21 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.53 -7.9 59.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.614 0.245 . . . . 63.450000000000003 110.921 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 79.26 1.63 2.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 60.409999999999997 111.024 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.1 m -113.69 -65.41 1.19 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.973 0.416 . . . . 54.229999999999997 110.084 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.59 25.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.858 -0.61 . . . . 72.140000000000001 112.476 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -118.13 145.05 45.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.04 0.448 . . . . 72.230000000000004 111.446 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t -141.18 134.84 30.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 71.439999999999998 110.15 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -158.03 149.27 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.812 0.339 . . . . 71.540000000000006 111.4 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 131.85 48.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.229 -0.441 . . . . 51.409999999999997 110.292 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.15 165.36 27.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.521 . . . . 60.229999999999997 111.885 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.7 t -117.06 16.28 15.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.467 -0.788 . . . . 73.439999999999998 110.396 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.85 96.88 2.41 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.997 -0.62 . . . . 52.240000000000002 112.505 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 44.310000000000002 110.949 179.893 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 119.009 -0.52 . . . . 52.450000000000003 112.039 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.2 p -144.43 152.67 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.877 0.735 . . . . 55.119999999999997 110.839 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -134.1 139.57 46.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.030000000000001 110.925 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -109.67 172.19 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.416 . . . . 71.519999999999996 111.222 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 m -56.79 -62.94 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.120000000000005 110.996 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.8 m -147.17 132.5 18.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.316 -0.402 . . . . 72.120000000000005 111.238 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -116.22 121.29 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.703 -0.48 . . . . 72.319999999999993 109.703 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.13 146.62 33.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 54.340000000000003 111.713 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -141.71 128.09 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.539 -0.755 . . . . 63.130000000000003 110.322 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 17.28 51.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 44.030000000000001 112.685 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.38 47.78 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 73.340000000000003 110.939 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.04 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.571 -0.823 . . . . 75.349999999999994 112.891 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.39 155.61 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 73.310000000000002 111.091 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.36 161.89 22.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 61.109999999999999 110.988 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.68 150.99 21.75 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.898 -0.667 . . . . 32.789999999999999 112.141 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -83.8 -9.6 58.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.697 0.285 . . . . 71.540000000000006 110.991 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 75.75 5.41 3.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.361 -0.381 . . . . 62.530000000000001 110.81 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.98 -7.21 10.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.501 -0.318 . . . . 52.049999999999997 110.903 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 11.77 2.7 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.75 -0.738 . . . . 71.439999999999998 113.17 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -109.18 146.11 34.69 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.963 0.411 . . . . 72.409999999999997 111.304 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.22 139.24 33.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.864 -0.607 . . . . 72.319999999999993 110.396 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -161.0 149.38 16.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.529 -0.305 . . . . 71.319999999999993 111.368 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.48 130.16 43.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 73.420000000000002 110.344 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.6 p -140.14 165.41 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 75.329999999999998 111.914 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -106.1 -20.5 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.502 -0.772 . . . . 44.240000000000002 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.69 97.03 0.47 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.993 -0.622 . . . . 33.229999999999997 112.485 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.889 . . . . 54.329999999999998 110.93 179.895 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 119.025 -0.512 . . . . 71.129999999999995 112.037 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 p -143.67 161.0 39.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.877 0.736 . . . . 61.119999999999997 110.762 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -139.84 144.28 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 33.439999999999998 110.899 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.7 m -112.33 172.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 73.140000000000001 111.177 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.83 -62.82 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 63.25 110.921 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -147.14 135.16 21.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 72.329999999999998 111.224 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 m -118.74 121.33 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.664 -0.495 . . . . 54.409999999999997 109.664 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.2 t-20 -78.81 147.24 33.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 64.129999999999995 111.789 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.9 m-85 -142.12 127.58 18.91 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.49 -0.777 . . . . 61.32 110.332 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.35 51.01 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 73.219999999999999 112.671 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.56 47.52 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 110.905 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.46 -37.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.654 -0.784 . . . . 61.539999999999999 112.926 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -106.35 155.74 19.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 74.109999999999999 111.094 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.39 162.21 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.44 . . . . 55.420000000000002 110.947 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.27 150.84 21.85 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.776 -0.647 . . . . 51.109999999999999 112.114 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -83.07 -9.42 59.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.769 0.319 . . . . 74.219999999999999 111.047 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.45 4.79 3.59 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.333 -0.394 . . . . 74.239999999999995 110.86 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.66 -7.89 10.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.497 -0.32 . . . . 60.219999999999999 110.906 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.88 9.11 2.87 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.759 -0.734 . . . . 64.129999999999995 113.262 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -106.34 146.25 30.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.027 0.442 . . . . 64.129999999999995 111.315 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -141.2 139.88 33.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 64.420000000000002 110.356 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -161.64 149.35 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.328 . . . . 54.219999999999999 111.325 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.31 129.96 42.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 65.510000000000005 110.354 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.13 165.36 27.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 73.340000000000003 111.926 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 p -106.06 -19.62 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 51.030000000000001 110.332 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.92 96.84 0.5 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.009 -0.615 . . . . 63.420000000000002 112.522 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.252 -0.88 . . . . 55.329999999999998 110.95 179.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 118.963 -0.542 . . . . 54.210000000000001 111.975 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 p -145.17 133.32 21.53 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 123.854 0.721 . . . . 54.420000000000002 110.904 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.5 m -116.14 144.73 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.911 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -111.37 172.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.419 . . . . 72.510000000000005 111.215 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 p -57.14 -62.69 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 74.349999999999994 111.002 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -148.74 131.54 16.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 52.149999999999999 111.236 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 m -115.53 121.35 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.767 -0.457 . . . . 73.219999999999999 109.767 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.1 t-20 -78.93 146.58 33.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.184 0.516 . . . . 64.219999999999999 111.734 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -141.58 128.36 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.466 -0.788 . . . . 74.439999999999998 110.328 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.64 16.55 51.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.818 -0.706 . . . . 74.319999999999993 112.687 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 57.28 49.15 13.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 71.319999999999993 110.817 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.59 -36.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.486 -0.864 . . . . 71.530000000000001 112.876 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.34 155.71 19.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 75.519999999999996 111.061 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.49 160.51 25.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 55.32 111.0 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.75 150.13 20.98 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.946 -0.645 . . . . 71.129999999999995 112.11 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -83.39 -9.76 58.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.711 0.291 . . . . 75.409999999999997 110.969 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 76.21 4.76 3.71 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.326 -0.397 . . . . 72.140000000000001 110.86 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.09 -8.29 10.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.456 -0.338 . . . . 45.229999999999997 110.845 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.9 11.66 2.56 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.724 -0.751 . . . . 64.239999999999995 113.075 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -108.62 146.35 33.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.999 0.428 . . . . 44.450000000000003 111.309 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.17 139.58 33.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.848 -0.615 . . . . 65.140000000000001 110.303 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -160.91 149.46 16.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.45 -0.341 . . . . 73.140000000000001 111.43 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.09 129.75 41.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 74.230000000000004 110.251 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.16 165.39 27.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.118 0.485 . . . . 63.549999999999997 111.867 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.51 17.01 14.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 63.420000000000002 110.338 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.84 97.73 2.45 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.958 -0.639 . . . . 42.520000000000003 112.607 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.325 -0.845 . . . . 71.109999999999999 110.884 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . 0.43 ' O4 ' ' CH3' ' A' ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.032 -0.508 . . . . 73.420000000000002 112.03 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.0 p -134.2 161.98 33.42 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.814 0.696 . . . . 63.32 110.857 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -132.18 127.52 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 110.977 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.1 m -101.47 172.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 53.340000000000003 111.353 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 t -60.64 -61.87 2.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 73.150000000000006 111.052 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.7 m -149.24 134.28 18.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 61.329999999999998 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.41 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 2.8 m -120.04 121.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 40.039999999999999 109.798 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -77.57 146.28 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.112 0.482 . . . . 75.409999999999997 111.762 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CZ ' HG21 ' A' ' 7' ' ' VAL . 25.9 m-85 -140.89 128.52 21.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.557 -0.747 . . . . 60.32 110.309 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.69 50.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.617 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 57.55 49.19 13.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.866 0.365 . . . . 74.540000000000006 110.861 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.62 -36.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.475 -0.869 . . . . 65.219999999999999 113.013 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -106.43 155.76 19.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.912 0.387 . . . . 52.140000000000001 111.171 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -121.19 158.07 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 60.219999999999999 110.923 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.84 149.53 20.24 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.806 -0.634 . . . . 72.329999999999998 112.091 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -85.73 -11.59 53.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 74.349999999999994 110.987 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.34 7.33 4.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 52.439999999999998 110.602 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.53 -6.1 10.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.316 -0.402 . . . . 60.450000000000003 110.767 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.69 17.94 2.51 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.903 -0.665 . . . . 43.140000000000001 112.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.401 ' OD1' ' CE3' ' A' ' 22' ' ' TRP . 5.3 t-20 -116.17 145.29 43.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.993 0.425 . . . . 74.540000000000006 111.371 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 p -141.07 137.09 32.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.601 . . . . 54.229999999999997 110.276 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.401 ' CE3' ' OD1' ' A' ' 20' ' ' ASN . 37.4 p90 -158.61 149.28 20.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.799 0.333 . . . . 74.209999999999994 111.471 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.29 129.3 39.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.156 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.1 165.41 27.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.197 0.522 . . . . 64.209999999999994 111.934 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.33 16.28 14.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 62.43 110.319 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.09 96.45 2.46 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.036 -0.602 . . . . 75.209999999999994 112.494 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.274 -0.869 . . . . 62.140000000000001 110.923 179.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . 0.426 ' O4 ' ' CH3' ' A' ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 118.97 -0.538 . . . . 74.530000000000001 112.01 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.6 p -149.89 160.01 43.92 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.923 0.764 . . . . 72.329999999999998 110.89 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -129.68 138.3 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 m -110.2 172.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.120000000000005 111.195 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -56.76 -62.94 1.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 75.209999999999994 110.924 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.9 m -147.91 131.69 16.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.247 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.33 121.31 66.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.759 -0.46 . . . . 63.130000000000003 109.759 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.32 146.21 33.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.471 . . . . 73.310000000000002 111.768 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.3 m-85 -141.43 128.43 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.563 -0.744 . . . . 74.209999999999994 110.349 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.0 51.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.319999999999993 112.644 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 56.38 47.49 18.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 75.150000000000006 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.72 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.572 -0.823 . . . . 74.450000000000003 112.916 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.38 155.65 19.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 111.102 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.51 160.75 24.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 54.119999999999997 110.983 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.88 150.61 20.96 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.747 -0.66 . . . . 55.219999999999999 112.108 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -84.0 -10.29 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.702 0.287 . . . . 73.519999999999996 111.0 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 75.25 6.2 4.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.368 -0.378 . . . . 72.140000000000001 110.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.17 -6.64 9.91 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.461 -0.336 . . . . 61.420000000000002 111.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.85 15.69 2.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.744 -0.741 . . . . 55.340000000000003 113.166 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.37 146.31 39.68 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.972 0.415 . . . . 72.430000000000007 111.375 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.16 138.41 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 55.329999999999998 110.3 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -160.67 149.46 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.81 0.338 . . . . 75.530000000000001 111.344 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 130.56 44.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.274 -0.421 . . . . 64.540000000000006 110.244 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.12 165.39 27.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.144 0.497 . . . . 64.409999999999997 111.932 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -117.9 15.96 14.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.51 -0.768 . . . . 65.150000000000006 110.38 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.37 98.4 2.51 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.984 -0.627 . . . . 40.340000000000003 112.559 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.225 -0.893 . . . . 72.230000000000004 110.917 179.923 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 118.864 -0.588 . . . . 72.230000000000004 111.981 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p -151.7 140.06 20.46 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.949 0.781 . . . . 51.409999999999997 110.898 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -116.13 145.33 43.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.866 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.33 172.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 71.340000000000003 111.227 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.93 -62.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 60.219999999999999 111.023 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.1 m -147.82 133.81 19.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.419 . . . . 55.009999999999998 111.265 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.408 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 3.1 m -117.27 121.27 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.764 -0.458 . . . . 53.109999999999999 109.764 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.4 t-20 -78.56 147.4 33.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.742 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.408 ' CZ ' HG21 ' A' ' 7' ' ' VAL . 26.8 m-85 -142.15 127.26 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.764 . . . . 71.329999999999998 110.356 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.16 17.17 51.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.732 -0.747 . . . . 72.519999999999996 112.707 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.66 47.94 17.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 74.319999999999993 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.99 -37.43 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.545 -0.836 . . . . 42.020000000000003 112.878 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.41 155.7 19.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 61.210000000000001 110.999 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.15 161.81 22.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 110.975 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.92 150.21 21.32 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.93 -0.653 . . . . 71.329999999999998 112.118 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -82.45 -9.56 59.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 72.109999999999999 111.007 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.3 4.91 3.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.318 -0.401 . . . . 62.509999999999998 110.866 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.58 -8.04 10.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.427 -0.351 . . . . 72.310000000000002 110.967 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.52 10.2 2.71 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 113.19 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -107.52 146.57 31.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.041 0.448 . . . . 74.420000000000002 111.282 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -141.2 140.57 34.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.825 -0.625 . . . . 72.430000000000007 110.342 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -161.76 149.43 14.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.317 . . . . 71.109999999999999 111.373 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 129.66 41.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 64.540000000000006 110.265 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.11 165.41 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.201 0.524 . . . . 61.130000000000003 111.887 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -117.24 16.39 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.541 -0.754 . . . . 63.210000000000001 110.313 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.01 97.99 2.47 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.061 -0.59 . . . . 65.420000000000002 112.54 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.266 -0.873 . . . . 72.150000000000006 110.933 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 119.01 -0.519 . . . . 52.030000000000001 111.99 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -148.32 138.45 22.55 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.902 0.751 . . . . 65.310000000000002 110.894 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -116.16 138.6 51.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 71.109999999999999 110.817 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -108.55 172.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.248 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -57.48 -62.75 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 43.240000000000002 110.944 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.52 130.07 15.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 111.232 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 m -113.93 121.33 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.738 -0.467 . . . . 65.209999999999994 109.738 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.71 146.51 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.081 0.467 . . . . 63.25 111.66 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -141.53 128.17 20.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.608 -0.724 . . . . 72.540000000000006 110.4 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.22 17.12 51.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.219999999999999 112.678 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 m120 56.39 47.36 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.354 . . . . 73.239999999999995 110.93 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 64.420000000000002 112.879 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -106.44 155.69 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 62.229999999999997 111.06 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.21 161.56 23.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 74.540000000000006 110.947 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.03 150.78 21.42 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.76 -0.654 . . . . 72.319999999999993 112.173 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -84.04 -10.49 57.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.639 0.257 . . . . 60.119999999999997 110.931 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 75.5 5.89 4.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.37 -0.377 . . . . 75.140000000000001 110.762 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -119.8 -6.84 10.08 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.416 -0.356 . . . . 62.450000000000003 110.873 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 16.06 2.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.82 -0.705 . . . . 52.219999999999999 113.07 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.74 145.7 40.97 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.0 0.429 . . . . 74.310000000000002 111.312 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 p -141.03 138.52 33.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 63.229999999999997 110.316 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.4 149.53 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 74.420000000000002 111.376 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 130.19 43.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.32 -0.4 . . . . 63.340000000000003 110.31 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.9 p -140.17 165.35 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.508 . . . . 72.430000000000007 111.834 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.09 -19.83 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.474 -0.784 . . . . 73.519999999999996 110.316 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 97.56 0.53 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.01 -0.614 . . . . 71.219999999999999 112.514 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.212 -0.899 . . . . 51.049999999999997 110.962 179.834 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.019 -0.515 . . . . 73.239999999999995 111.999 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 p -141.77 150.03 41.2 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.863 0.727 . . . . 65.109999999999999 110.921 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.4 m -132.09 147.16 52.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 33.43 110.843 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.7 m -115.95 172.2 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 63.119999999999997 111.202 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.6 -62.79 1.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 51.439999999999998 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.2 m -147.75 133.22 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 52.020000000000003 111.319 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 2.8 m -117.21 121.31 67.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.584 -0.525 . . . . 61.149999999999999 109.584 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.0 t-20 -78.5 147.07 34.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 74.209999999999994 111.798 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -142.03 127.24 18.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 64.430000000000007 110.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.39 17.18 52.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.712 -0.756 . . . . 32.25 112.653 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.53 47.81 17.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 53.229999999999997 110.945 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.87 -37.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.515 -0.85 . . . . 41.149999999999999 112.867 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -106.44 155.64 19.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.843 0.354 . . . . 64.510000000000005 111.084 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.01 161.8 22.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 73.209999999999994 110.964 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.94 150.95 21.81 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.15 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -83.87 -9.83 58.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.675 0.274 . . . . 63.439999999999998 111.003 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 76.29 4.96 3.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.337 -0.392 . . . . 62.520000000000003 110.837 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.31 -7.81 10.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.544 -0.298 . . . . 71.409999999999997 110.912 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.75 2.78 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.73 -0.747 . . . . 72.349999999999994 113.134 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -107.95 146.04 32.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 72.519999999999996 111.339 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.16 139.06 33.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 72.430000000000007 110.327 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -160.49 149.36 16.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.348 . . . . 73.439999999999998 111.337 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.62 129.78 41.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 54.149999999999999 110.302 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.18 165.3 27.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.192 0.52 . . . . 55.32 111.863 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 p -105.35 -21.08 13.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.522 -0.763 . . . . 73.409999999999997 110.282 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.32 96.4 0.42 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.913 -0.66 . . . . 52.310000000000002 112.502 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.225 -0.893 . . . . 74.510000000000005 110.937 179.856 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 118.948 -0.549 . . . . 73.439999999999998 111.943 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.1 p -135.06 140.12 45.3 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.918 0.761 . . . . 63.409999999999997 110.889 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.97 138.34 51.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.25 172.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 54.310000000000002 111.197 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -62.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.939 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -148.81 130.02 14.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 64.239999999999995 111.227 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 m -113.81 121.35 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.763 -0.458 . . . . 62.25 109.763 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.86 145.21 32.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 65.129999999999995 111.739 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.8 m-85 -141.0 129.19 22.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.541 -0.754 . . . . 73.420000000000002 110.362 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.98 51.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.575 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.0 46.59 21.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.874 0.369 . . . . 54.520000000000003 110.891 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -37.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 34.509999999999998 112.982 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -106.48 155.67 19.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 64.239999999999995 110.997 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.6 159.84 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 52.350000000000001 110.939 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.8 150.3 20.3 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.865 -0.684 . . . . 73.530000000000001 112.084 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -84.14 -10.86 57.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.713 0.292 . . . . 52.43 111.003 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 75.25 6.12 4.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 74.329999999999998 110.685 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.38 -6.21 9.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.492 -0.322 . . . . 72.129999999999995 111.027 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.52 18.53 2.21 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.806 -0.712 . . . . 40.039999999999999 113.054 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -116.53 146.47 42.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 72.310000000000002 111.312 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 p -141.17 138.66 33.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 71.219999999999999 110.241 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.62 149.63 16.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 74.140000000000001 111.417 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 130.84 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 63.219999999999999 110.207 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.13 165.38 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 73.439999999999998 111.966 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.5 t -118.61 16.38 13.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.519 -0.764 . . . . 62.32 110.324 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.19 97.6 2.46 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.034 -0.603 . . . . 74.319999999999993 112.529 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.177 -0.916 . . . . 74.140000000000001 111.008 179.819 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.671 0 CA-C-O 118.976 -0.535 . . . . 72.239999999999995 111.965 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.2 p -150.4 133.69 16.32 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.925 0.766 . . . . 62.32 110.939 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.91 138.95 50.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 62.350000000000001 110.867 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.9 m -106.6 172.15 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.245 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -57.29 -63.07 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 73.510000000000005 110.935 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.0 m -148.87 131.16 15.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 63.43 111.282 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -113.98 121.37 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.761 -0.459 . . . . 65.219999999999999 109.761 178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.93 146.12 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.121 0.486 . . . . 45.210000000000001 111.721 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.7 m-85 -141.66 128.15 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.521 -0.763 . . . . 71.140000000000001 110.337 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.18 51.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 73.310000000000002 112.6 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.09 46.94 20.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 60.420000000000002 110.902 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -38.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.583 -0.817 . . . . 44.039999999999999 112.937 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -106.46 155.69 19.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 111.045 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.5 161.27 23.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.978 0.418 . . . . 61.350000000000001 111.021 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.78 150.92 20.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.792 -0.64 . . . . 54.030000000000001 112.106 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -84.35 -11.08 56.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.79 0.329 . . . . 73.109999999999999 111.067 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 76.05 5.28 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.322 -0.399 . . . . 62.43 110.724 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.21 -6.97 10.35 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.445 -0.343 . . . . 43.240000000000002 110.933 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 17.75 2.15 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.758 -0.734 . . . . 74.239999999999995 112.995 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -115.3 146.6 41.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.971 0.415 . . . . 75.340000000000003 111.288 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.17 138.44 33.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.868 -0.605 . . . . 40.119999999999997 110.284 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -160.58 149.48 16.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 63.539999999999999 111.355 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.24 130.9 46.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.388 . . . . 75.140000000000001 110.239 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.13 165.4 27.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.128 0.489 . . . . 73.329999999999998 111.894 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.63 16.18 14.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.537 -0.756 . . . . 44.329999999999998 110.386 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.45 97.42 2.42 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.955 -0.64 . . . . 75.409999999999997 112.569 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 74.219999999999999 110.908 179.905 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 118.938 -0.554 . . . . 53.329999999999998 111.968 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p -151.68 149.4 29.06 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.948 0.78 . . . . 52.049999999999997 110.956 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -124.23 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 53.109999999999999 110.956 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.5 m -110.81 172.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 111.234 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -62.89 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 111.053 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.3 m -147.29 132.41 18.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 54.32 111.318 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.63 121.34 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.732 -0.47 . . . . 74.439999999999998 109.732 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.82 146.2 33.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.749 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.1 m-85 -141.51 128.22 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.533 -0.758 . . . . 55.020000000000003 110.31 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.77 52.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.747 -0.74 . . . . 61.130000000000003 112.57 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.75 48.18 16.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.845 0.355 . . . . 74.319999999999993 110.843 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.87 -36.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.536 -0.84 . . . . 72.25 112.895 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -106.36 155.76 19.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.847 0.356 . . . . 63.219999999999999 111.165 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -121.91 160.95 23.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 110.878 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.06 150.63 21.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.917 -0.658 . . . . 44.409999999999997 112.227 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -83.83 -10.09 58.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.689 0.28 . . . . 54.009999999999998 110.989 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 74.95 6.57 4.31 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.342 -0.39 . . . . 60.329999999999998 110.765 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.13 -6.62 9.93 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.381 -0.372 . . . . 60.350000000000001 110.89 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.45 13.4 2.58 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.824 -0.703 . . . . 51.409999999999997 113.167 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -111.61 146.0 38.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.969 0.414 . . . . 62.210000000000001 111.325 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -141.24 139.3 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.783 -0.644 . . . . 71.310000000000002 110.209 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -160.87 149.38 16.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.326 . . . . 75.219999999999999 111.423 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.99 129.93 42.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 45.210000000000001 110.263 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.39 27.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.506 . . . . 63.43 111.908 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -117.19 16.85 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 75.310000000000002 110.388 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.56 98.0 2.46 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.978 -0.629 . . . . 53.149999999999999 112.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.184 -0.912 . . . . 61.310000000000002 111.017 179.803 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 119.035 -0.507 . . . . 75.329999999999998 112.002 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.5 p -131.27 140.66 49.85 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.835 0.709 . . . . 61.450000000000003 110.853 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -122.56 139.0 54.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.239999999999995 110.866 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.6 m -108.3 172.19 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 71.340000000000003 111.215 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.32 -62.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.340000000000003 110.965 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 74.530000000000001 111.232 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 m -112.1 121.41 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.692 -0.484 . . . . 62.439999999999998 109.692 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.5 t-20 -79.43 146.43 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 71.209999999999994 111.698 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -141.66 128.01 19.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 110.439 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.13 17.24 51.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.686 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.26 47.02 20.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 52.219999999999999 110.891 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.95 -37.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 63.219999999999999 112.887 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.36 155.63 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.781 0.324 . . . . 43.530000000000001 111.087 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.41 161.37 23.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 64.310000000000002 110.987 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.33 150.22 20.9 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.743 -0.662 . . . . 54.350000000000001 112.057 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -83.61 -10.39 58.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.697 0.284 . . . . 54.020000000000003 110.983 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 75.51 5.72 4.04 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.329 -0.396 . . . . 74.329999999999998 110.815 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.67 -7.1 10.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.43 -0.35 . . . . 72.319999999999993 110.95 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.18 16.09 2.19 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.809 -0.71 . . . . 51.149999999999999 113.06 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -113.92 146.03 40.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.04 0.448 . . . . 74.230000000000004 111.261 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.1 138.74 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.848 -0.615 . . . . 53.539999999999999 110.295 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.77 149.56 16.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.516 -0.311 . . . . 55.439999999999998 111.419 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 130.38 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 62.32 110.199 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.17 165.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 73.140000000000001 111.87 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 p -117.82 16.63 14.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.533 -0.758 . . . . 53.219999999999999 110.339 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 97.82 2.43 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.987 -0.625 . . . . 51.020000000000003 112.513 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 74.439999999999998 110.89 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 118.947 -0.549 . . . . 44.030000000000001 112.089 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.2 p -152.07 151.32 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.95 0.781 . . . . 62.310000000000002 110.888 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -125.3 138.87 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.310000000000002 110.902 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -110.11 172.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 44.219999999999999 111.253 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 m -56.78 -62.58 1.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 52.43 111.031 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.6 m -147.46 129.23 15.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.394 . . . . 65.109999999999999 111.235 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.413 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 m -112.8 121.43 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.694 -0.484 . . . . 72.430000000000007 109.694 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.48 147.37 33.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 71.230000000000004 111.738 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.413 ' CZ ' HG23 ' A' ' 7' ' ' VAL . 26.7 m-85 -142.04 127.33 18.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 72.409999999999997 110.349 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.92 17.32 50.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.737 -0.744 . . . . 54.229999999999997 112.674 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 56.61 47.67 18.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.862 0.363 . . . . 73.129999999999995 110.911 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.48 -37.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.542 -0.837 . . . . 72.129999999999995 112.838 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -106.38 155.64 19.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.846 0.355 . . . . 74.310000000000002 111.099 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.96 161.96 21.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 32.530000000000001 110.918 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.36 150.24 21.46 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.931 -0.652 . . . . 61.210000000000001 112.081 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -82.89 -9.36 59.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.707 0.289 . . . . 73.109999999999999 110.901 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 75.41 5.78 4.09 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.312 -0.403 . . . . 43.340000000000003 110.787 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.63 -6.87 10.16 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.497 -0.32 . . . . 62.119999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.25 2.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.648 -0.787 . . . . 31.52 113.125 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -108.51 146.03 33.84 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.068 0.434 . . . . 72.439999999999998 111.346 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 t -141.12 140.47 34.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 62.530000000000001 110.316 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -161.79 149.38 14.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 71.219999999999999 111.383 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 129.73 41.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.36 -0.382 . . . . 74.129999999999995 110.238 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.36 27.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.125 0.488 . . . . 65.519999999999996 111.948 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.19 16.59 14.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.557 -0.747 . . . . 71.150000000000006 110.325 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.39 97.89 2.44 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.035 -0.602 . . . . 75.239999999999995 112.527 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.197 -0.906 . . . . 61.240000000000002 110.968 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 118.975 -0.536 . . . . 64.239999999999995 111.972 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.8 p -140.31 155.09 46.95 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.897 0.748 . . . . 43.210000000000001 110.872 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -129.26 126.98 40.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 40.020000000000003 110.992 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.4 m -97.84 172.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 54.240000000000002 111.242 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 t -58.52 -62.58 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 45.520000000000003 110.97 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.5 m -148.02 133.14 18.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 75.230000000000004 111.244 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 m -116.83 121.32 67.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.755 -0.461 . . . . 71.530000000000001 109.755 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.6 t-20 -78.89 146.08 33.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 62.109999999999999 111.721 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.0 m-85 -141.27 128.79 21.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.5 -0.773 . . . . 75.120000000000005 110.3 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.15 51.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.764 -0.731 . . . . 43.329999999999998 112.621 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.6 m120 56.53 47.53 18.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.816 0.341 . . . . 74.120000000000005 110.943 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.92 -37.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.485 -0.864 . . . . 74.120000000000005 112.923 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 54.9 m-85 -106.34 155.56 19.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 72.409999999999997 111.192 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.49 160.42 24.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 110.948 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.46 150.83 21.25 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.86 -0.686 . . . . 44.25 112.16 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -85.36 -10.05 56.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.312 . . . . 52.140000000000001 110.952 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 72.83 7.79 5.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.33 -0.395 . . . . 75.120000000000005 110.679 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.71 -6.8 10.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 72.420000000000002 110.739 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 15.87 2.43 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.821 -0.704 . . . . 60.43 112.953 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -114.54 145.84 41.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.956 0.408 . . . . 74.310000000000002 111.356 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -141.12 137.22 32.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 61.140000000000001 110.227 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -159.37 149.29 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.412 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.404 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . . . -64.15 130.55 44.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 73.109999999999999 110.348 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -140.1 165.44 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.224 0.535 . . . . 71.430000000000007 111.885 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -105.78 -19.65 13.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 62.310000000000002 110.256 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 96.92 0.49 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.057 -0.592 . . . . 74.319999999999993 112.5 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.208 -0.901 . . . . 51.119999999999997 110.977 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 119.017 -0.516 . . . . 73.439999999999998 111.981 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p -141.72 161.68 37.34 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.916 0.76 . . . . 61.409999999999997 110.792 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -137.2 128.1 27.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 75.109999999999999 110.964 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.5 m -100.14 172.17 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 43.140000000000001 111.276 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.5 p -58.62 -62.7 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.938 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.7 m -146.85 137.36 23.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 111.155 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -120.87 121.31 64.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.772 -0.455 . . . . 75.409999999999997 109.772 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -78.71 147.12 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.093 0.473 . . . . 63.509999999999998 111.801 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -142.09 128.17 19.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 73.219999999999999 110.392 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.34 17.69 47.54 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.737 -0.744 . . . . 30.91 112.65 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 56.23 46.7 20.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.794 0.33 . . . . 73.25 110.932 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.03 -38.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.512 -0.852 . . . . 63.240000000000002 112.908 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -106.42 155.77 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 73.129999999999995 111.072 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.23 162.84 20.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 61.520000000000003 111.029 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.51 150.43 21.63 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.902 -0.666 . . . . 71.120000000000005 112.067 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -82.27 -9.59 59.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.744 0.307 . . . . 73.219999999999999 110.98 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.5 t30 75.24 6.63 4.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.309 -0.405 . . . . 60.409999999999997 110.723 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -119.79 -6.8 10.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.329 -0.396 . . . . 72.329999999999998 110.929 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.26 10.29 3.08 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.743 -0.741 . . . . 42.539999999999999 113.13 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -108.84 146.97 32.82 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.055 0.455 . . . . 74.519999999999996 111.426 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.2 140.77 34.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.66 . . . . 42.409999999999997 110.249 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -162.53 148.96 12.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.486 -0.325 . . . . 73.329999999999998 111.302 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.75 130.71 46.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 64.420000000000002 110.231 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.4 p -140.1 165.36 27.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 71.430000000000007 111.936 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.3 p -106.58 -18.37 13.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.239999999999995 110.234 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.84 97.63 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.0 -0.619 . . . . 60.210000000000001 112.493 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.204 -0.903 . . . . 72.319999999999993 110.9 179.827 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 118.982 -0.533 . . . . 63.240000000000002 112.028 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p -143.44 146.18 33.23 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.889 0.743 . . . . 72.209999999999994 110.936 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -120.82 127.24 51.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.934 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.17 172.18 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 111.211 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 t -55.65 -62.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.082 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -149.09 127.86 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 52.329999999999998 111.271 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.411 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 2.9 m -111.03 121.29 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.756 -0.461 . . . . 55.210000000000001 109.756 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -78.27 146.41 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.139 0.495 . . . . 64.340000000000003 111.73 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.411 ' CZ ' HG21 ' A' ' 7' ' ' VAL . 26.0 m-85 -141.18 128.41 20.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.563 -0.744 . . . . 71.340000000000003 110.333 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.78 50.47 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.74 -0.743 . . . . 71.510000000000005 112.703 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 m120 57.21 48.52 15.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 74.420000000000002 110.818 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.44 -36.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.506 -0.854 . . . . 52.039999999999999 112.987 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.44 155.7 19.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.943 0.401 . . . . 72.329999999999998 111.11 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.69 159.52 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 64.230000000000004 110.73 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.85 149.54 20.46 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.814 -0.708 . . . . 64.140000000000001 112.285 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -86.26 -7.95 58.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.673 0.273 . . . . 74.450000000000003 111.024 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 68.76 10.17 7.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.342 -0.39 . . . . 61.25 110.745 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 m -121.17 -5.5 9.46 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.335 -0.393 . . . . 36.270000000000003 110.736 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.96 16.86 2.87 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.949 -0.643 . . . . 60.340000000000003 112.832 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -116.42 145.74 43.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.998 0.428 . . . . 75.230000000000004 111.398 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -141.14 136.93 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 64.109999999999999 110.145 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.21 149.17 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.521 -0.308 . . . . 74.340000000000003 111.53 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.15 129.96 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 73.549999999999997 110.321 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.14 165.34 27.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 111.843 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.7 m -116.56 17.67 15.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.572 -0.74 . . . . 55.329999999999998 110.327 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.14 97.23 2.4 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.923 -0.656 . . . . 64.109999999999999 112.567 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.198 -0.905 . . . . 73.340000000000003 110.978 179.85 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 118.997 -0.525 . . . . 73.230000000000004 112.007 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -150.65 162.04 41.44 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.948 0.78 . . . . 71.319999999999993 110.817 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 m -140.49 141.43 35.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.963 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.4 m -112.22 172.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 111.183 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.87 -62.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 110.974 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -146.52 134.01 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 31.129999999999999 111.221 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.41 HG22 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 m -117.74 121.24 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.622 -0.51 . . . . 63.420000000000002 109.622 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -77.96 147.32 34.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.18 0.515 . . . . 74.430000000000007 111.747 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.41 ' CZ ' HG22 ' A' ' 7' ' ' VAL . 26.6 m-85 -142.22 126.84 17.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 73.150000000000006 110.319 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.06 17.38 51.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 31.199999999999999 112.661 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 56.41 47.19 19.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.896 0.379 . . . . 62.450000000000003 110.981 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.59 -38.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.587 -0.816 . . . . 55.009999999999998 112.871 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -106.43 155.71 19.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 74.519999999999996 111.02 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.17 162.27 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 75.510000000000005 110.884 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.49 150.84 21.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.916 -0.659 . . . . 44.240000000000002 112.196 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -82.5 -9.33 59.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 42.520000000000003 110.874 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 76.25 5.07 3.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.298 -0.41 . . . . 73.25 110.876 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.93 -7.56 10.4 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.479 -0.328 . . . . 71.430000000000007 111.0 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.29 7.29 3.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.669 -0.777 . . . . 72.439999999999998 113.264 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -105.22 146.28 29.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 111.309 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.27 140.9 33.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 71.430000000000007 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -162.19 149.28 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 73.340000000000003 111.384 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 129.91 42.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 73.219999999999999 110.284 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.2 p -140.16 165.44 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.131 0.491 . . . . 62.130000000000003 111.898 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.1 p -116.89 16.22 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.543 -0.753 . . . . 71.209999999999994 110.389 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.53 97.5 2.43 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.895 -0.669 . . . . 72.340000000000003 112.484 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.252 -0.88 . . . . 62.130000000000003 110.907 179.817 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.723 0 CA-C-O 118.947 -0.549 . . . . 72.140000000000001 111.995 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.4 p -132.35 156.01 47.38 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.901 0.751 . . . . 65.340000000000003 110.885 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 m -132.61 127.47 35.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.938 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.4 m -102.37 172.23 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 54.409999999999997 111.106 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.9 p -55.46 -62.91 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 45.039999999999999 111.085 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.0 m -149.05 129.97 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 60.130000000000003 111.286 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 m -113.26 121.37 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.36 146.13 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.123 0.487 . . . . 51.409999999999997 111.706 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.03 128.5 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 72.239999999999995 110.269 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.4 16.79 51.08 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.754 -0.736 . . . . 32.530000000000001 112.643 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.1 48.65 15.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 74.140000000000001 110.808 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.53 -36.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.48 -0.866 . . . . 42.32 113.033 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -106.39 155.64 19.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 73.140000000000001 111.177 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.74 159.32 25.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 61.32 110.762 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.43 149.28 20.25 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.92 -0.657 . . . . 63.219999999999999 112.296 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.8 p-10 -85.95 -7.47 58.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 32.409999999999997 111.128 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 68.26 10.85 8.09 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.257 -0.429 . . . . 54.43 110.634 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -122.09 -5.02 8.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.441 -0.345 . . . . 74.439999999999998 110.79 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.47 16.74 3.05 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.827 -0.701 . . . . 74.230000000000004 112.85 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -116.53 145.98 42.94 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.992 0.425 . . . . 63.539999999999999 111.341 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 p -141.17 136.97 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 61.240000000000002 110.146 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.22 149.2 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 63.210000000000001 111.49 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 129.91 41.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 62.350000000000001 110.317 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.12 165.4 27.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.232 0.539 . . . . 73.510000000000005 111.81 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -116.71 17.25 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.501 -0.772 . . . . 71.450000000000003 110.36 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.87 97.56 2.44 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.973 -0.632 . . . . 65.430000000000007 112.559 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.249 -0.882 . . . . 73.150000000000006 110.97 179.865 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 118.995 -0.526 . . . . 75.310000000000002 111.988 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.0 p -148.82 159.89 43.74 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.866 0.729 . . . . 54.520000000000003 110.92 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.7 m -132.86 127.01 33.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 110.961 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.9 m -101.41 172.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 111.221 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.06 -62.91 1.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 60.310000000000002 111.005 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.4 m -147.7 130.33 15.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.3 -0.409 . . . . 45.210000000000001 111.255 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 3.0 m -113.96 121.28 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 61.229999999999997 109.709 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -78.73 146.34 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.184 0.516 . . . . 74.140000000000001 111.709 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CZ ' HG21 ' A' ' 7' ' ' VAL . 26.2 m-85 -140.93 128.11 20.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 75.109999999999999 110.316 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.89 51.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.765 -0.731 . . . . 63.420000000000002 112.626 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.04 48.5 15.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.84 0.353 . . . . 62.450000000000003 110.91 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.27 -36.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.559 -0.829 . . . . 74.420000000000002 112.987 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.41 155.66 19.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 74.340000000000003 111.149 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.82 160.15 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.219999999999999 110.83 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -138.93 150.26 21.1 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.864 -0.684 . . . . 71.540000000000006 112.21 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -86.26 -7.19 58.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.762 0.315 . . . . 63.32 111.095 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 68.49 10.34 7.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.277 -0.42 . . . . 73.310000000000002 110.759 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -121.85 -5.63 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.387 -0.37 . . . . 72.420000000000002 110.788 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.88 15.88 2.81 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.862 -0.685 . . . . 53.219999999999999 112.985 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -115.12 145.38 42.41 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.948 0.404 . . . . 62.530000000000001 111.402 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -141.15 136.32 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 71.409999999999997 110.202 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -158.27 149.22 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 73.209999999999994 111.383 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.97 41.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.355 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.16 165.34 27.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 60.240000000000002 111.895 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.87 -19.43 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.576 -0.738 . . . . 35.789999999999999 110.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.33 0.52 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.974 -0.631 . . . . 73.120000000000005 112.525 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.215 -0.897 . . . . 73.510000000000005 111.008 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.644 0 CA-C-O 119.001 -0.523 . . . . 74.120000000000005 111.977 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.9 p -142.02 140.1 32.54 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.875 0.734 . . . . 73.409999999999997 110.799 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -127.03 128.75 46.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 52.329999999999998 110.912 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.0 m -88.58 172.19 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 72.310000000000002 111.308 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -59.41 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 34.409999999999997 110.891 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -146.0 131.54 18.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.388 -0.369 . . . . 63.229999999999997 111.253 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -115.85 121.29 67.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.722 -0.473 . . . . 73.430000000000007 109.722 178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.48 144.92 35.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.167 0.508 . . . . 64.319999999999993 111.733 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.4 m-85 -140.84 129.28 22.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 64.409999999999997 110.27 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.2 17.04 51.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.733 -0.746 . . . . 62.329999999999998 112.678 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 56.18 46.93 20.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 60.310000000000002 110.874 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.02 -37.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.517 -0.849 . . . . 64.140000000000001 112.939 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -106.45 155.68 19.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 74.230000000000004 111.134 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.8 158.79 28.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 110.817 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.89 151.76 20.8 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 73.219999999999999 112.21 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.53 -7.9 59.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.614 0.245 . . . . 63.450000000000003 110.921 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 79.26 1.63 2.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 60.409999999999997 111.024 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.1 m -113.69 -65.41 1.19 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.973 0.416 . . . . 54.229999999999997 110.084 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.59 25.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.858 -0.61 . . . . 72.140000000000001 112.476 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -118.13 145.05 45.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.04 0.448 . . . . 72.230000000000004 111.446 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t -141.18 134.84 30.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 71.439999999999998 110.15 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -158.03 149.27 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.812 0.339 . . . . 71.540000000000006 111.4 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 131.85 48.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.229 -0.441 . . . . 51.409999999999997 110.292 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.15 165.36 27.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.521 . . . . 60.229999999999997 111.885 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.7 t -117.06 16.28 15.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.467 -0.788 . . . . 73.439999999999998 110.396 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.85 96.88 2.41 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.997 -0.62 . . . . 52.240000000000002 112.505 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 44.310000000000002 110.949 179.893 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.882 0.373 . . . . 55.119999999999997 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -134.1 139.57 46.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.030000000000001 110.925 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.733 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -109.67 172.19 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.416 . . . . 71.519999999999996 111.222 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 m -56.79 -62.94 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.120000000000005 110.996 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.8 m -147.17 132.5 18.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.316 -0.402 . . . . 72.120000000000005 111.238 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -116.22 121.29 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.703 -0.48 . . . . 72.319999999999993 109.703 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.13 146.62 33.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 54.340000000000003 111.713 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -141.71 128.09 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.539 -0.755 . . . . 63.130000000000003 110.322 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 17.28 51.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 44.030000000000001 112.685 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.38 47.78 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 73.340000000000003 110.939 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.04 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.571 -0.823 . . . . 75.349999999999994 112.891 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.39 155.61 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 73.310000000000002 111.091 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.2 m -122.36 161.89 22.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 61.109999999999999 110.988 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.747 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.68 150.99 21.75 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.898 -0.667 . . . . 32.530000000000001 112.141 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -83.8 -9.6 58.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.697 0.285 . . . . 71.540000000000006 110.991 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.75 5.41 3.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.361 -0.381 . . . . 62.530000000000001 110.81 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.98 -7.21 10.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.501 -0.318 . . . . 52.049999999999997 110.903 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 11.77 2.7 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.75 -0.738 . . . . 71.439999999999998 113.17 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -109.18 146.11 34.69 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.963 0.411 . . . . 72.409999999999997 111.304 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.22 139.24 33.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.864 -0.607 . . . . 72.319999999999993 110.396 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -161.0 149.38 16.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.529 -0.305 . . . . 71.319999999999993 111.368 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.48 130.16 43.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 73.420000000000002 110.344 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.6 p -140.14 165.41 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 75.329999999999998 111.914 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -106.1 -20.5 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.502 -0.772 . . . . 44.240000000000002 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.69 97.03 0.47 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.993 -0.622 . . . . 33.229999999999997 112.485 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.889 . . . . 54.329999999999998 110.93 179.895 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.855 0.359 . . . . 61.119999999999997 110.762 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -139.84 144.28 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 33.439999999999998 110.899 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.696 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.7 m -112.33 172.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 73.140000000000001 111.177 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.83 -62.82 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 63.25 110.921 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -147.14 135.16 21.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 72.329999999999998 111.224 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.9 m -118.74 121.33 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.664 -0.495 . . . . 54.409999999999997 109.664 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.2 t-20 -78.81 147.24 33.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 64.129999999999995 111.789 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.9 m-85 -142.12 127.58 18.91 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.49 -0.777 . . . . 61.32 110.332 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.35 51.01 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 73.219999999999999 112.671 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.56 47.52 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 110.905 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.46 -37.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.654 -0.784 . . . . 61.539999999999999 112.926 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -106.35 155.74 19.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 74.109999999999999 111.094 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.39 162.21 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.44 . . . . 55.420000000000002 110.947 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.76 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.27 150.84 21.85 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.776 -0.647 . . . . 51.109999999999999 112.114 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -83.07 -9.42 59.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.769 0.319 . . . . 74.219999999999999 111.047 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.45 4.79 3.59 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.333 -0.394 . . . . 74.239999999999995 110.86 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.66 -7.89 10.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.497 -0.32 . . . . 60.219999999999999 110.906 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.88 9.11 2.87 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.759 -0.734 . . . . 64.129999999999995 113.262 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -106.34 146.25 30.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.027 0.442 . . . . 64.129999999999995 111.315 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -141.2 139.88 33.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 64.420000000000002 110.356 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -161.64 149.35 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.328 . . . . 54.219999999999999 111.325 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.31 129.96 42.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 65.510000000000005 110.354 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.13 165.36 27.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 73.340000000000003 111.926 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 p -106.06 -19.62 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 51.030000000000001 110.332 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.92 96.84 0.5 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.009 -0.615 . . . . 63.420000000000002 112.522 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.252 -0.88 . . . . 55.329999999999998 110.95 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.827 0.346 . . . . 54.420000000000002 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.5 m -116.14 144.73 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.911 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.724 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -111.37 172.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.419 . . . . 72.510000000000005 111.215 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 p -57.14 -62.69 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 74.349999999999994 111.002 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -148.74 131.54 16.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 52.149999999999999 111.236 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -115.53 121.35 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.767 -0.457 . . . . 73.219999999999999 109.767 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.1 t-20 -78.93 146.58 33.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.184 0.516 . . . . 64.219999999999999 111.734 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -141.58 128.36 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.466 -0.788 . . . . 74.439999999999998 110.328 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.64 16.55 51.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.818 -0.706 . . . . 74.319999999999993 112.687 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 57.28 49.15 13.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 71.319999999999993 110.817 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.59 -36.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.486 -0.864 . . . . 71.530000000000001 112.876 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.34 155.71 19.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 75.519999999999996 111.061 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.49 160.51 25.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 55.32 111.0 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.75 150.13 20.98 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.946 -0.645 . . . . 71.129999999999995 112.11 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -83.39 -9.76 58.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.711 0.291 . . . . 75.409999999999997 110.969 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 76.21 4.76 3.71 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.326 -0.397 . . . . 72.140000000000001 110.86 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.09 -8.29 10.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.456 -0.338 . . . . 45.229999999999997 110.845 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.9 11.66 2.56 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.724 -0.751 . . . . 64.239999999999995 113.075 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.547 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 45.9 t30 -108.62 146.35 33.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.999 0.428 . . . . 44.450000000000003 111.309 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.17 139.58 33.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.848 -0.615 . . . . 65.140000000000001 110.303 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.547 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 40.2 p90 -160.91 149.46 16.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.45 -0.341 . . . . 73.140000000000001 111.43 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.09 129.75 41.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 74.230000000000004 110.251 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.16 165.39 27.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.118 0.485 . . . . 63.549999999999997 111.867 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.51 17.01 14.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 63.420000000000002 110.338 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.84 97.73 2.45 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.958 -0.639 . . . . 42.520000000000003 112.607 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.325 -0.845 . . . . 71.109999999999999 110.884 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.868 0.366 . . . . 63.32 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.9 m -132.18 127.52 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 110.977 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.695 ' CG2' HG13 ' A' ' 7' ' ' VAL . 28.1 m -101.47 172.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 53.340000000000003 111.353 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 t -60.64 -61.87 2.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 73.150000000000006 111.052 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.7 m -149.24 134.28 18.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 61.329999999999998 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.8 m -120.04 121.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 40.039999999999999 109.798 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -77.57 146.28 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.112 0.482 . . . . 75.409999999999997 111.762 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -140.89 128.52 21.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.557 -0.747 . . . . 60.32 110.309 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.69 50.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.617 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 57.55 49.19 13.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.866 0.365 . . . . 74.540000000000006 110.861 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.62 -36.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.475 -0.869 . . . . 65.219999999999999 113.013 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -106.43 155.76 19.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.912 0.387 . . . . 52.140000000000001 111.171 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -121.19 158.07 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 60.219999999999999 110.923 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.766 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -136.84 149.53 20.24 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.806 -0.634 . . . . 72.329999999999998 112.091 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -85.73 -11.59 53.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 74.349999999999994 110.987 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 1.0 OUTLIER 74.34 7.33 4.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 52.439999999999998 110.602 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.53 -6.1 10.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.316 -0.402 . . . . 60.450000000000003 110.767 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.69 17.94 2.51 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.903 -0.665 . . . . 43.140000000000001 112.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.527 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 8.5 t30 -116.17 145.29 43.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.993 0.425 . . . . 74.540000000000006 111.371 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 p -141.07 137.09 32.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.601 . . . . 54.229999999999997 110.276 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 37.4 p90 -158.61 149.28 20.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.799 0.333 . . . . 74.209999999999994 111.471 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.29 129.3 39.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.156 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.1 165.41 27.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.197 0.522 . . . . 64.209999999999994 111.934 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.33 16.28 14.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 62.43 110.319 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.09 96.45 2.46 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.036 -0.602 . . . . 75.209999999999994 112.494 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.274 -0.869 . . . . 62.140000000000001 110.923 179.891 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.6 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.778 0.323 . . . . 72.329999999999998 110.89 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -129.68 138.3 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.728 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -110.2 172.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.120000000000005 111.195 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -56.76 -62.94 1.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 75.209999999999994 110.924 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.9 m -147.91 131.69 16.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.247 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.4 m -115.33 121.31 66.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.759 -0.46 . . . . 63.130000000000003 109.759 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.32 146.21 33.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.471 . . . . 73.310000000000002 111.768 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.3 m-85 -141.43 128.43 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.563 -0.744 . . . . 74.209999999999994 110.349 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.0 51.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.319999999999993 112.644 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 56.38 47.49 18.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 75.150000000000006 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.72 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.572 -0.823 . . . . 74.450000000000003 112.916 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.38 155.65 19.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 111.102 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.51 160.75 24.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 54.119999999999997 110.983 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.729 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.88 150.61 20.96 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.747 -0.66 . . . . 55.219999999999999 112.108 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -84.0 -10.29 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.702 0.287 . . . . 73.519999999999996 111.0 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.449 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.25 6.2 4.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.368 -0.378 . . . . 72.140000000000001 110.676 -179.046 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.17 -6.64 9.91 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.461 -0.336 . . . . 61.420000000000002 111.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.85 15.69 2.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.744 -0.741 . . . . 55.340000000000003 113.166 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.502 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 28.6 t30 -113.37 146.31 39.68 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.972 0.415 . . . . 72.430000000000007 111.375 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.16 138.41 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 55.329999999999998 110.3 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 38.4 p90 -160.67 149.46 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.81 0.338 . . . . 75.530000000000001 111.344 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 130.56 44.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.274 -0.421 . . . . 64.540000000000006 110.244 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.12 165.39 27.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.144 0.497 . . . . 64.409999999999997 111.932 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -117.9 15.96 14.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.51 -0.768 . . . . 65.150000000000006 110.38 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.37 98.4 2.51 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.984 -0.627 . . . . 40.340000000000003 112.559 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.225 -0.893 . . . . 72.230000000000004 110.917 179.923 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.814 0.34 . . . . 51.409999999999997 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -116.13 145.33 43.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.866 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.71 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -112.33 172.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 71.340000000000003 111.227 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.93 -62.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 60.219999999999999 111.023 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.1 m -147.82 133.81 19.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.419 . . . . 55.009999999999998 111.265 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.1 m -117.27 121.27 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.764 -0.458 . . . . 53.109999999999999 109.764 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.4 t-20 -78.56 147.4 33.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.742 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.8 m-85 -142.15 127.26 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.764 . . . . 71.329999999999998 110.356 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.16 17.17 51.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.732 -0.747 . . . . 72.519999999999996 112.707 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.66 47.94 17.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 74.319999999999993 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.99 -37.43 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.545 -0.836 . . . . 42.020000000000003 112.878 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.41 155.7 19.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 61.210000000000001 110.999 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.15 161.81 22.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 110.975 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.765 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.92 150.21 21.32 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.93 -0.653 . . . . 71.329999999999998 112.118 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -82.45 -9.56 59.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 72.109999999999999 111.007 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.3 4.91 3.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.318 -0.401 . . . . 62.509999999999998 110.866 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.58 -8.04 10.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.427 -0.351 . . . . 72.310000000000002 110.967 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.52 10.2 2.71 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 113.19 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -107.52 146.57 31.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.041 0.448 . . . . 74.420000000000002 111.282 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -141.2 140.57 34.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.825 -0.625 . . . . 72.430000000000007 110.342 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -161.76 149.43 14.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.317 . . . . 71.109999999999999 111.373 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 129.66 41.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 64.540000000000006 110.265 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.11 165.41 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.201 0.524 . . . . 61.130000000000003 111.887 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -117.24 16.39 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.541 -0.754 . . . . 63.210000000000001 110.313 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.01 97.99 2.47 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.061 -0.59 . . . . 65.420000000000002 112.54 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.266 -0.873 . . . . 72.150000000000006 110.933 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.767 0.318 . . . . 65.310000000000002 110.894 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -116.16 138.6 51.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 71.109999999999999 110.817 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.786 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -108.55 172.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.248 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -57.48 -62.75 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 43.240000000000002 110.944 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.52 130.07 15.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 111.232 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.786 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.7 m -113.93 121.33 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.738 -0.467 . . . . 65.209999999999994 109.738 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.71 146.51 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.081 0.467 . . . . 63.25 111.66 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -141.53 128.17 20.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.608 -0.724 . . . . 72.540000000000006 110.4 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.22 17.12 51.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.219999999999999 112.678 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 m120 56.39 47.36 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.354 . . . . 73.239999999999995 110.93 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 64.420000000000002 112.879 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -106.44 155.69 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 62.229999999999997 111.06 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.21 161.56 23.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 74.540000000000006 110.947 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.741 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.03 150.78 21.42 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.76 -0.654 . . . . 72.319999999999993 112.173 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -84.04 -10.49 57.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.639 0.257 . . . . 60.119999999999997 110.931 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.5 5.89 4.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.37 -0.377 . . . . 75.140000000000001 110.762 -179.002 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -119.8 -6.84 10.08 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.416 -0.356 . . . . 62.450000000000003 110.873 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 16.06 2.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.82 -0.705 . . . . 52.219999999999999 113.07 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.74 145.7 40.97 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.0 0.429 . . . . 74.310000000000002 111.312 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 p -141.03 138.52 33.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 63.229999999999997 110.316 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.4 149.53 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 74.420000000000002 111.376 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 130.19 43.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.32 -0.4 . . . . 63.340000000000003 110.31 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.9 p -140.17 165.35 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.508 . . . . 72.430000000000007 111.834 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.09 -19.83 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.474 -0.784 . . . . 73.519999999999996 110.316 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 97.56 0.53 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.01 -0.614 . . . . 71.219999999999999 112.514 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.212 -0.899 . . . . 51.049999999999997 110.962 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.766 0.317 . . . . 65.109999999999999 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.4 m -132.09 147.16 52.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 33.43 110.843 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.716 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.7 m -115.95 172.2 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 63.119999999999997 111.202 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.6 -62.79 1.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 51.439999999999998 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.2 m -147.75 133.22 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 52.020000000000003 111.319 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.8 m -117.21 121.31 67.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.584 -0.525 . . . . 61.149999999999999 109.584 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.0 t-20 -78.5 147.07 34.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 74.209999999999994 111.798 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -142.03 127.24 18.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 64.430000000000007 110.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.39 17.18 52.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.712 -0.756 . . . . 20.300000000000001 112.653 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.53 47.81 17.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 53.229999999999997 110.945 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.87 -37.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.515 -0.85 . . . . 41.149999999999999 112.867 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -106.44 155.64 19.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.843 0.354 . . . . 64.510000000000005 111.084 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.01 161.8 22.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 73.209999999999994 110.964 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.765 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.94 150.95 21.81 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.15 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -83.87 -9.83 58.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.675 0.274 . . . . 63.439999999999998 111.003 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 76.29 4.96 3.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.337 -0.392 . . . . 62.520000000000003 110.837 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.31 -7.81 10.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.544 -0.298 . . . . 71.409999999999997 110.912 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.75 2.78 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.73 -0.747 . . . . 72.349999999999994 113.134 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -107.95 146.04 32.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 72.519999999999996 111.339 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.16 139.06 33.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 72.430000000000007 110.327 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -160.49 149.36 16.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.348 . . . . 73.439999999999998 111.337 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.62 129.78 41.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 54.149999999999999 110.302 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.18 165.3 27.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.192 0.52 . . . . 55.32 111.863 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 p -105.35 -21.08 13.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.522 -0.763 . . . . 73.409999999999997 110.282 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.32 96.4 0.42 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.913 -0.66 . . . . 52.310000000000002 112.502 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.225 -0.893 . . . . 74.510000000000005 110.937 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.1 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.785 0.326 . . . . 63.409999999999997 110.889 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.97 138.34 51.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.729 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.4 m -109.25 172.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 54.310000000000002 111.197 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -62.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.939 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -148.81 130.02 14.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 64.239999999999995 111.227 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG13 ' CG2' ' A' ' 4' ' ' VAL . 1.7 m -113.81 121.35 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.763 -0.458 . . . . 62.25 109.763 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.86 145.21 32.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 65.129999999999995 111.739 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.8 m-85 -141.0 129.19 22.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.541 -0.754 . . . . 73.420000000000002 110.362 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.98 51.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.575 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.0 46.59 21.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.874 0.369 . . . . 54.520000000000003 110.891 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -37.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 24.109999999999999 112.982 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -106.48 155.67 19.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 64.239999999999995 110.997 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.6 159.84 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 52.350000000000001 110.939 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.689 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -135.8 150.3 20.3 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.865 -0.684 . . . . 73.530000000000001 112.084 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -84.14 -10.86 57.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.713 0.292 . . . . 52.43 111.003 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.449 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.25 6.12 4.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 74.329999999999998 110.685 -179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.38 -6.21 9.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.492 -0.322 . . . . 72.129999999999995 111.027 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.52 18.53 2.21 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.806 -0.712 . . . . 40.039999999999999 113.054 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -116.53 146.47 42.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 72.310000000000002 111.312 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 p -141.17 138.66 33.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 71.219999999999999 110.241 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.62 149.63 16.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 74.140000000000001 111.417 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 130.84 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 63.219999999999999 110.207 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.13 165.38 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 73.439999999999998 111.966 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.5 t -118.61 16.38 13.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.519 -0.764 . . . . 62.32 110.324 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.19 97.6 2.46 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.034 -0.603 . . . . 74.319999999999993 112.529 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.177 -0.916 . . . . 74.140000000000001 111.008 179.819 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.454 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 30.2 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.743 0.306 . . . . 62.32 110.939 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.91 138.95 50.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 62.350000000000001 110.867 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.714 ' CG2' HG13 ' A' ' 7' ' ' VAL . 32.9 m -106.6 172.15 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.245 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -57.29 -63.07 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 73.510000000000005 110.935 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.0 m -148.87 131.16 15.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 63.43 111.282 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.714 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.6 m -113.98 121.37 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.761 -0.459 . . . . 65.219999999999999 109.761 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.93 146.12 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.121 0.486 . . . . 45.210000000000001 111.721 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.7 m-85 -141.66 128.15 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.521 -0.763 . . . . 71.140000000000001 110.337 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.18 51.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 73.310000000000002 112.6 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.09 46.94 20.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 60.420000000000002 110.902 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -38.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.583 -0.817 . . . . 44.039999999999999 112.937 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -106.46 155.69 19.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 111.045 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.2 m -122.5 161.27 23.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.978 0.418 . . . . 61.350000000000001 111.021 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.684 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -136.78 150.92 20.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.792 -0.64 . . . . 54.030000000000001 112.106 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -84.35 -11.08 56.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.79 0.329 . . . . 73.109999999999999 111.067 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.3 OUTLIER 76.05 5.28 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.322 -0.399 . . . . 62.43 110.724 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.21 -6.97 10.35 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.445 -0.343 . . . . 43.240000000000002 110.933 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 17.75 2.15 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.758 -0.734 . . . . 74.239999999999995 112.995 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -115.3 146.6 41.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.971 0.415 . . . . 75.340000000000003 111.288 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.17 138.44 33.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.868 -0.605 . . . . 40.119999999999997 110.284 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -160.58 149.48 16.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 63.539999999999999 111.355 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.24 130.9 46.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.388 . . . . 75.140000000000001 110.239 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.13 165.4 27.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.128 0.489 . . . . 73.329999999999998 111.894 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.63 16.18 14.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.537 -0.756 . . . . 44.329999999999998 110.386 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.45 97.42 2.42 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.955 -0.64 . . . . 75.409999999999997 112.569 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 74.219999999999999 110.908 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.836 0.351 . . . . 52.049999999999997 110.956 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -124.23 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 53.109999999999999 110.956 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.732 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -110.81 172.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 111.234 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -62.89 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 111.053 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.3 m -147.29 132.41 18.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 54.32 111.318 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -116.63 121.34 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.732 -0.47 . . . . 74.439999999999998 109.732 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.82 146.2 33.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.749 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.1 m-85 -141.51 128.22 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.533 -0.758 . . . . 55.020000000000003 110.31 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.77 52.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.747 -0.74 . . . . 61.130000000000003 112.57 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.75 48.18 16.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.845 0.355 . . . . 74.319999999999993 110.843 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.87 -36.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.536 -0.84 . . . . 72.25 112.895 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -106.36 155.76 19.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.847 0.356 . . . . 63.219999999999999 111.165 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -121.91 160.95 23.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 110.878 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.737 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.06 150.63 21.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.917 -0.658 . . . . 44.409999999999997 112.227 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -83.83 -10.09 58.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.689 0.28 . . . . 54.009999999999998 110.989 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 74.95 6.57 4.31 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.342 -0.39 . . . . 60.329999999999998 110.765 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.13 -6.62 9.93 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.381 -0.372 . . . . 60.350000000000001 110.89 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.45 13.4 2.58 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.824 -0.703 . . . . 51.409999999999997 113.167 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -111.61 146.0 38.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.969 0.414 . . . . 62.210000000000001 111.325 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -141.24 139.3 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.783 -0.644 . . . . 71.310000000000002 110.209 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -160.87 149.38 16.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.326 . . . . 75.219999999999999 111.423 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.99 129.93 42.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 45.210000000000001 110.263 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.39 27.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.506 . . . . 63.43 111.908 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -117.19 16.85 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 75.310000000000002 110.388 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.56 98.0 2.46 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.978 -0.629 . . . . 53.149999999999999 112.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.184 -0.912 . . . . 61.310000000000002 111.017 179.803 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.83 0.348 . . . . 61.450000000000003 110.853 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -122.56 139.0 54.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.239999999999995 110.866 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.775 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -108.3 172.19 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 71.340000000000003 111.215 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.32 -62.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.340000000000003 110.965 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 74.530000000000001 111.232 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.775 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.5 m -112.1 121.41 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.692 -0.484 . . . . 62.439999999999998 109.692 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.5 t-20 -79.43 146.43 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 71.209999999999994 111.698 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -141.66 128.01 19.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 110.439 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.13 17.24 51.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.686 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.26 47.02 20.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 52.219999999999999 110.891 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.95 -37.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 63.219999999999999 112.887 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.36 155.63 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.781 0.324 . . . . 43.530000000000001 111.087 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.41 161.37 23.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 64.310000000000002 110.987 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.734 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.33 150.22 20.9 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.743 -0.662 . . . . 54.350000000000001 112.057 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -83.61 -10.39 58.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.697 0.284 . . . . 54.020000000000003 110.983 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.51 5.72 4.04 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.329 -0.396 . . . . 74.329999999999998 110.815 -178.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.67 -7.1 10.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.43 -0.35 . . . . 72.319999999999993 110.95 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.18 16.09 2.19 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.809 -0.71 . . . . 51.149999999999999 113.06 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -113.92 146.03 40.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.04 0.448 . . . . 74.230000000000004 111.261 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.1 138.74 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.848 -0.615 . . . . 53.539999999999999 110.295 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.77 149.56 16.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.516 -0.311 . . . . 55.439999999999998 111.419 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 130.38 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 62.32 110.199 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.17 165.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 73.140000000000001 111.87 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 p -117.82 16.63 14.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.533 -0.758 . . . . 53.219999999999999 110.339 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 97.82 2.43 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.987 -0.625 . . . . 51.020000000000003 112.513 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 74.439999999999998 110.89 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.867 0.365 . . . . 62.310000000000002 110.888 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -125.3 138.87 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.310000000000002 110.902 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.779 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.9 m -110.11 172.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 44.219999999999999 111.253 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 m -56.78 -62.58 1.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 52.43 111.031 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.6 m -147.46 129.23 15.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.394 . . . . 65.109999999999999 111.235 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG13 ' CG2' ' A' ' 4' ' ' VAL . 3.0 m -112.8 121.43 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.694 -0.484 . . . . 72.430000000000007 109.694 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.48 147.37 33.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 71.230000000000004 111.738 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -142.04 127.33 18.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 72.409999999999997 110.349 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.92 17.32 50.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.737 -0.744 . . . . 54.229999999999997 112.674 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 56.61 47.67 18.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.862 0.363 . . . . 73.129999999999995 110.911 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.48 -37.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.542 -0.837 . . . . 72.129999999999995 112.838 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -106.38 155.64 19.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.846 0.355 . . . . 74.310000000000002 111.099 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.96 161.96 21.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 32.530000000000001 110.918 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.36 150.24 21.46 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.931 -0.652 . . . . 61.210000000000001 112.081 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -82.89 -9.36 59.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.707 0.289 . . . . 73.109999999999999 110.901 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.453 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.41 5.78 4.09 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.312 -0.403 . . . . 43.340000000000003 110.787 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.63 -6.87 10.16 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.497 -0.32 . . . . 62.119999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.25 2.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.648 -0.787 . . . . 14.31 113.125 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -108.51 146.03 33.84 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.068 0.434 . . . . 72.439999999999998 111.346 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 t -141.12 140.47 34.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 62.530000000000001 110.316 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -161.79 149.38 14.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 71.219999999999999 111.383 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 129.73 41.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.36 -0.382 . . . . 74.129999999999995 110.238 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.36 27.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.125 0.488 . . . . 65.519999999999996 111.948 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.19 16.59 14.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.557 -0.747 . . . . 71.150000000000006 110.325 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.39 97.89 2.44 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.035 -0.602 . . . . 75.239999999999995 112.527 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.197 -0.906 . . . . 61.240000000000002 110.968 179.877 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.8 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.78 0.324 . . . . 43.210000000000001 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -129.26 126.98 40.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 40.020000000000003 110.992 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.701 ' CG2' HG13 ' A' ' 7' ' ' VAL . 32.4 m -97.84 172.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 54.240000000000002 111.242 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 t -58.52 -62.58 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 45.520000000000003 110.97 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.5 m -148.02 133.14 18.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 75.230000000000004 111.244 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -116.83 121.32 67.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.755 -0.461 . . . . 71.530000000000001 109.755 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.6 t-20 -78.89 146.08 33.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 62.109999999999999 111.721 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.0 m-85 -141.27 128.79 21.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.5 -0.773 . . . . 75.120000000000005 110.3 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.15 51.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.764 -0.731 . . . . 43.329999999999998 112.621 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.6 m120 56.53 47.53 18.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.816 0.341 . . . . 74.120000000000005 110.943 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.92 -37.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.485 -0.864 . . . . 74.120000000000005 112.923 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 54.9 m-85 -106.34 155.56 19.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 72.409999999999997 111.192 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.49 160.42 24.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 110.948 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.742 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.46 150.83 21.25 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.86 -0.686 . . . . 44.25 112.16 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -85.36 -10.05 56.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.312 . . . . 52.140000000000001 110.952 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 1.2 m-20 72.83 7.79 5.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.33 -0.395 . . . . 75.120000000000005 110.679 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.71 -6.8 10.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 72.420000000000002 110.739 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 15.87 2.43 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.821 -0.704 . . . . 60.43 112.953 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -114.54 145.84 41.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.956 0.408 . . . . 74.310000000000002 111.356 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -141.12 137.22 32.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 61.140000000000001 110.227 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -159.37 149.29 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.412 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . . . -64.15 130.55 44.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 73.109999999999999 110.348 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -140.1 165.44 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.224 0.535 . . . . 71.430000000000007 111.885 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -105.78 -19.65 13.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 62.310000000000002 110.256 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 96.92 0.49 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.057 -0.592 . . . . 74.319999999999993 112.5 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.208 -0.901 . . . . 51.119999999999997 110.977 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.843 0.354 . . . . 61.409999999999997 110.792 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -137.2 128.1 27.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 75.109999999999999 110.964 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.669 ' CG2' HG13 ' A' ' 7' ' ' VAL . 31.5 m -100.14 172.17 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 43.140000000000001 111.276 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.5 p -58.62 -62.7 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.938 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.7 m -146.85 137.36 23.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 111.155 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -120.87 121.31 64.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.772 -0.455 . . . . 75.409999999999997 109.772 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -78.71 147.12 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.093 0.473 . . . . 63.509999999999998 111.801 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -142.09 128.17 19.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 73.219999999999999 110.392 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.34 17.69 47.54 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.737 -0.744 . . . . 13.25 112.65 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 56.23 46.7 20.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.794 0.33 . . . . 73.25 110.932 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.03 -38.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.512 -0.852 . . . . 63.240000000000002 112.908 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -106.42 155.77 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 73.129999999999995 111.072 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.23 162.84 20.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 61.520000000000003 111.029 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.758 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.51 150.43 21.63 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.902 -0.666 . . . . 71.120000000000005 112.067 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -82.27 -9.59 59.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.744 0.307 . . . . 73.219999999999999 110.98 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 2.5 t30 75.24 6.63 4.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.309 -0.405 . . . . 60.409999999999997 110.723 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -119.79 -6.8 10.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.329 -0.396 . . . . 72.329999999999998 110.929 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.26 10.29 3.08 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.743 -0.741 . . . . 42.539999999999999 113.13 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -108.84 146.97 32.82 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.055 0.455 . . . . 74.519999999999996 111.426 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.2 140.77 34.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.66 . . . . 42.409999999999997 110.249 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -162.53 148.96 12.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.486 -0.325 . . . . 73.329999999999998 111.302 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.75 130.71 46.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 64.420000000000002 110.231 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.4 p -140.1 165.36 27.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 71.430000000000007 111.936 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.3 p -106.58 -18.37 13.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.239999999999995 110.234 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.84 97.63 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.0 -0.619 . . . . 60.210000000000001 112.493 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.204 -0.903 . . . . 72.319999999999993 110.9 179.827 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.802 0.334 . . . . 72.209999999999994 110.936 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -120.82 127.24 51.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.934 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.78 ' CG2' HG13 ' A' ' 7' ' ' VAL . 34.6 m -100.17 172.18 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 111.211 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 t -55.65 -62.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.082 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -149.09 127.86 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 52.329999999999998 111.271 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.9 m -111.03 121.29 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.756 -0.461 . . . . 55.210000000000001 109.756 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -78.27 146.41 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.139 0.495 . . . . 64.340000000000003 111.73 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -141.18 128.41 20.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.563 -0.744 . . . . 71.340000000000003 110.333 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.78 50.47 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.74 -0.743 . . . . 71.510000000000005 112.703 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 m120 57.21 48.52 15.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 74.420000000000002 110.818 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.44 -36.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.506 -0.854 . . . . 52.039999999999999 112.987 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.44 155.7 19.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.943 0.401 . . . . 72.329999999999998 111.11 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.69 159.52 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 64.230000000000004 110.73 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.763 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.85 149.54 20.46 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.814 -0.708 . . . . 64.140000000000001 112.285 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -86.26 -7.95 58.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.673 0.273 . . . . 74.450000000000003 111.024 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.513 ' OD1' HG21 ' A' ' 7' ' ' VAL . 2.3 m-20 68.76 10.17 7.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.342 -0.39 . . . . 61.25 110.745 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 m -121.17 -5.5 9.46 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.335 -0.393 . . . . 32.219999999999999 110.736 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.96 16.86 2.87 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.949 -0.643 . . . . 60.340000000000003 112.832 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -116.42 145.74 43.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.998 0.428 . . . . 75.230000000000004 111.398 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -141.14 136.93 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 64.109999999999999 110.145 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.21 149.17 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.521 -0.308 . . . . 74.340000000000003 111.53 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.15 129.96 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 73.549999999999997 110.321 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.14 165.34 27.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 111.843 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.7 m -116.56 17.67 15.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.572 -0.74 . . . . 55.329999999999998 110.327 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.14 97.23 2.4 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.923 -0.656 . . . . 64.109999999999999 112.567 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.198 -0.905 . . . . 73.340000000000003 110.978 179.85 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.849 0.357 . . . . 71.319999999999993 110.817 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -140.49 141.43 35.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.963 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.713 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.4 m -112.22 172.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 111.183 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.87 -62.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 110.974 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -146.52 134.01 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 31.129999999999999 111.221 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.0 m -117.74 121.24 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.622 -0.51 . . . . 63.420000000000002 109.622 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -77.96 147.32 34.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.18 0.515 . . . . 74.430000000000007 111.747 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -142.22 126.84 17.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 73.150000000000006 110.319 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.06 17.38 51.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 31.199999999999999 112.661 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 56.41 47.19 19.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.896 0.379 . . . . 62.450000000000003 110.981 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.59 -38.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.587 -0.816 . . . . 55.009999999999998 112.871 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -106.43 155.71 19.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 74.519999999999996 111.02 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.17 162.27 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 75.510000000000005 110.884 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.49 150.84 21.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.916 -0.659 . . . . 44.240000000000002 112.196 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -82.5 -9.33 59.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 42.520000000000003 110.874 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 0.9 OUTLIER 76.25 5.07 3.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.298 -0.41 . . . . 73.25 110.876 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.93 -7.56 10.4 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.479 -0.328 . . . . 71.430000000000007 111.0 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.29 7.29 3.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.669 -0.777 . . . . 72.439999999999998 113.264 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -105.22 146.28 29.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 111.309 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.27 140.9 33.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 71.430000000000007 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -162.19 149.28 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 73.340000000000003 111.384 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 129.91 42.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 73.219999999999999 110.284 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.2 p -140.16 165.44 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.131 0.491 . . . . 62.130000000000003 111.898 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.1 p -116.89 16.22 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.543 -0.753 . . . . 71.209999999999994 110.389 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.53 97.5 2.43 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.895 -0.669 . . . . 72.340000000000003 112.484 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.252 -0.88 . . . . 62.130000000000003 110.907 179.817 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.4 p . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.789 0.328 . . . . 65.340000000000003 110.885 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -132.61 127.47 35.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.938 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.731 ' CG2' HG13 ' A' ' 7' ' ' VAL . 34.4 m -102.37 172.23 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 54.409999999999997 111.106 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.9 p -55.46 -62.91 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 45.039999999999999 111.085 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.0 m -149.05 129.97 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 60.130000000000003 111.286 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -113.26 121.37 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.36 146.13 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.123 0.487 . . . . 51.409999999999997 111.706 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.03 128.5 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 72.239999999999995 110.269 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.4 16.79 51.08 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.754 -0.736 . . . . 32.530000000000001 112.643 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.1 48.65 15.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 74.140000000000001 110.808 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.53 -36.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.48 -0.866 . . . . 42.32 113.033 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -106.39 155.64 19.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 73.140000000000001 111.177 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.74 159.32 25.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 61.32 110.762 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.43 149.28 20.25 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.92 -0.657 . . . . 63.219999999999999 112.296 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 31.8 p-10 -85.95 -7.47 58.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 32.409999999999997 111.128 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.498 ' OD1' HG21 ' A' ' 7' ' ' VAL . 4.1 m-20 68.26 10.85 8.09 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.257 -0.429 . . . . 54.43 110.634 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -122.09 -5.02 8.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.441 -0.345 . . . . 74.439999999999998 110.79 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.47 16.74 3.05 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.827 -0.701 . . . . 74.230000000000004 112.85 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -116.53 145.98 42.94 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.992 0.425 . . . . 63.539999999999999 111.341 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 p -141.17 136.97 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 61.240000000000002 110.146 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.22 149.2 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 63.210000000000001 111.49 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 129.91 41.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 62.350000000000001 110.317 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.12 165.4 27.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.232 0.539 . . . . 73.510000000000005 111.81 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -116.71 17.25 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.501 -0.772 . . . . 71.450000000000003 110.36 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.87 97.56 2.44 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.973 -0.632 . . . . 65.430000000000007 112.559 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.249 -0.882 . . . . 73.150000000000006 110.97 179.865 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.0 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.774 0.321 . . . . 54.520000000000003 110.92 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -132.86 127.01 33.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 110.961 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.75 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.9 m -101.41 172.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 111.221 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.06 -62.91 1.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 60.310000000000002 111.005 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.4 m -147.7 130.33 15.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.3 -0.409 . . . . 45.210000000000001 111.255 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.767 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.0 m -113.96 121.28 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 61.229999999999997 109.709 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -78.73 146.34 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.184 0.516 . . . . 74.140000000000001 111.709 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.93 128.11 20.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 75.109999999999999 110.316 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.89 51.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.765 -0.731 . . . . 63.420000000000002 112.626 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.04 48.5 15.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.84 0.353 . . . . 62.450000000000003 110.91 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.27 -36.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.559 -0.829 . . . . 74.420000000000002 112.987 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.41 155.66 19.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 74.340000000000003 111.149 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.82 160.15 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.219999999999999 110.83 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.767 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.93 150.26 21.1 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.864 -0.684 . . . . 71.540000000000006 112.21 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 31.0 p-10 -86.26 -7.19 58.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.762 0.315 . . . . 63.32 111.095 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.499 ' OD1' HG11 ' A' ' 7' ' ' VAL . 3.6 m-20 68.49 10.34 7.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.277 -0.42 . . . . 73.310000000000002 110.759 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -121.85 -5.63 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.387 -0.37 . . . . 72.420000000000002 110.788 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.88 15.88 2.81 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.862 -0.685 . . . . 53.219999999999999 112.985 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.478 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 21.7 t30 -115.12 145.38 42.41 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.948 0.404 . . . . 62.530000000000001 111.402 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -141.15 136.32 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 71.409999999999997 110.202 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.478 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 36.3 p90 -158.27 149.22 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 73.209999999999994 111.383 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.97 41.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.355 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.16 165.34 27.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 60.240000000000002 111.895 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.87 -19.43 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.576 -0.738 . . . . 33.219999999999999 110.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.33 0.52 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.974 -0.631 . . . . 73.120000000000005 112.525 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.215 -0.897 . . . . 73.510000000000005 111.008 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.842 0.353 . . . . 73.409999999999997 110.799 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -127.03 128.75 46.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 52.329999999999998 110.912 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.747 ' CG2' HG13 ' A' ' 7' ' ' VAL . 31.0 m -88.58 172.19 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 72.310000000000002 111.308 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -59.41 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 34.409999999999997 110.891 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -146.0 131.54 18.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.388 -0.369 . . . . 63.229999999999997 111.253 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.747 HG13 ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -115.85 121.29 67.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.722 -0.473 . . . . 73.430000000000007 109.722 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.48 144.92 35.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.167 0.508 . . . . 64.319999999999993 111.733 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.4 m-85 -140.84 129.28 22.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 64.409999999999997 110.27 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.2 17.04 51.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.733 -0.746 . . . . 62.329999999999998 112.678 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 56.18 46.93 20.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 60.310000000000002 110.874 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.02 -37.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.517 -0.849 . . . . 64.140000000000001 112.939 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -106.45 155.68 19.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 74.230000000000004 111.134 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.8 158.79 28.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 110.817 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.703 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -135.89 151.76 20.8 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 73.219999999999999 112.21 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.53 -7.9 59.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.614 0.245 . . . . 63.450000000000003 110.921 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 79.26 1.63 2.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 60.409999999999997 111.024 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.1 m -113.69 -65.41 1.19 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.973 0.416 . . . . 54.229999999999997 110.084 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.59 25.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.858 -0.61 . . . . 72.140000000000001 112.476 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.536 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 14.4 t30 -118.13 145.05 45.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.04 0.448 . . . . 72.230000000000004 111.446 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t -141.18 134.84 30.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 71.439999999999998 110.15 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.536 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 34.6 p90 -158.03 149.27 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.812 0.339 . . . . 71.540000000000006 111.4 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 131.85 48.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.229 -0.441 . . . . 51.409999999999997 110.292 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.15 165.36 27.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.521 . . . . 60.229999999999997 111.885 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.7 t -117.06 16.28 15.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.467 -0.788 . . . . 73.439999999999998 110.396 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.85 96.88 2.41 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.997 -0.62 . . . . 52.240000000000002 112.505 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 44.310000000000002 110.949 179.893 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 119.009 -0.52 . . . . 52.450000000000003 112.039 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.469 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 66.2 p -144.43 152.67 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.877 0.735 . . . . 55.119999999999997 110.839 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -134.1 139.57 46.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.030000000000001 110.925 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.733 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -109.67 172.19 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.416 . . . . 71.519999999999996 111.222 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 m -56.79 -62.94 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.120000000000005 110.996 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.8 m -147.17 132.5 18.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.316 -0.402 . . . . 72.120000000000005 111.238 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -116.22 121.29 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.703 -0.48 . . . . 72.319999999999993 109.703 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.13 146.62 33.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 54.340000000000003 111.713 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -141.71 128.09 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.539 -0.755 . . . . 63.130000000000003 110.322 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 17.28 51.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 44.030000000000001 112.685 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.38 47.78 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 73.340000000000003 110.939 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.04 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.571 -0.823 . . . . 75.349999999999994 112.891 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.39 155.61 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 73.310000000000002 111.091 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.2 m -122.36 161.89 22.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 61.109999999999999 110.988 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.747 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.68 150.99 21.75 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.898 -0.667 . . . . 32.530000000000001 112.141 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -83.8 -9.6 58.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.697 0.285 . . . . 71.540000000000006 110.991 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.75 5.41 3.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.361 -0.381 . . . . 62.530000000000001 110.81 -179.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.98 -7.21 10.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.501 -0.318 . . . . 52.049999999999997 110.903 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 11.77 2.7 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.75 -0.738 . . . . 71.439999999999998 113.17 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -109.18 146.11 34.69 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.963 0.411 . . . . 72.409999999999997 111.304 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.22 139.24 33.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.864 -0.607 . . . . 72.319999999999993 110.396 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -161.0 149.38 16.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.529 -0.305 . . . . 71.319999999999993 111.368 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.48 130.16 43.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 73.420000000000002 110.344 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.6 p -140.14 165.41 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 75.329999999999998 111.914 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -106.1 -20.5 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.502 -0.772 . . . . 44.240000000000002 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.69 97.03 0.47 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.993 -0.622 . . . . 33.229999999999997 112.485 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.889 . . . . 54.329999999999998 110.93 179.895 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . 0.469 ' C5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 119.025 -0.512 . . . . 71.129999999999995 112.037 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 p -143.67 161.0 39.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.877 0.736 . . . . 61.119999999999997 110.762 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -139.84 144.28 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 33.439999999999998 110.899 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.696 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.7 m -112.33 172.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 73.140000000000001 111.177 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.83 -62.82 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 63.25 110.921 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -147.14 135.16 21.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 72.329999999999998 111.224 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.9 m -118.74 121.33 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.664 -0.495 . . . . 54.409999999999997 109.664 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.2 t-20 -78.81 147.24 33.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 64.129999999999995 111.789 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.9 m-85 -142.12 127.58 18.91 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.49 -0.777 . . . . 61.32 110.332 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.35 51.01 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 73.219999999999999 112.671 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.56 47.52 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 110.905 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.46 -37.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.654 -0.784 . . . . 61.539999999999999 112.926 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -106.35 155.74 19.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 74.109999999999999 111.094 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.39 162.21 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.44 . . . . 55.420000000000002 110.947 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.76 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.27 150.84 21.85 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.776 -0.647 . . . . 51.109999999999999 112.114 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -83.07 -9.42 59.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.769 0.319 . . . . 74.219999999999999 111.047 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.45 4.79 3.59 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.333 -0.394 . . . . 74.239999999999995 110.86 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.66 -7.89 10.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.497 -0.32 . . . . 60.219999999999999 110.906 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.88 9.11 2.87 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.759 -0.734 . . . . 64.129999999999995 113.262 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -106.34 146.25 30.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.027 0.442 . . . . 64.129999999999995 111.315 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -141.2 139.88 33.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 64.420000000000002 110.356 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -161.64 149.35 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.328 . . . . 54.219999999999999 111.325 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.31 129.96 42.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 65.510000000000005 110.354 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.13 165.36 27.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 73.340000000000003 111.926 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 p -106.06 -19.62 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 51.030000000000001 110.332 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.92 96.84 0.5 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.009 -0.615 . . . . 63.420000000000002 112.522 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.252 -0.88 . . . . 55.329999999999998 110.95 179.834 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 118.963 -0.542 . . . . 54.210000000000001 111.975 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 p -145.17 133.32 21.53 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 123.854 0.721 . . . . 54.420000000000002 110.904 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.5 m -116.14 144.73 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.911 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.724 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -111.37 172.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.419 . . . . 72.510000000000005 111.215 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 p -57.14 -62.69 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 74.349999999999994 111.002 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -148.74 131.54 16.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 52.149999999999999 111.236 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -115.53 121.35 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.767 -0.457 . . . . 73.219999999999999 109.767 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.1 t-20 -78.93 146.58 33.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.184 0.516 . . . . 64.219999999999999 111.734 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -141.58 128.36 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.466 -0.788 . . . . 74.439999999999998 110.328 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.64 16.55 51.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.818 -0.706 . . . . 74.319999999999993 112.687 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 57.28 49.15 13.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 71.319999999999993 110.817 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.59 -36.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.486 -0.864 . . . . 71.530000000000001 112.876 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.34 155.71 19.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 75.519999999999996 111.061 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.49 160.51 25.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 55.32 111.0 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.75 150.13 20.98 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.946 -0.645 . . . . 71.129999999999995 112.11 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -83.39 -9.76 58.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.711 0.291 . . . . 75.409999999999997 110.969 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 76.21 4.76 3.71 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.326 -0.397 . . . . 72.140000000000001 110.86 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.09 -8.29 10.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.456 -0.338 . . . . 45.229999999999997 110.845 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.9 11.66 2.56 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.724 -0.751 . . . . 64.239999999999995 113.075 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.547 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 45.9 t30 -108.62 146.35 33.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.999 0.428 . . . . 44.450000000000003 111.309 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.17 139.58 33.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.848 -0.615 . . . . 65.140000000000001 110.303 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.547 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 40.2 p90 -160.91 149.46 16.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.45 -0.341 . . . . 73.140000000000001 111.43 -179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.09 129.75 41.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 74.230000000000004 110.251 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.16 165.39 27.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.118 0.485 . . . . 63.549999999999997 111.867 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.51 17.01 14.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 63.420000000000002 110.338 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.84 97.73 2.45 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.958 -0.639 . . . . 42.520000000000003 112.607 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.325 -0.845 . . . . 71.109999999999999 110.884 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . 0.646 ' H33' ' O4 ' ' A' ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.032 -0.508 . . . . 73.420000000000002 112.03 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.454 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 40.0 p -134.2 161.98 33.42 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.814 0.696 . . . . 63.32 110.857 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.9 m -132.18 127.52 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 110.977 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.695 ' CG2' HG13 ' A' ' 7' ' ' VAL . 28.1 m -101.47 172.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 53.340000000000003 111.353 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 t -60.64 -61.87 2.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 73.150000000000006 111.052 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.7 m -149.24 134.28 18.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 61.329999999999998 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.8 m -120.04 121.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 40.039999999999999 109.798 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -77.57 146.28 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.112 0.482 . . . . 75.409999999999997 111.762 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -140.89 128.52 21.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.557 -0.747 . . . . 60.32 110.309 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.69 50.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.617 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 57.55 49.19 13.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.866 0.365 . . . . 74.540000000000006 110.861 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.62 -36.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.475 -0.869 . . . . 65.219999999999999 113.013 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -106.43 155.76 19.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.912 0.387 . . . . 52.140000000000001 111.171 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -121.19 158.07 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 60.219999999999999 110.923 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.766 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -136.84 149.53 20.24 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.806 -0.634 . . . . 72.329999999999998 112.091 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -85.73 -11.59 53.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 74.349999999999994 110.987 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 1.0 OUTLIER 74.34 7.33 4.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 52.439999999999998 110.602 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.53 -6.1 10.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.316 -0.402 . . . . 60.450000000000003 110.767 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.69 17.94 2.51 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.903 -0.665 . . . . 43.140000000000001 112.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.527 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 8.5 t30 -116.17 145.29 43.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.993 0.425 . . . . 74.540000000000006 111.371 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 p -141.07 137.09 32.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.601 . . . . 54.229999999999997 110.276 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 37.4 p90 -158.61 149.28 20.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.799 0.333 . . . . 74.209999999999994 111.471 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.29 129.3 39.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.156 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.1 165.41 27.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.197 0.522 . . . . 64.209999999999994 111.934 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.33 16.28 14.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 62.43 110.319 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.09 96.45 2.46 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.036 -0.602 . . . . 75.209999999999994 112.494 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.274 -0.869 . . . . 62.140000000000001 110.923 179.891 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . 0.644 ' H33' ' O4 ' ' A' ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 118.97 -0.538 . . . . 74.530000000000001 112.01 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.425 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 61.6 p -149.89 160.01 43.92 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.923 0.764 . . . . 72.329999999999998 110.89 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -129.68 138.3 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.728 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -110.2 172.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.120000000000005 111.195 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -56.76 -62.94 1.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 75.209999999999994 110.924 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.9 m -147.91 131.69 16.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.247 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.4 m -115.33 121.31 66.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.759 -0.46 . . . . 63.130000000000003 109.759 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.32 146.21 33.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.471 . . . . 73.310000000000002 111.768 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.3 m-85 -141.43 128.43 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.563 -0.744 . . . . 74.209999999999994 110.349 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.0 51.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.319999999999993 112.644 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 56.38 47.49 18.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 75.150000000000006 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.72 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.572 -0.823 . . . . 74.450000000000003 112.916 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.38 155.65 19.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 111.102 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.51 160.75 24.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 54.119999999999997 110.983 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.729 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.88 150.61 20.96 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.747 -0.66 . . . . 55.219999999999999 112.108 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -84.0 -10.29 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.702 0.287 . . . . 73.519999999999996 111.0 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.449 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.25 6.2 4.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.368 -0.378 . . . . 72.140000000000001 110.676 -179.046 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.17 -6.64 9.91 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.461 -0.336 . . . . 61.420000000000002 111.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.85 15.69 2.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.744 -0.741 . . . . 55.340000000000003 113.166 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 28.6 t30 -113.37 146.31 39.68 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.972 0.415 . . . . 72.430000000000007 111.375 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.16 138.41 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 55.329999999999998 110.3 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 38.4 p90 -160.67 149.46 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.81 0.338 . . . . 75.530000000000001 111.344 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 130.56 44.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.274 -0.421 . . . . 64.540000000000006 110.244 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.12 165.39 27.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.144 0.497 . . . . 64.409999999999997 111.932 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -117.9 15.96 14.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.51 -0.768 . . . . 65.150000000000006 110.38 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.37 98.4 2.51 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.984 -0.627 . . . . 40.340000000000003 112.559 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.225 -0.893 . . . . 72.230000000000004 110.917 179.923 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . 0.425 ' C5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 118.864 -0.588 . . . . 72.230000000000004 111.981 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p -151.7 140.06 20.46 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.949 0.781 . . . . 51.409999999999997 110.898 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -116.13 145.33 43.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.866 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.71 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -112.33 172.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 71.340000000000003 111.227 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.93 -62.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 60.219999999999999 111.023 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.1 m -147.82 133.81 19.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.419 . . . . 55.009999999999998 111.265 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.1 m -117.27 121.27 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.764 -0.458 . . . . 53.109999999999999 109.764 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.4 t-20 -78.56 147.4 33.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.742 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.8 m-85 -142.15 127.26 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.764 . . . . 71.329999999999998 110.356 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.16 17.17 51.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.732 -0.747 . . . . 72.519999999999996 112.707 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.66 47.94 17.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 74.319999999999993 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.99 -37.43 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.545 -0.836 . . . . 42.020000000000003 112.878 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.41 155.7 19.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 61.210000000000001 110.999 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.15 161.81 22.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 110.975 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.765 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.92 150.21 21.32 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.93 -0.653 . . . . 71.329999999999998 112.118 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -82.45 -9.56 59.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 72.109999999999999 111.007 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.3 4.91 3.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.318 -0.401 . . . . 62.509999999999998 110.866 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.58 -8.04 10.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.427 -0.351 . . . . 72.310000000000002 110.967 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.52 10.2 2.71 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 113.19 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -107.52 146.57 31.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.041 0.448 . . . . 74.420000000000002 111.282 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -141.2 140.57 34.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.825 -0.625 . . . . 72.430000000000007 110.342 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -161.76 149.43 14.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.317 . . . . 71.109999999999999 111.373 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 129.66 41.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 64.540000000000006 110.265 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.11 165.41 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.201 0.524 . . . . 61.130000000000003 111.887 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -117.24 16.39 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.541 -0.754 . . . . 63.210000000000001 110.313 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.01 97.99 2.47 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.061 -0.59 . . . . 65.420000000000002 112.54 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.266 -0.873 . . . . 72.150000000000006 110.933 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 119.01 -0.519 . . . . 52.030000000000001 111.99 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -148.32 138.45 22.55 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.902 0.751 . . . . 65.310000000000002 110.894 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -116.16 138.6 51.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 71.109999999999999 110.817 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.786 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -108.55 172.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.248 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -57.48 -62.75 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 43.240000000000002 110.944 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.52 130.07 15.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 111.232 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.786 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.7 m -113.93 121.33 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.738 -0.467 . . . . 65.209999999999994 109.738 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.71 146.51 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.081 0.467 . . . . 63.25 111.66 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -141.53 128.17 20.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.608 -0.724 . . . . 72.540000000000006 110.4 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.22 17.12 51.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.219999999999999 112.678 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 m120 56.39 47.36 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.354 . . . . 73.239999999999995 110.93 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 64.420000000000002 112.879 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -106.44 155.69 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 62.229999999999997 111.06 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.21 161.56 23.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 74.540000000000006 110.947 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.741 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.03 150.78 21.42 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.76 -0.654 . . . . 72.319999999999993 112.173 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -84.04 -10.49 57.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.639 0.257 . . . . 60.119999999999997 110.931 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.5 5.89 4.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.37 -0.377 . . . . 75.140000000000001 110.762 -179.002 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -119.8 -6.84 10.08 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.416 -0.356 . . . . 62.450000000000003 110.873 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 16.06 2.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.82 -0.705 . . . . 52.219999999999999 113.07 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.74 145.7 40.97 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.0 0.429 . . . . 74.310000000000002 111.312 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 p -141.03 138.52 33.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 63.229999999999997 110.316 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.4 149.53 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 74.420000000000002 111.376 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 130.19 43.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.32 -0.4 . . . . 63.340000000000003 110.31 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.9 p -140.17 165.35 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.508 . . . . 72.430000000000007 111.834 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.09 -19.83 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.474 -0.784 . . . . 73.519999999999996 110.316 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 97.56 0.53 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.01 -0.614 . . . . 71.219999999999999 112.514 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.212 -0.899 . . . . 51.049999999999997 110.962 179.834 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.019 -0.515 . . . . 73.239999999999995 111.999 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 p -141.77 150.03 41.2 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.863 0.727 . . . . 65.109999999999999 110.921 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.4 m -132.09 147.16 52.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 33.43 110.843 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.716 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.7 m -115.95 172.2 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 63.119999999999997 111.202 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.6 -62.79 1.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 51.439999999999998 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.2 m -147.75 133.22 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 52.020000000000003 111.319 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.8 m -117.21 121.31 67.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.584 -0.525 . . . . 61.149999999999999 109.584 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.0 t-20 -78.5 147.07 34.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 74.209999999999994 111.798 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -142.03 127.24 18.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 64.430000000000007 110.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.39 17.18 52.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.712 -0.756 . . . . 20.300000000000001 112.653 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.53 47.81 17.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 53.229999999999997 110.945 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.87 -37.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.515 -0.85 . . . . 41.149999999999999 112.867 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -106.44 155.64 19.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.843 0.354 . . . . 64.510000000000005 111.084 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.01 161.8 22.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 73.209999999999994 110.964 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.765 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.94 150.95 21.81 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.15 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -83.87 -9.83 58.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.675 0.274 . . . . 63.439999999999998 111.003 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 76.29 4.96 3.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.337 -0.392 . . . . 62.520000000000003 110.837 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.31 -7.81 10.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.544 -0.298 . . . . 71.409999999999997 110.912 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.75 2.78 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.73 -0.747 . . . . 72.349999999999994 113.134 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -107.95 146.04 32.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 72.519999999999996 111.339 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.16 139.06 33.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 72.430000000000007 110.327 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -160.49 149.36 16.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.348 . . . . 73.439999999999998 111.337 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.62 129.78 41.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 54.149999999999999 110.302 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.18 165.3 27.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.192 0.52 . . . . 55.32 111.863 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 p -105.35 -21.08 13.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.522 -0.763 . . . . 73.409999999999997 110.282 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.32 96.4 0.42 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.913 -0.66 . . . . 52.310000000000002 112.502 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.225 -0.893 . . . . 74.510000000000005 110.937 179.856 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 118.948 -0.549 . . . . 73.439999999999998 111.943 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.1 p -135.06 140.12 45.3 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.918 0.761 . . . . 63.409999999999997 110.889 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.97 138.34 51.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.729 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.4 m -109.25 172.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 54.310000000000002 111.197 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -62.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.939 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -148.81 130.02 14.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 64.239999999999995 111.227 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG13 ' CG2' ' A' ' 4' ' ' VAL . 1.7 m -113.81 121.35 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.763 -0.458 . . . . 62.25 109.763 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.86 145.21 32.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 65.129999999999995 111.739 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.8 m-85 -141.0 129.19 22.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.541 -0.754 . . . . 73.420000000000002 110.362 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.98 51.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.575 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.0 46.59 21.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.874 0.369 . . . . 54.520000000000003 110.891 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -37.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 24.109999999999999 112.982 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -106.48 155.67 19.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 64.239999999999995 110.997 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.6 159.84 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 52.350000000000001 110.939 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.689 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -135.8 150.3 20.3 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.865 -0.684 . . . . 73.530000000000001 112.084 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -84.14 -10.86 57.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.713 0.292 . . . . 52.43 111.003 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.449 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.25 6.12 4.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 74.329999999999998 110.685 -179.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.38 -6.21 9.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.492 -0.322 . . . . 72.129999999999995 111.027 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.52 18.53 2.21 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.806 -0.712 . . . . 40.039999999999999 113.054 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -116.53 146.47 42.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 72.310000000000002 111.312 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 p -141.17 138.66 33.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 71.219999999999999 110.241 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.62 149.63 16.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 74.140000000000001 111.417 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 130.84 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 63.219999999999999 110.207 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.13 165.38 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 73.439999999999998 111.966 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.5 t -118.61 16.38 13.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.519 -0.764 . . . . 62.32 110.324 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.19 97.6 2.46 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.034 -0.603 . . . . 74.319999999999993 112.529 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.177 -0.916 . . . . 74.140000000000001 111.008 179.819 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.671 0 CA-C-O 118.976 -0.535 . . . . 72.239999999999995 111.965 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.454 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 30.2 p -150.4 133.69 16.32 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.925 0.766 . . . . 62.32 110.939 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.91 138.95 50.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 62.350000000000001 110.867 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.714 ' CG2' HG13 ' A' ' 7' ' ' VAL . 32.9 m -106.6 172.15 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.245 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -57.29 -63.07 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 73.510000000000005 110.935 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.0 m -148.87 131.16 15.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 63.43 111.282 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.714 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.6 m -113.98 121.37 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.761 -0.459 . . . . 65.219999999999999 109.761 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.93 146.12 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.121 0.486 . . . . 45.210000000000001 111.721 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.7 m-85 -141.66 128.15 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.521 -0.763 . . . . 71.140000000000001 110.337 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.18 51.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 73.310000000000002 112.6 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.09 46.94 20.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 60.420000000000002 110.902 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -38.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.583 -0.817 . . . . 44.039999999999999 112.937 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -106.46 155.69 19.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 111.045 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.2 m -122.5 161.27 23.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.978 0.418 . . . . 61.350000000000001 111.021 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.684 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -136.78 150.92 20.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.792 -0.64 . . . . 54.030000000000001 112.106 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -84.35 -11.08 56.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.79 0.329 . . . . 73.109999999999999 111.067 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.455 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.3 OUTLIER 76.05 5.28 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.322 -0.399 . . . . 62.43 110.724 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.21 -6.97 10.35 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.445 -0.343 . . . . 43.240000000000002 110.933 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 17.75 2.15 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.758 -0.734 . . . . 74.239999999999995 112.995 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -115.3 146.6 41.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.971 0.415 . . . . 75.340000000000003 111.288 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.17 138.44 33.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.868 -0.605 . . . . 40.119999999999997 110.284 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -160.58 149.48 16.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 63.539999999999999 111.355 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.24 130.9 46.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.388 . . . . 75.140000000000001 110.239 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.13 165.4 27.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.128 0.489 . . . . 73.329999999999998 111.894 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.63 16.18 14.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.537 -0.756 . . . . 44.329999999999998 110.386 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.45 97.42 2.42 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.955 -0.64 . . . . 75.409999999999997 112.569 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 74.219999999999999 110.908 179.905 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 118.938 -0.554 . . . . 53.329999999999998 111.968 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.437 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 44.9 p -151.68 149.4 29.06 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.948 0.78 . . . . 52.049999999999997 110.956 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -124.23 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 53.109999999999999 110.956 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.732 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -110.81 172.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 111.234 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -62.89 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 111.053 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.3 m -147.29 132.41 18.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 54.32 111.318 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -116.63 121.34 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.732 -0.47 . . . . 74.439999999999998 109.732 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.82 146.2 33.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.749 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.1 m-85 -141.51 128.22 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.533 -0.758 . . . . 55.020000000000003 110.31 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.77 52.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.747 -0.74 . . . . 61.130000000000003 112.57 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.75 48.18 16.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.845 0.355 . . . . 74.319999999999993 110.843 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.87 -36.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.536 -0.84 . . . . 72.25 112.895 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -106.36 155.76 19.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.847 0.356 . . . . 63.219999999999999 111.165 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -121.91 160.95 23.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 110.878 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.737 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.06 150.63 21.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.917 -0.658 . . . . 44.409999999999997 112.227 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -83.83 -10.09 58.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.689 0.28 . . . . 54.009999999999998 110.989 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 74.95 6.57 4.31 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.342 -0.39 . . . . 60.329999999999998 110.765 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.13 -6.62 9.93 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.381 -0.372 . . . . 60.350000000000001 110.89 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.45 13.4 2.58 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.824 -0.703 . . . . 51.409999999999997 113.167 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -111.61 146.0 38.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.969 0.414 . . . . 62.210000000000001 111.325 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -141.24 139.3 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.783 -0.644 . . . . 71.310000000000002 110.209 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -160.87 149.38 16.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.326 . . . . 75.219999999999999 111.423 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.99 129.93 42.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 45.210000000000001 110.263 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.39 27.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.506 . . . . 63.43 111.908 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -117.19 16.85 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 75.310000000000002 110.388 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.56 98.0 2.46 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.978 -0.629 . . . . 53.149999999999999 112.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.184 -0.912 . . . . 61.310000000000002 111.017 179.803 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . 0.437 ' C5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 119.035 -0.507 . . . . 75.329999999999998 112.002 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.5 p -131.27 140.66 49.85 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.835 0.709 . . . . 61.450000000000003 110.853 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -122.56 139.0 54.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.239999999999995 110.866 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.775 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -108.3 172.19 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 71.340000000000003 111.215 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.32 -62.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.340000000000003 110.965 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 74.530000000000001 111.232 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.775 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.5 m -112.1 121.41 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.692 -0.484 . . . . 62.439999999999998 109.692 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.5 t-20 -79.43 146.43 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 71.209999999999994 111.698 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -141.66 128.01 19.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 110.439 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.13 17.24 51.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.686 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.26 47.02 20.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 52.219999999999999 110.891 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.95 -37.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 63.219999999999999 112.887 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.36 155.63 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.781 0.324 . . . . 43.530000000000001 111.087 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.41 161.37 23.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 64.310000000000002 110.987 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.734 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.33 150.22 20.9 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.743 -0.662 . . . . 54.350000000000001 112.057 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -83.61 -10.39 58.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.697 0.284 . . . . 54.020000000000003 110.983 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.51 5.72 4.04 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.329 -0.396 . . . . 74.329999999999998 110.815 -178.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.67 -7.1 10.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.43 -0.35 . . . . 72.319999999999993 110.95 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.18 16.09 2.19 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.809 -0.71 . . . . 51.149999999999999 113.06 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -113.92 146.03 40.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.04 0.448 . . . . 74.230000000000004 111.261 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.1 138.74 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.848 -0.615 . . . . 53.539999999999999 110.295 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.77 149.56 16.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.516 -0.311 . . . . 55.439999999999998 111.419 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 130.38 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 62.32 110.199 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.17 165.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 73.140000000000001 111.87 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 p -117.82 16.63 14.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.533 -0.758 . . . . 53.219999999999999 110.339 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 97.82 2.43 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.987 -0.625 . . . . 51.020000000000003 112.513 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 74.439999999999998 110.89 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 118.947 -0.549 . . . . 44.030000000000001 112.089 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.2 p -152.07 151.32 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.95 0.781 . . . . 62.310000000000002 110.888 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -125.3 138.87 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.310000000000002 110.902 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.779 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.9 m -110.11 172.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 44.219999999999999 111.253 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 m -56.78 -62.58 1.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 52.43 111.031 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.6 m -147.46 129.23 15.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.394 . . . . 65.109999999999999 111.235 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.779 HG13 ' CG2' ' A' ' 4' ' ' VAL . 3.0 m -112.8 121.43 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.694 -0.484 . . . . 72.430000000000007 109.694 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.48 147.37 33.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 71.230000000000004 111.738 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -142.04 127.33 18.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 72.409999999999997 110.349 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.92 17.32 50.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.737 -0.744 . . . . 54.229999999999997 112.674 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 56.61 47.67 18.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.862 0.363 . . . . 73.129999999999995 110.911 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.48 -37.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.542 -0.837 . . . . 72.129999999999995 112.838 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -106.38 155.64 19.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.846 0.355 . . . . 74.310000000000002 111.099 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.96 161.96 21.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 32.530000000000001 110.918 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.36 150.24 21.46 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.931 -0.652 . . . . 61.210000000000001 112.081 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -82.89 -9.36 59.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.707 0.289 . . . . 73.109999999999999 110.901 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.453 ' O ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 75.41 5.78 4.09 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.312 -0.403 . . . . 43.340000000000003 110.787 -179.156 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.63 -6.87 10.16 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.497 -0.32 . . . . 62.119999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.25 2.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.648 -0.787 . . . . 14.31 113.125 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -108.51 146.03 33.84 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.068 0.434 . . . . 72.439999999999998 111.346 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 t -141.12 140.47 34.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 62.530000000000001 110.316 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -161.79 149.38 14.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 71.219999999999999 111.383 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 129.73 41.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.36 -0.382 . . . . 74.129999999999995 110.238 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.36 27.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.125 0.488 . . . . 65.519999999999996 111.948 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.19 16.59 14.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.557 -0.747 . . . . 71.150000000000006 110.325 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.39 97.89 2.44 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.035 -0.602 . . . . 75.239999999999995 112.527 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.197 -0.906 . . . . 61.240000000000002 110.968 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 118.975 -0.536 . . . . 64.239999999999995 111.972 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.8 p -140.31 155.09 46.95 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.897 0.748 . . . . 43.210000000000001 110.872 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -129.26 126.98 40.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 40.020000000000003 110.992 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.701 ' CG2' HG13 ' A' ' 7' ' ' VAL . 32.4 m -97.84 172.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 54.240000000000002 111.242 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 t -58.52 -62.58 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 45.520000000000003 110.97 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.5 m -148.02 133.14 18.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 75.230000000000004 111.244 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -116.83 121.32 67.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.755 -0.461 . . . . 71.530000000000001 109.755 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.6 t-20 -78.89 146.08 33.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 62.109999999999999 111.721 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.0 m-85 -141.27 128.79 21.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.5 -0.773 . . . . 75.120000000000005 110.3 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.15 51.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.764 -0.731 . . . . 43.329999999999998 112.621 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.6 m120 56.53 47.53 18.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.816 0.341 . . . . 74.120000000000005 110.943 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.92 -37.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.485 -0.864 . . . . 74.120000000000005 112.923 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 54.9 m-85 -106.34 155.56 19.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 72.409999999999997 111.192 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.49 160.42 24.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 110.948 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.742 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.46 150.83 21.25 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.86 -0.686 . . . . 44.25 112.16 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -85.36 -10.05 56.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.312 . . . . 52.140000000000001 110.952 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 1.2 m-20 72.83 7.79 5.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.33 -0.395 . . . . 75.120000000000005 110.679 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.71 -6.8 10.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 72.420000000000002 110.739 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 15.87 2.43 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.821 -0.704 . . . . 60.43 112.953 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -114.54 145.84 41.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.956 0.408 . . . . 74.310000000000002 111.356 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -141.12 137.22 32.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 61.140000000000001 110.227 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -159.37 149.29 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.412 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . . . -64.15 130.55 44.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 73.109999999999999 110.348 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -140.1 165.44 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.224 0.535 . . . . 71.430000000000007 111.885 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -105.78 -19.65 13.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 62.310000000000002 110.256 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 96.92 0.49 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.057 -0.592 . . . . 74.319999999999993 112.5 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.208 -0.901 . . . . 51.119999999999997 110.977 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 119.017 -0.516 . . . . 73.439999999999998 111.981 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.423 HG21 ' O5 ' ' A' ' 28' ' ' 3HD . 30.5 p -141.72 161.68 37.34 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.916 0.76 . . . . 61.409999999999997 110.792 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -137.2 128.1 27.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 75.109999999999999 110.964 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.669 ' CG2' HG13 ' A' ' 7' ' ' VAL . 31.5 m -100.14 172.17 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 43.140000000000001 111.276 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.5 p -58.62 -62.7 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.938 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.7 m -146.85 137.36 23.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 111.155 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -120.87 121.31 64.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.772 -0.455 . . . . 75.409999999999997 109.772 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -78.71 147.12 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.093 0.473 . . . . 63.509999999999998 111.801 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -142.09 128.17 19.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 73.219999999999999 110.392 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.34 17.69 47.54 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.737 -0.744 . . . . 13.25 112.65 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 56.23 46.7 20.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.794 0.33 . . . . 73.25 110.932 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.03 -38.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.512 -0.852 . . . . 63.240000000000002 112.908 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -106.42 155.77 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 73.129999999999995 111.072 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.23 162.84 20.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 61.520000000000003 111.029 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.758 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.51 150.43 21.63 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.902 -0.666 . . . . 71.120000000000005 112.067 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -82.27 -9.59 59.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.744 0.307 . . . . 73.219999999999999 110.98 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 2.5 t30 75.24 6.63 4.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.309 -0.405 . . . . 60.409999999999997 110.723 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -119.79 -6.8 10.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.329 -0.396 . . . . 72.329999999999998 110.929 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.26 10.29 3.08 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.743 -0.741 . . . . 42.539999999999999 113.13 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -108.84 146.97 32.82 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.055 0.455 . . . . 74.519999999999996 111.426 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.2 140.77 34.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.66 . . . . 42.409999999999997 110.249 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -162.53 148.96 12.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.486 -0.325 . . . . 73.329999999999998 111.302 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.75 130.71 46.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 64.420000000000002 110.231 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.4 p -140.1 165.36 27.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 71.430000000000007 111.936 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.3 p -106.58 -18.37 13.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.239999999999995 110.234 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.84 97.63 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.0 -0.619 . . . . 60.210000000000001 112.493 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.204 -0.903 . . . . 72.319999999999993 110.9 179.827 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . 0.423 ' O5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 118.982 -0.533 . . . . 63.240000000000002 112.028 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p -143.44 146.18 33.23 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.889 0.743 . . . . 72.209999999999994 110.936 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -120.82 127.24 51.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.934 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.78 ' CG2' HG13 ' A' ' 7' ' ' VAL . 34.6 m -100.17 172.18 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 111.211 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 t -55.65 -62.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.082 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -149.09 127.86 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 52.329999999999998 111.271 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.9 m -111.03 121.29 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.756 -0.461 . . . . 55.210000000000001 109.756 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -78.27 146.41 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.139 0.495 . . . . 64.340000000000003 111.73 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -141.18 128.41 20.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.563 -0.744 . . . . 71.340000000000003 110.333 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.78 50.47 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.74 -0.743 . . . . 71.510000000000005 112.703 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 m120 57.21 48.52 15.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 74.420000000000002 110.818 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.44 -36.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.506 -0.854 . . . . 52.039999999999999 112.987 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.44 155.7 19.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.943 0.401 . . . . 72.329999999999998 111.11 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.69 159.52 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 64.230000000000004 110.73 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.763 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.85 149.54 20.46 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.814 -0.708 . . . . 64.140000000000001 112.285 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -86.26 -7.95 58.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.673 0.273 . . . . 74.450000000000003 111.024 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.513 ' OD1' HG21 ' A' ' 7' ' ' VAL . 2.3 m-20 68.76 10.17 7.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.342 -0.39 . . . . 61.25 110.745 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 m -121.17 -5.5 9.46 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.335 -0.393 . . . . 32.219999999999999 110.736 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.96 16.86 2.87 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.949 -0.643 . . . . 60.340000000000003 112.832 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -116.42 145.74 43.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.998 0.428 . . . . 75.230000000000004 111.398 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -141.14 136.93 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 64.109999999999999 110.145 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.21 149.17 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.521 -0.308 . . . . 74.340000000000003 111.53 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.15 129.96 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 73.549999999999997 110.321 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.14 165.34 27.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 111.843 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.7 m -116.56 17.67 15.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.572 -0.74 . . . . 55.329999999999998 110.327 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.14 97.23 2.4 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.923 -0.656 . . . . 64.109999999999999 112.567 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.198 -0.905 . . . . 73.340000000000003 110.978 179.85 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 118.997 -0.525 . . . . 73.230000000000004 112.007 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -150.65 162.04 41.44 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.948 0.78 . . . . 71.319999999999993 110.817 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -140.49 141.43 35.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.963 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.713 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.4 m -112.22 172.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 111.183 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.87 -62.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 110.974 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -146.52 134.01 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 31.129999999999999 111.221 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.0 m -117.74 121.24 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.622 -0.51 . . . . 63.420000000000002 109.622 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -77.96 147.32 34.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.18 0.515 . . . . 74.430000000000007 111.747 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -142.22 126.84 17.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 73.150000000000006 110.319 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.06 17.38 51.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 31.199999999999999 112.661 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 56.41 47.19 19.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.896 0.379 . . . . 62.450000000000003 110.981 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.59 -38.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.587 -0.816 . . . . 55.009999999999998 112.871 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -106.43 155.71 19.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 74.519999999999996 111.02 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.17 162.27 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 75.510000000000005 110.884 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.49 150.84 21.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.916 -0.659 . . . . 44.240000000000002 112.196 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -82.5 -9.33 59.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 42.520000000000003 110.874 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 0.9 OUTLIER 76.25 5.07 3.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.298 -0.41 . . . . 73.25 110.876 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.93 -7.56 10.4 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.479 -0.328 . . . . 71.430000000000007 111.0 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.29 7.29 3.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.669 -0.777 . . . . 72.439999999999998 113.264 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -105.22 146.28 29.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 111.309 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.27 140.9 33.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 71.430000000000007 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -162.19 149.28 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 73.340000000000003 111.384 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 129.91 42.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 73.219999999999999 110.284 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.2 p -140.16 165.44 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.131 0.491 . . . . 62.130000000000003 111.898 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.1 p -116.89 16.22 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.543 -0.753 . . . . 71.209999999999994 110.389 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.53 97.5 2.43 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.895 -0.669 . . . . 72.340000000000003 112.484 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.252 -0.88 . . . . 62.130000000000003 110.907 179.817 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.723 0 CA-C-O 118.947 -0.549 . . . . 72.140000000000001 111.995 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.4 p -132.35 156.01 47.38 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.901 0.751 . . . . 65.340000000000003 110.885 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -132.61 127.47 35.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.938 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.731 ' CG2' HG13 ' A' ' 7' ' ' VAL . 34.4 m -102.37 172.23 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 54.409999999999997 111.106 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.9 p -55.46 -62.91 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 45.039999999999999 111.085 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.0 m -149.05 129.97 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 60.130000000000003 111.286 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -113.26 121.37 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.36 146.13 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.123 0.487 . . . . 51.409999999999997 111.706 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.03 128.5 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 72.239999999999995 110.269 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.4 16.79 51.08 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.754 -0.736 . . . . 32.530000000000001 112.643 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.1 48.65 15.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 74.140000000000001 110.808 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.53 -36.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.48 -0.866 . . . . 42.32 113.033 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -106.39 155.64 19.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 73.140000000000001 111.177 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.74 159.32 25.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 61.32 110.762 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.43 149.28 20.25 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.92 -0.657 . . . . 63.219999999999999 112.296 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 31.8 p-10 -85.95 -7.47 58.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 32.409999999999997 111.128 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.498 ' OD1' HG21 ' A' ' 7' ' ' VAL . 4.1 m-20 68.26 10.85 8.09 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.257 -0.429 . . . . 54.43 110.634 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -122.09 -5.02 8.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.441 -0.345 . . . . 74.439999999999998 110.79 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.47 16.74 3.05 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.827 -0.701 . . . . 74.230000000000004 112.85 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -116.53 145.98 42.94 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.992 0.425 . . . . 63.539999999999999 111.341 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 p -141.17 136.97 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 61.240000000000002 110.146 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.22 149.2 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 63.210000000000001 111.49 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 129.91 41.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 62.350000000000001 110.317 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.12 165.4 27.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.232 0.539 . . . . 73.510000000000005 111.81 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -116.71 17.25 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.501 -0.772 . . . . 71.450000000000003 110.36 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.87 97.56 2.44 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.973 -0.632 . . . . 65.430000000000007 112.559 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.249 -0.882 . . . . 73.150000000000006 110.97 179.865 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 118.995 -0.526 . . . . 75.310000000000002 111.988 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.459 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 61.0 p -148.82 159.89 43.74 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.866 0.729 . . . . 54.520000000000003 110.92 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -132.86 127.01 33.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 110.961 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.75 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.9 m -101.41 172.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 111.221 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.06 -62.91 1.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 60.310000000000002 111.005 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.4 m -147.7 130.33 15.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.3 -0.409 . . . . 45.210000000000001 111.255 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.767 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.0 m -113.96 121.28 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 61.229999999999997 109.709 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -78.73 146.34 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.184 0.516 . . . . 74.140000000000001 111.709 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.93 128.11 20.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 75.109999999999999 110.316 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.89 51.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.765 -0.731 . . . . 63.420000000000002 112.626 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.04 48.5 15.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.84 0.353 . . . . 62.450000000000003 110.91 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.27 -36.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.559 -0.829 . . . . 74.420000000000002 112.987 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.41 155.66 19.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 74.340000000000003 111.149 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.82 160.15 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.219999999999999 110.83 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.767 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.93 150.26 21.1 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.864 -0.684 . . . . 71.540000000000006 112.21 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 31.0 p-10 -86.26 -7.19 58.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.762 0.315 . . . . 63.32 111.095 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.499 ' OD1' HG11 ' A' ' 7' ' ' VAL . 3.6 m-20 68.49 10.34 7.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.277 -0.42 . . . . 73.310000000000002 110.759 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -121.85 -5.63 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.387 -0.37 . . . . 72.420000000000002 110.788 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.88 15.88 2.81 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.862 -0.685 . . . . 53.219999999999999 112.985 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.478 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 21.7 t30 -115.12 145.38 42.41 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.948 0.404 . . . . 62.530000000000001 111.402 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -141.15 136.32 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 71.409999999999997 110.202 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.478 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 36.3 p90 -158.27 149.22 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 73.209999999999994 111.383 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.97 41.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.355 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.16 165.34 27.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 60.240000000000002 111.895 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.87 -19.43 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.576 -0.738 . . . . 33.219999999999999 110.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.33 0.52 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.974 -0.631 . . . . 73.120000000000005 112.525 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.215 -0.897 . . . . 73.510000000000005 111.008 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . 0.459 ' C5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.644 0 CA-C-O 119.001 -0.523 . . . . 74.120000000000005 111.977 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.9 p -142.02 140.1 32.54 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.875 0.734 . . . . 73.409999999999997 110.799 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -127.03 128.75 46.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 52.329999999999998 110.912 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.747 ' CG2' HG13 ' A' ' 7' ' ' VAL . 31.0 m -88.58 172.19 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 72.310000000000002 111.308 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -59.41 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 34.409999999999997 110.891 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -146.0 131.54 18.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.388 -0.369 . . . . 63.229999999999997 111.253 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.747 HG13 ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -115.85 121.29 67.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.722 -0.473 . . . . 73.430000000000007 109.722 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.48 144.92 35.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.167 0.508 . . . . 64.319999999999993 111.733 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.4 m-85 -140.84 129.28 22.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 64.409999999999997 110.27 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.2 17.04 51.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.733 -0.746 . . . . 62.329999999999998 112.678 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 56.18 46.93 20.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 60.310000000000002 110.874 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.02 -37.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.517 -0.849 . . . . 64.140000000000001 112.939 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -106.45 155.68 19.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 74.230000000000004 111.134 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.8 158.79 28.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 110.817 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.703 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -135.89 151.76 20.8 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 73.219999999999999 112.21 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.53 -7.9 59.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.614 0.245 . . . . 63.450000000000003 110.921 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 79.26 1.63 2.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 60.409999999999997 111.024 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.1 m -113.69 -65.41 1.19 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.973 0.416 . . . . 54.229999999999997 110.084 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.59 25.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.858 -0.61 . . . . 72.140000000000001 112.476 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.536 ' ND2' ' CE3' ' A' ' 22' ' ' TRP . 14.4 t30 -118.13 145.05 45.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.04 0.448 . . . . 72.230000000000004 111.446 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t -141.18 134.84 30.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 71.439999999999998 110.15 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.536 ' CE3' ' ND2' ' A' ' 20' ' ' ASN . 34.6 p90 -158.03 149.27 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.812 0.339 . . . . 71.540000000000006 111.4 -178.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 131.85 48.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.229 -0.441 . . . . 51.409999999999997 110.292 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.15 165.36 27.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.521 . . . . 60.229999999999997 111.885 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.7 t -117.06 16.28 15.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.467 -0.788 . . . . 73.439999999999998 110.396 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.85 96.88 2.41 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.997 -0.62 . . . . 52.240000000000002 112.505 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 44.310000000000002 110.949 179.893 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.882 0.373 . . . . 55.119999999999997 110.839 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -134.1 139.57 46.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.030000000000001 110.925 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.733 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -109.67 172.19 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.416 . . . . 71.519999999999996 111.222 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 m -56.79 -62.94 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.120000000000005 110.996 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.8 m -147.17 132.5 18.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.316 -0.402 . . . . 72.120000000000005 111.238 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -116.22 121.29 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.703 -0.48 . . . . 72.319999999999993 109.703 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.13 146.62 33.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 54.340000000000003 111.713 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -141.71 128.09 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.539 -0.755 . . . . 63.130000000000003 110.322 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 17.28 51.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 44.030000000000001 112.685 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.38 47.78 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 73.340000000000003 110.939 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.04 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.571 -0.823 . . . . 75.349999999999994 112.891 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.39 155.61 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 73.310000000000002 111.091 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.2 m -122.36 161.89 22.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 61.109999999999999 110.988 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.747 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.68 150.99 21.75 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.898 -0.667 . . . . 32.530000000000001 112.141 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -83.8 -9.6 58.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.697 0.285 . . . . 71.540000000000006 110.991 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 75.75 5.41 3.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.361 -0.381 . . . . 62.530000000000001 110.81 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.98 -7.21 10.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.501 -0.318 . . . . 52.049999999999997 110.903 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 11.77 2.7 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.75 -0.738 . . . . 71.439999999999998 113.17 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -109.18 146.11 34.69 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.963 0.411 . . . . 72.409999999999997 111.304 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.22 139.24 33.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.864 -0.607 . . . . 72.319999999999993 110.396 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -161.0 149.38 16.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.529 -0.305 . . . . 71.319999999999993 111.368 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.48 130.16 43.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 73.420000000000002 110.344 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.6 p -140.14 165.41 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 75.329999999999998 111.914 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -106.1 -20.5 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.502 -0.772 . . . . 44.240000000000002 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.69 97.03 0.47 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.993 -0.622 . . . . 33.229999999999997 112.485 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.889 . . . . 54.329999999999998 110.93 179.895 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.855 0.359 . . . . 61.119999999999997 110.762 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -139.84 144.28 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 33.439999999999998 110.899 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.696 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.7 m -112.33 172.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 73.140000000000001 111.177 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.83 -62.82 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 63.25 110.921 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -147.14 135.16 21.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 72.329999999999998 111.224 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.9 m -118.74 121.33 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.664 -0.495 . . . . 54.409999999999997 109.664 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.2 t-20 -78.81 147.24 33.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 64.129999999999995 111.789 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.9 m-85 -142.12 127.58 18.91 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.49 -0.777 . . . . 61.32 110.332 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.35 51.01 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 73.219999999999999 112.671 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.56 47.52 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 110.905 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.46 -37.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.654 -0.784 . . . . 61.539999999999999 112.926 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -106.35 155.74 19.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 74.109999999999999 111.094 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.39 162.21 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.44 . . . . 55.420000000000002 110.947 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.76 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.27 150.84 21.85 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.776 -0.647 . . . . 51.109999999999999 112.114 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -83.07 -9.42 59.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.769 0.319 . . . . 74.219999999999999 111.047 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.45 4.79 3.59 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.333 -0.394 . . . . 74.239999999999995 110.86 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.66 -7.89 10.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.497 -0.32 . . . . 60.219999999999999 110.906 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.88 9.11 2.87 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.759 -0.734 . . . . 64.129999999999995 113.262 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -106.34 146.25 30.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.027 0.442 . . . . 64.129999999999995 111.315 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -141.2 139.88 33.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 64.420000000000002 110.356 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -161.64 149.35 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.328 . . . . 54.219999999999999 111.325 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.31 129.96 42.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 65.510000000000005 110.354 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.13 165.36 27.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 73.340000000000003 111.926 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 p -106.06 -19.62 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 51.030000000000001 110.332 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.92 96.84 0.5 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.009 -0.615 . . . . 63.420000000000002 112.522 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.252 -0.88 . . . . 55.329999999999998 110.95 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.827 0.346 . . . . 54.420000000000002 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.5 m -116.14 144.73 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.911 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.724 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -111.37 172.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.419 . . . . 72.510000000000005 111.215 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 p -57.14 -62.69 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 74.349999999999994 111.002 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -148.74 131.54 16.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 52.149999999999999 111.236 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -115.53 121.35 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.767 -0.457 . . . . 73.219999999999999 109.767 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.1 t-20 -78.93 146.58 33.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.184 0.516 . . . . 64.219999999999999 111.734 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -141.58 128.36 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.466 -0.788 . . . . 74.439999999999998 110.328 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.64 16.55 51.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.818 -0.706 . . . . 74.319999999999993 112.687 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 57.28 49.15 13.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 71.319999999999993 110.817 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.59 -36.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.486 -0.864 . . . . 71.530000000000001 112.876 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.34 155.71 19.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 75.519999999999996 111.061 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.49 160.51 25.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 55.32 111.0 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.75 150.13 20.98 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.946 -0.645 . . . . 71.129999999999995 112.11 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -83.39 -9.76 58.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.711 0.291 . . . . 75.409999999999997 110.969 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 76.21 4.76 3.71 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.326 -0.397 . . . . 72.140000000000001 110.86 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.09 -8.29 10.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.456 -0.338 . . . . 45.229999999999997 110.845 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.9 11.66 2.56 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.724 -0.751 . . . . 64.239999999999995 113.075 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -108.62 146.35 33.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.999 0.428 . . . . 44.450000000000003 111.309 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.17 139.58 33.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.848 -0.615 . . . . 65.140000000000001 110.303 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -160.91 149.46 16.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.45 -0.341 . . . . 73.140000000000001 111.43 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.09 129.75 41.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 74.230000000000004 110.251 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.16 165.39 27.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.118 0.485 . . . . 63.549999999999997 111.867 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.51 17.01 14.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 63.420000000000002 110.338 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.84 97.73 2.45 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.958 -0.639 . . . . 42.520000000000003 112.607 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.325 -0.845 . . . . 71.109999999999999 110.884 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.0 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.868 0.366 . . . . 63.32 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.9 m -132.18 127.52 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 110.977 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.695 ' CG2' HG13 ' A' ' 7' ' ' VAL . 28.1 m -101.47 172.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 53.340000000000003 111.353 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 t -60.64 -61.87 2.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 73.150000000000006 111.052 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.7 m -149.24 134.28 18.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 61.329999999999998 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.8 m -120.04 121.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 40.039999999999999 109.798 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -77.57 146.28 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.112 0.482 . . . . 75.409999999999997 111.762 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -140.89 128.52 21.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.557 -0.747 . . . . 60.32 110.309 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.69 50.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.617 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 57.55 49.19 13.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.866 0.365 . . . . 74.540000000000006 110.861 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.62 -36.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.475 -0.869 . . . . 65.219999999999999 113.013 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -106.43 155.76 19.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.912 0.387 . . . . 52.140000000000001 111.171 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -121.19 158.07 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 60.219999999999999 110.923 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.766 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -136.84 149.53 20.24 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.806 -0.634 . . . . 72.329999999999998 112.091 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -85.73 -11.59 53.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 74.349999999999994 110.987 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 74.34 7.33 4.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 52.439999999999998 110.602 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.53 -6.1 10.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.316 -0.402 . . . . 60.450000000000003 110.767 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.69 17.94 2.51 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.903 -0.665 . . . . 43.140000000000001 112.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.401 ' OD1' ' CE3' ' A' ' 22' ' ' TRP . 5.3 t-20 -116.17 145.29 43.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.993 0.425 . . . . 74.540000000000006 111.371 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 p -141.07 137.09 32.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.601 . . . . 54.229999999999997 110.276 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.401 ' CE3' ' OD1' ' A' ' 20' ' ' ASN . 37.4 p90 -158.61 149.28 20.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.799 0.333 . . . . 74.209999999999994 111.471 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.29 129.3 39.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.156 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.1 165.41 27.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.197 0.522 . . . . 64.209999999999994 111.934 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.33 16.28 14.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 62.43 110.319 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.09 96.45 2.46 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.036 -0.602 . . . . 75.209999999999994 112.494 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.274 -0.869 . . . . 62.140000000000001 110.923 179.891 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.6 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.778 0.323 . . . . 72.329999999999998 110.89 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -129.68 138.3 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.728 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -110.2 172.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.120000000000005 111.195 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -56.76 -62.94 1.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 75.209999999999994 110.924 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.9 m -147.91 131.69 16.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.247 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.4 m -115.33 121.31 66.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.759 -0.46 . . . . 63.130000000000003 109.759 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.32 146.21 33.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.471 . . . . 73.310000000000002 111.768 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.3 m-85 -141.43 128.43 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.563 -0.744 . . . . 74.209999999999994 110.349 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.0 51.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.319999999999993 112.644 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 56.38 47.49 18.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 75.150000000000006 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.72 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.572 -0.823 . . . . 74.450000000000003 112.916 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.38 155.65 19.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 111.102 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.51 160.75 24.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 54.119999999999997 110.983 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.729 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.88 150.61 20.96 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.747 -0.66 . . . . 55.219999999999999 112.108 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -84.0 -10.29 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.702 0.287 . . . . 73.519999999999996 111.0 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 75.25 6.2 4.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.368 -0.378 . . . . 72.140000000000001 110.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.17 -6.64 9.91 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.461 -0.336 . . . . 61.420000000000002 111.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.85 15.69 2.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.744 -0.741 . . . . 55.340000000000003 113.166 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.37 146.31 39.68 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.972 0.415 . . . . 72.430000000000007 111.375 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.16 138.41 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 55.329999999999998 110.3 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -160.67 149.46 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.81 0.338 . . . . 75.530000000000001 111.344 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 130.56 44.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.274 -0.421 . . . . 64.540000000000006 110.244 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.12 165.39 27.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.144 0.497 . . . . 64.409999999999997 111.932 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -117.9 15.96 14.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.51 -0.768 . . . . 65.150000000000006 110.38 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.37 98.4 2.51 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.984 -0.627 . . . . 40.340000000000003 112.559 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.225 -0.893 . . . . 72.230000000000004 110.917 179.923 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.814 0.34 . . . . 51.409999999999997 110.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -116.13 145.33 43.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.866 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.71 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -112.33 172.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 71.340000000000003 111.227 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.93 -62.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 60.219999999999999 111.023 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.1 m -147.82 133.81 19.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.419 . . . . 55.009999999999998 111.265 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.1 m -117.27 121.27 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.764 -0.458 . . . . 53.109999999999999 109.764 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.4 t-20 -78.56 147.4 33.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.742 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.8 m-85 -142.15 127.26 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.764 . . . . 71.329999999999998 110.356 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.16 17.17 51.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.732 -0.747 . . . . 72.519999999999996 112.707 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.66 47.94 17.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 74.319999999999993 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.99 -37.43 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.545 -0.836 . . . . 42.020000000000003 112.878 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.41 155.7 19.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 61.210000000000001 110.999 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.15 161.81 22.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 110.975 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.765 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.92 150.21 21.32 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.93 -0.653 . . . . 71.329999999999998 112.118 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -82.45 -9.56 59.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 72.109999999999999 111.007 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.3 4.91 3.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.318 -0.401 . . . . 62.509999999999998 110.866 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.58 -8.04 10.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.427 -0.351 . . . . 72.310000000000002 110.967 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.52 10.2 2.71 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 113.19 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -107.52 146.57 31.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.041 0.448 . . . . 74.420000000000002 111.282 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -141.2 140.57 34.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.825 -0.625 . . . . 72.430000000000007 110.342 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -161.76 149.43 14.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.317 . . . . 71.109999999999999 111.373 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 129.66 41.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 64.540000000000006 110.265 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.11 165.41 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.201 0.524 . . . . 61.130000000000003 111.887 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -117.24 16.39 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.541 -0.754 . . . . 63.210000000000001 110.313 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.01 97.99 2.47 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.061 -0.59 . . . . 65.420000000000002 112.54 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.266 -0.873 . . . . 72.150000000000006 110.933 179.88 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.767 0.318 . . . . 65.310000000000002 110.894 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -116.16 138.6 51.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 71.109999999999999 110.817 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.786 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -108.55 172.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.248 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -57.48 -62.75 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 43.240000000000002 110.944 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.52 130.07 15.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 111.232 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.786 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.7 m -113.93 121.33 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.738 -0.467 . . . . 65.209999999999994 109.738 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.71 146.51 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.081 0.467 . . . . 63.25 111.66 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -141.53 128.17 20.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.608 -0.724 . . . . 72.540000000000006 110.4 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.22 17.12 51.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.219999999999999 112.678 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 m120 56.39 47.36 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.354 . . . . 73.239999999999995 110.93 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 64.420000000000002 112.879 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -106.44 155.69 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 62.229999999999997 111.06 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.21 161.56 23.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 74.540000000000006 110.947 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.741 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.03 150.78 21.42 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.76 -0.654 . . . . 72.319999999999993 112.173 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -84.04 -10.49 57.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.639 0.257 . . . . 60.119999999999997 110.931 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 75.5 5.89 4.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.37 -0.377 . . . . 75.140000000000001 110.762 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -119.8 -6.84 10.08 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.416 -0.356 . . . . 62.450000000000003 110.873 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 16.06 2.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.82 -0.705 . . . . 52.219999999999999 113.07 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.74 145.7 40.97 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.0 0.429 . . . . 74.310000000000002 111.312 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 p -141.03 138.52 33.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 63.229999999999997 110.316 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.4 149.53 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 74.420000000000002 111.376 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 130.19 43.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.32 -0.4 . . . . 63.340000000000003 110.31 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.9 p -140.17 165.35 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.508 . . . . 72.430000000000007 111.834 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.09 -19.83 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.474 -0.784 . . . . 73.519999999999996 110.316 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 97.56 0.53 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.01 -0.614 . . . . 71.219999999999999 112.514 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.212 -0.899 . . . . 51.049999999999997 110.962 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 p . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.766 0.317 . . . . 65.109999999999999 110.921 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.4 m -132.09 147.16 52.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 33.43 110.843 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.716 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.7 m -115.95 172.2 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 63.119999999999997 111.202 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.6 -62.79 1.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 51.439999999999998 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.2 m -147.75 133.22 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 52.020000000000003 111.319 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.8 m -117.21 121.31 67.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.584 -0.525 . . . . 61.149999999999999 109.584 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.0 t-20 -78.5 147.07 34.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 74.209999999999994 111.798 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -142.03 127.24 18.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 64.430000000000007 110.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.39 17.18 52.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.712 -0.756 . . . . 20.300000000000001 112.653 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.53 47.81 17.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 53.229999999999997 110.945 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.87 -37.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.515 -0.85 . . . . 41.149999999999999 112.867 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -106.44 155.64 19.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.843 0.354 . . . . 64.510000000000005 111.084 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.01 161.8 22.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 73.209999999999994 110.964 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.765 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.94 150.95 21.81 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.15 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -83.87 -9.83 58.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.675 0.274 . . . . 63.439999999999998 111.003 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 76.29 4.96 3.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.337 -0.392 . . . . 62.520000000000003 110.837 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.31 -7.81 10.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.544 -0.298 . . . . 71.409999999999997 110.912 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.75 2.78 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.73 -0.747 . . . . 72.349999999999994 113.134 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -107.95 146.04 32.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 72.519999999999996 111.339 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.16 139.06 33.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 72.430000000000007 110.327 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -160.49 149.36 16.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.348 . . . . 73.439999999999998 111.337 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.62 129.78 41.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 54.149999999999999 110.302 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.18 165.3 27.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.192 0.52 . . . . 55.32 111.863 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 p -105.35 -21.08 13.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.522 -0.763 . . . . 73.409999999999997 110.282 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.32 96.4 0.42 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.913 -0.66 . . . . 52.310000000000002 112.502 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.225 -0.893 . . . . 74.510000000000005 110.937 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.1 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.785 0.326 . . . . 63.409999999999997 110.889 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.97 138.34 51.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.729 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.4 m -109.25 172.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 54.310000000000002 111.197 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -62.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.939 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -148.81 130.02 14.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 64.239999999999995 111.227 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.729 HG13 ' CG2' ' A' ' 4' ' ' VAL . 1.7 m -113.81 121.35 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.763 -0.458 . . . . 62.25 109.763 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.86 145.21 32.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 65.129999999999995 111.739 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.8 m-85 -141.0 129.19 22.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.541 -0.754 . . . . 73.420000000000002 110.362 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.98 51.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.575 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.0 46.59 21.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.874 0.369 . . . . 54.520000000000003 110.891 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -37.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 24.109999999999999 112.982 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -106.48 155.67 19.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 64.239999999999995 110.997 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.6 159.84 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 52.350000000000001 110.939 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.689 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -135.8 150.3 20.3 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.865 -0.684 . . . . 73.530000000000001 112.084 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -84.14 -10.86 57.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.713 0.292 . . . . 52.43 111.003 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 75.25 6.12 4.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 74.329999999999998 110.685 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.38 -6.21 9.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.492 -0.322 . . . . 72.129999999999995 111.027 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.52 18.53 2.21 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.806 -0.712 . . . . 40.039999999999999 113.054 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -116.53 146.47 42.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 72.310000000000002 111.312 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 p -141.17 138.66 33.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 71.219999999999999 110.241 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.62 149.63 16.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 74.140000000000001 111.417 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 130.84 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 63.219999999999999 110.207 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.13 165.38 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 73.439999999999998 111.966 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.5 t -118.61 16.38 13.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.519 -0.764 . . . . 62.32 110.324 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.19 97.6 2.46 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.034 -0.603 . . . . 74.319999999999993 112.529 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.177 -0.916 . . . . 74.140000000000001 111.008 179.819 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.743 0.306 . . . . 62.32 110.939 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.91 138.95 50.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 62.350000000000001 110.867 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.714 ' CG2' HG13 ' A' ' 7' ' ' VAL . 32.9 m -106.6 172.15 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.245 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -57.29 -63.07 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 73.510000000000005 110.935 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.0 m -148.87 131.16 15.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 63.43 111.282 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.714 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.6 m -113.98 121.37 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.761 -0.459 . . . . 65.219999999999999 109.761 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.93 146.12 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.121 0.486 . . . . 45.210000000000001 111.721 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.7 m-85 -141.66 128.15 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.521 -0.763 . . . . 71.140000000000001 110.337 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.18 51.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 73.310000000000002 112.6 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.09 46.94 20.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 60.420000000000002 110.902 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -38.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.583 -0.817 . . . . 44.039999999999999 112.937 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -106.46 155.69 19.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 111.045 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.2 m -122.5 161.27 23.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.978 0.418 . . . . 61.350000000000001 111.021 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.684 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -136.78 150.92 20.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.792 -0.64 . . . . 54.030000000000001 112.106 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -84.35 -11.08 56.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.79 0.329 . . . . 73.109999999999999 111.067 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 76.05 5.28 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.322 -0.399 . . . . 62.43 110.724 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.21 -6.97 10.35 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.445 -0.343 . . . . 43.240000000000002 110.933 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 17.75 2.15 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.758 -0.734 . . . . 74.239999999999995 112.995 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -115.3 146.6 41.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.971 0.415 . . . . 75.340000000000003 111.288 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.17 138.44 33.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.868 -0.605 . . . . 40.119999999999997 110.284 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -160.58 149.48 16.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 63.539999999999999 111.355 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.24 130.9 46.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.388 . . . . 75.140000000000001 110.239 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.13 165.4 27.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.128 0.489 . . . . 73.329999999999998 111.894 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.63 16.18 14.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.537 -0.756 . . . . 44.329999999999998 110.386 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.45 97.42 2.42 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.955 -0.64 . . . . 75.409999999999997 112.569 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 74.219999999999999 110.908 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.836 0.351 . . . . 52.049999999999997 110.956 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -124.23 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 53.109999999999999 110.956 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.732 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -110.81 172.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 111.234 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -62.89 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 111.053 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.3 m -147.29 132.41 18.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 54.32 111.318 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -116.63 121.34 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.732 -0.47 . . . . 74.439999999999998 109.732 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.82 146.2 33.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.749 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.1 m-85 -141.51 128.22 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.533 -0.758 . . . . 55.020000000000003 110.31 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.77 52.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.747 -0.74 . . . . 61.130000000000003 112.57 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.75 48.18 16.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.845 0.355 . . . . 74.319999999999993 110.843 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.87 -36.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.536 -0.84 . . . . 72.25 112.895 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -106.36 155.76 19.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.847 0.356 . . . . 63.219999999999999 111.165 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -121.91 160.95 23.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 110.878 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.737 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.06 150.63 21.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.917 -0.658 . . . . 44.409999999999997 112.227 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -83.83 -10.09 58.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.689 0.28 . . . . 54.009999999999998 110.989 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 74.95 6.57 4.31 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.342 -0.39 . . . . 60.329999999999998 110.765 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.13 -6.62 9.93 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.381 -0.372 . . . . 60.350000000000001 110.89 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.45 13.4 2.58 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.824 -0.703 . . . . 51.409999999999997 113.167 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -111.61 146.0 38.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.969 0.414 . . . . 62.210000000000001 111.325 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -141.24 139.3 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.783 -0.644 . . . . 71.310000000000002 110.209 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -160.87 149.38 16.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.326 . . . . 75.219999999999999 111.423 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.99 129.93 42.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 45.210000000000001 110.263 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.39 27.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.506 . . . . 63.43 111.908 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -117.19 16.85 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 75.310000000000002 110.388 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.56 98.0 2.46 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.978 -0.629 . . . . 53.149999999999999 112.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.184 -0.912 . . . . 61.310000000000002 111.017 179.803 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.83 0.348 . . . . 61.450000000000003 110.853 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -122.56 139.0 54.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.239999999999995 110.866 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.775 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -108.3 172.19 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 71.340000000000003 111.215 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.32 -62.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.340000000000003 110.965 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 74.530000000000001 111.232 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.775 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.5 m -112.1 121.41 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.692 -0.484 . . . . 62.439999999999998 109.692 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.5 t-20 -79.43 146.43 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 71.209999999999994 111.698 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -141.66 128.01 19.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 110.439 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.13 17.24 51.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.686 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.26 47.02 20.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 52.219999999999999 110.891 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.95 -37.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 63.219999999999999 112.887 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.36 155.63 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.781 0.324 . . . . 43.530000000000001 111.087 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.41 161.37 23.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 64.310000000000002 110.987 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.734 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.33 150.22 20.9 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.743 -0.662 . . . . 54.350000000000001 112.057 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -83.61 -10.39 58.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.697 0.284 . . . . 54.020000000000003 110.983 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 75.51 5.72 4.04 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.329 -0.396 . . . . 74.329999999999998 110.815 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.67 -7.1 10.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.43 -0.35 . . . . 72.319999999999993 110.95 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.18 16.09 2.19 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.809 -0.71 . . . . 51.149999999999999 113.06 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -113.92 146.03 40.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.04 0.448 . . . . 74.230000000000004 111.261 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.1 138.74 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.848 -0.615 . . . . 53.539999999999999 110.295 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.77 149.56 16.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.516 -0.311 . . . . 55.439999999999998 111.419 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 130.38 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 62.32 110.199 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.17 165.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 73.140000000000001 111.87 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 p -117.82 16.63 14.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.533 -0.758 . . . . 53.219999999999999 110.339 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 97.82 2.43 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.987 -0.625 . . . . 51.020000000000003 112.513 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 74.439999999999998 110.89 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.867 0.365 . . . . 62.310000000000002 110.888 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -125.3 138.87 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.310000000000002 110.902 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.779 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.9 m -110.11 172.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 44.219999999999999 111.253 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 m -56.78 -62.58 1.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 52.43 111.031 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.6 m -147.46 129.23 15.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.394 . . . . 65.109999999999999 111.235 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.779 HG13 ' CG2' ' A' ' 4' ' ' VAL . 3.0 m -112.8 121.43 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.694 -0.484 . . . . 72.430000000000007 109.694 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.48 147.37 33.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 71.230000000000004 111.738 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -142.04 127.33 18.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 72.409999999999997 110.349 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.92 17.32 50.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.737 -0.744 . . . . 54.229999999999997 112.674 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 56.61 47.67 18.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.862 0.363 . . . . 73.129999999999995 110.911 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.48 -37.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.542 -0.837 . . . . 72.129999999999995 112.838 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -106.38 155.64 19.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.846 0.355 . . . . 74.310000000000002 111.099 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.96 161.96 21.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 32.530000000000001 110.918 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.36 150.24 21.46 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.931 -0.652 . . . . 61.210000000000001 112.081 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -82.89 -9.36 59.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.707 0.289 . . . . 73.109999999999999 110.901 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 75.41 5.78 4.09 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.312 -0.403 . . . . 43.340000000000003 110.787 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.63 -6.87 10.16 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.497 -0.32 . . . . 62.119999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.25 2.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.648 -0.787 . . . . 14.31 113.125 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -108.51 146.03 33.84 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.068 0.434 . . . . 72.439999999999998 111.346 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 t -141.12 140.47 34.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 62.530000000000001 110.316 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -161.79 149.38 14.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 71.219999999999999 111.383 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 129.73 41.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.36 -0.382 . . . . 74.129999999999995 110.238 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.36 27.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.125 0.488 . . . . 65.519999999999996 111.948 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.19 16.59 14.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.557 -0.747 . . . . 71.150000000000006 110.325 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.39 97.89 2.44 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.035 -0.602 . . . . 75.239999999999995 112.527 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.197 -0.906 . . . . 61.240000000000002 110.968 179.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.8 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.78 0.324 . . . . 43.210000000000001 110.872 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -129.26 126.98 40.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 40.020000000000003 110.992 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.701 ' CG2' HG13 ' A' ' 7' ' ' VAL . 32.4 m -97.84 172.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 54.240000000000002 111.242 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 t -58.52 -62.58 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 45.520000000000003 110.97 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.5 m -148.02 133.14 18.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 75.230000000000004 111.244 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -116.83 121.32 67.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.755 -0.461 . . . . 71.530000000000001 109.755 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.6 t-20 -78.89 146.08 33.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 62.109999999999999 111.721 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.0 m-85 -141.27 128.79 21.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.5 -0.773 . . . . 75.120000000000005 110.3 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.15 51.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.764 -0.731 . . . . 43.329999999999998 112.621 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.6 m120 56.53 47.53 18.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.816 0.341 . . . . 74.120000000000005 110.943 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.92 -37.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.485 -0.864 . . . . 74.120000000000005 112.923 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 54.9 m-85 -106.34 155.56 19.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 72.409999999999997 111.192 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.49 160.42 24.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 110.948 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.742 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.46 150.83 21.25 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.86 -0.686 . . . . 44.25 112.16 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -85.36 -10.05 56.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.312 . . . . 52.140000000000001 110.952 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 1.2 m-20 72.83 7.79 5.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.33 -0.395 . . . . 75.120000000000005 110.679 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.71 -6.8 10.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 72.420000000000002 110.739 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 15.87 2.43 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.821 -0.704 . . . . 60.43 112.953 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -114.54 145.84 41.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.956 0.408 . . . . 74.310000000000002 111.356 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -141.12 137.22 32.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 61.140000000000001 110.227 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -159.37 149.29 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.412 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . . . -64.15 130.55 44.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 73.109999999999999 110.348 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -140.1 165.44 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.224 0.535 . . . . 71.430000000000007 111.885 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -105.78 -19.65 13.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 62.310000000000002 110.256 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 96.92 0.49 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.057 -0.592 . . . . 74.319999999999993 112.5 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.208 -0.901 . . . . 51.119999999999997 110.977 179.928 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.843 0.354 . . . . 61.409999999999997 110.792 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -137.2 128.1 27.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 75.109999999999999 110.964 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.669 ' CG2' HG13 ' A' ' 7' ' ' VAL . 31.5 m -100.14 172.17 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 43.140000000000001 111.276 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.5 p -58.62 -62.7 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.938 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.7 m -146.85 137.36 23.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 111.155 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -120.87 121.31 64.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.772 -0.455 . . . . 75.409999999999997 109.772 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -78.71 147.12 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.093 0.473 . . . . 63.509999999999998 111.801 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -142.09 128.17 19.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 73.219999999999999 110.392 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.34 17.69 47.54 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.737 -0.744 . . . . 13.25 112.65 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 56.23 46.7 20.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.794 0.33 . . . . 73.25 110.932 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.03 -38.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.512 -0.852 . . . . 63.240000000000002 112.908 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -106.42 155.77 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 73.129999999999995 111.072 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.23 162.84 20.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 61.520000000000003 111.029 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.758 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.51 150.43 21.63 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.902 -0.666 . . . . 71.120000000000005 112.067 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -82.27 -9.59 59.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.744 0.307 . . . . 73.219999999999999 110.98 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 2.5 t30 75.24 6.63 4.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.309 -0.405 . . . . 60.409999999999997 110.723 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -119.79 -6.8 10.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.329 -0.396 . . . . 72.329999999999998 110.929 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.26 10.29 3.08 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.743 -0.741 . . . . 42.539999999999999 113.13 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -108.84 146.97 32.82 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.055 0.455 . . . . 74.519999999999996 111.426 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.2 140.77 34.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.66 . . . . 42.409999999999997 110.249 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -162.53 148.96 12.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.486 -0.325 . . . . 73.329999999999998 111.302 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.75 130.71 46.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 64.420000000000002 110.231 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.4 p -140.1 165.36 27.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 71.430000000000007 111.936 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.3 p -106.58 -18.37 13.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.239999999999995 110.234 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.84 97.63 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.0 -0.619 . . . . 60.210000000000001 112.493 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.204 -0.903 . . . . 72.319999999999993 110.9 179.827 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.802 0.334 . . . . 72.209999999999994 110.936 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -120.82 127.24 51.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.934 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.78 ' CG2' HG13 ' A' ' 7' ' ' VAL . 34.6 m -100.17 172.18 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 111.211 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 t -55.65 -62.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.082 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -149.09 127.86 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 52.329999999999998 111.271 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.9 m -111.03 121.29 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.756 -0.461 . . . . 55.210000000000001 109.756 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -78.27 146.41 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.139 0.495 . . . . 64.340000000000003 111.73 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -141.18 128.41 20.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.563 -0.744 . . . . 71.340000000000003 110.333 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.78 50.47 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.74 -0.743 . . . . 71.510000000000005 112.703 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 m120 57.21 48.52 15.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 74.420000000000002 110.818 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.44 -36.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.506 -0.854 . . . . 52.039999999999999 112.987 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.44 155.7 19.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.943 0.401 . . . . 72.329999999999998 111.11 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.69 159.52 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 64.230000000000004 110.73 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.763 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.85 149.54 20.46 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.814 -0.708 . . . . 64.140000000000001 112.285 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -86.26 -7.95 58.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.673 0.273 . . . . 74.450000000000003 111.024 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.513 ' OD1' HG21 ' A' ' 7' ' ' VAL . 2.3 m-20 68.76 10.17 7.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.342 -0.39 . . . . 61.25 110.745 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 m -121.17 -5.5 9.46 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.335 -0.393 . . . . 32.219999999999999 110.736 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.96 16.86 2.87 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.949 -0.643 . . . . 60.340000000000003 112.832 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -116.42 145.74 43.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.998 0.428 . . . . 75.230000000000004 111.398 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -141.14 136.93 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 64.109999999999999 110.145 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.21 149.17 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.521 -0.308 . . . . 74.340000000000003 111.53 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.15 129.96 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 73.549999999999997 110.321 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.14 165.34 27.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 111.843 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.7 m -116.56 17.67 15.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.572 -0.74 . . . . 55.329999999999998 110.327 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.14 97.23 2.4 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.923 -0.656 . . . . 64.109999999999999 112.567 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.198 -0.905 . . . . 73.340000000000003 110.978 179.85 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.849 0.357 . . . . 71.319999999999993 110.817 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -140.49 141.43 35.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.963 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.713 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.4 m -112.22 172.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 111.183 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.87 -62.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 110.974 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -146.52 134.01 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 31.129999999999999 111.221 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.0 m -117.74 121.24 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.622 -0.51 . . . . 63.420000000000002 109.622 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -77.96 147.32 34.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.18 0.515 . . . . 74.430000000000007 111.747 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -142.22 126.84 17.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 73.150000000000006 110.319 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.06 17.38 51.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 31.199999999999999 112.661 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 56.41 47.19 19.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.896 0.379 . . . . 62.450000000000003 110.981 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.59 -38.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.587 -0.816 . . . . 55.009999999999998 112.871 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -106.43 155.71 19.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 74.519999999999996 111.02 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.17 162.27 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 75.510000000000005 110.884 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.49 150.84 21.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.916 -0.659 . . . . 44.240000000000002 112.196 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -82.5 -9.33 59.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 42.520000000000003 110.874 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 0.9 OUTLIER 76.25 5.07 3.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.298 -0.41 . . . . 73.25 110.876 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.93 -7.56 10.4 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.479 -0.328 . . . . 71.430000000000007 111.0 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.29 7.29 3.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.669 -0.777 . . . . 72.439999999999998 113.264 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -105.22 146.28 29.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 111.309 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.27 140.9 33.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 71.430000000000007 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -162.19 149.28 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 73.340000000000003 111.384 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 129.91 42.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 73.219999999999999 110.284 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.2 p -140.16 165.44 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.131 0.491 . . . . 62.130000000000003 111.898 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.1 p -116.89 16.22 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.543 -0.753 . . . . 71.209999999999994 110.389 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.53 97.5 2.43 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.895 -0.669 . . . . 72.340000000000003 112.484 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.252 -0.88 . . . . 62.130000000000003 110.907 179.817 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.4 p . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.789 0.328 . . . . 65.340000000000003 110.885 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -132.61 127.47 35.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.938 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.731 ' CG2' HG13 ' A' ' 7' ' ' VAL . 34.4 m -102.37 172.23 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 54.409999999999997 111.106 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.9 p -55.46 -62.91 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 45.039999999999999 111.085 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.0 m -149.05 129.97 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 60.130000000000003 111.286 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -113.26 121.37 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.36 146.13 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.123 0.487 . . . . 51.409999999999997 111.706 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.03 128.5 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 72.239999999999995 110.269 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.4 16.79 51.08 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.754 -0.736 . . . . 32.530000000000001 112.643 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.1 48.65 15.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 74.140000000000001 110.808 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.53 -36.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.48 -0.866 . . . . 42.32 113.033 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -106.39 155.64 19.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 73.140000000000001 111.177 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.74 159.32 25.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 61.32 110.762 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.43 149.28 20.25 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.92 -0.657 . . . . 63.219999999999999 112.296 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 31.8 p-10 -85.95 -7.47 58.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 32.409999999999997 111.128 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.498 ' OD1' HG21 ' A' ' 7' ' ' VAL . 4.1 m-20 68.26 10.85 8.09 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.257 -0.429 . . . . 54.43 110.634 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -122.09 -5.02 8.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.441 -0.345 . . . . 74.439999999999998 110.79 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.47 16.74 3.05 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.827 -0.701 . . . . 74.230000000000004 112.85 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -116.53 145.98 42.94 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.992 0.425 . . . . 63.539999999999999 111.341 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 p -141.17 136.97 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 61.240000000000002 110.146 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.22 149.2 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 63.210000000000001 111.49 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 129.91 41.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 62.350000000000001 110.317 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.12 165.4 27.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.232 0.539 . . . . 73.510000000000005 111.81 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -116.71 17.25 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.501 -0.772 . . . . 71.450000000000003 110.36 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.87 97.56 2.44 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.973 -0.632 . . . . 65.430000000000007 112.559 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.249 -0.882 . . . . 73.150000000000006 110.97 179.865 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 61.0 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.774 0.321 . . . . 54.520000000000003 110.92 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -132.86 127.01 33.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 110.961 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.75 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.9 m -101.41 172.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 111.221 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.06 -62.91 1.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 60.310000000000002 111.005 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.4 m -147.7 130.33 15.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.3 -0.409 . . . . 45.210000000000001 111.255 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.767 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.0 m -113.96 121.28 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 61.229999999999997 109.709 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -78.73 146.34 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.184 0.516 . . . . 74.140000000000001 111.709 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.93 128.11 20.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 75.109999999999999 110.316 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.89 51.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.765 -0.731 . . . . 63.420000000000002 112.626 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.04 48.5 15.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.84 0.353 . . . . 62.450000000000003 110.91 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.27 -36.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.559 -0.829 . . . . 74.420000000000002 112.987 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.41 155.66 19.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 74.340000000000003 111.149 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.82 160.15 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.219999999999999 110.83 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.767 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.93 150.26 21.1 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.864 -0.684 . . . . 71.540000000000006 112.21 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 31.0 p-10 -86.26 -7.19 58.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.762 0.315 . . . . 63.32 111.095 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.499 ' OD1' HG11 ' A' ' 7' ' ' VAL . 3.6 m-20 68.49 10.34 7.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.277 -0.42 . . . . 73.310000000000002 110.759 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -121.85 -5.63 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.387 -0.37 . . . . 72.420000000000002 110.788 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.88 15.88 2.81 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.862 -0.685 . . . . 53.219999999999999 112.985 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -115.12 145.38 42.41 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.948 0.404 . . . . 62.530000000000001 111.402 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -141.15 136.32 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 71.409999999999997 110.202 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -158.27 149.22 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 73.209999999999994 111.383 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.97 41.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.355 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.16 165.34 27.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 60.240000000000002 111.895 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.87 -19.43 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.576 -0.738 . . . . 33.219999999999999 110.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.33 0.52 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.974 -0.631 . . . . 73.120000000000005 112.525 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.215 -0.897 . . . . 73.510000000000005 111.008 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.842 0.353 . . . . 73.409999999999997 110.799 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -127.03 128.75 46.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 52.329999999999998 110.912 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.747 ' CG2' HG13 ' A' ' 7' ' ' VAL . 31.0 m -88.58 172.19 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 72.310000000000002 111.308 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -59.41 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 34.409999999999997 110.891 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -146.0 131.54 18.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.388 -0.369 . . . . 63.229999999999997 111.253 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.747 HG13 ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -115.85 121.29 67.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.722 -0.473 . . . . 73.430000000000007 109.722 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.48 144.92 35.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.167 0.508 . . . . 64.319999999999993 111.733 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.4 m-85 -140.84 129.28 22.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 64.409999999999997 110.27 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.2 17.04 51.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.733 -0.746 . . . . 62.329999999999998 112.678 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 56.18 46.93 20.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 60.310000000000002 110.874 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.02 -37.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.517 -0.849 . . . . 64.140000000000001 112.939 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -106.45 155.68 19.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 74.230000000000004 111.134 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.8 158.79 28.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 110.817 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.703 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -135.89 151.76 20.8 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 73.219999999999999 112.21 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.53 -7.9 59.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.614 0.245 . . . . 63.450000000000003 110.921 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 79.26 1.63 2.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 60.409999999999997 111.024 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.1 m -113.69 -65.41 1.19 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.973 0.416 . . . . 54.229999999999997 110.084 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.59 25.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.858 -0.61 . . . . 72.140000000000001 112.476 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -118.13 145.05 45.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.04 0.448 . . . . 72.230000000000004 111.446 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t -141.18 134.84 30.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 71.439999999999998 110.15 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -158.03 149.27 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.812 0.339 . . . . 71.540000000000006 111.4 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 131.85 48.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.229 -0.441 . . . . 51.409999999999997 110.292 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.15 165.36 27.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.521 . . . . 60.229999999999997 111.885 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.7 t -117.06 16.28 15.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.467 -0.788 . . . . 73.439999999999998 110.396 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.85 96.88 2.41 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.997 -0.62 . . . . 52.240000000000002 112.505 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 44.310000000000002 110.949 179.893 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.657 0 CA-C-O 119.009 -0.52 . . . . 52.450000000000003 112.039 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.469 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 66.2 p -144.43 152.67 40.99 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 123.877 0.735 . . . . 55.119999999999997 110.839 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -134.1 139.57 46.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 54.030000000000001 110.925 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.733 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -109.67 172.19 2.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.286 -0.416 . . . . 71.519999999999996 111.222 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 m -56.79 -62.94 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 75.120000000000005 110.996 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.8 m -147.17 132.5 18.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.316 -0.402 . . . . 72.120000000000005 111.238 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.747 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -116.22 121.29 67.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.703 -0.48 . . . . 72.319999999999993 109.703 178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -79.13 146.62 33.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.151 0.501 . . . . 54.340000000000003 111.713 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -141.71 128.09 19.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.539 -0.755 . . . . 63.130000000000003 110.322 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.01 17.28 51.22 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 44.030000000000001 112.685 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.38 47.78 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 73.340000000000003 110.939 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.04 -37.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.571 -0.823 . . . . 75.349999999999994 112.891 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -106.39 155.61 19.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.802 0.334 . . . . 73.310000000000002 111.091 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.2 m -122.36 161.89 22.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.016 0.436 . . . . 61.109999999999999 110.988 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.747 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.68 150.99 21.75 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.898 -0.667 . . . . 32.530000000000001 112.141 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -83.8 -9.6 58.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.697 0.285 . . . . 71.540000000000006 110.991 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.5 t-20 75.75 5.41 3.93 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.361 -0.381 . . . . 62.530000000000001 110.81 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.98 -7.21 10.43 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.501 -0.318 . . . . 52.049999999999997 110.903 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.29 11.77 2.7 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.75 -0.738 . . . . 71.439999999999998 113.17 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -109.18 146.11 34.69 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 120.963 0.411 . . . . 72.409999999999997 111.304 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.22 139.24 33.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.864 -0.607 . . . . 72.319999999999993 110.396 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -161.0 149.38 16.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.529 -0.305 . . . . 71.319999999999993 111.368 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.48 130.16 43.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.314 -0.403 . . . . 73.420000000000002 110.344 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.6 p -140.14 165.41 27.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.18 0.514 . . . . 75.329999999999998 111.914 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 m -106.1 -20.5 13.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.502 -0.772 . . . . 44.240000000000002 110.294 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.69 97.03 0.47 Allowed Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.993 -0.622 . . . . 33.229999999999997 112.485 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.232 -0.889 . . . . 54.329999999999998 110.93 179.895 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . 0.469 ' C5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 119.025 -0.512 . . . . 71.129999999999995 112.037 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.6 p -143.67 161.0 39.67 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.877 0.736 . . . . 61.119999999999997 110.762 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -139.84 144.28 37.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 33.439999999999998 110.899 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.696 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.7 m -112.33 172.24 3.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.13 -0.486 . . . . 73.140000000000001 111.177 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.83 -62.82 1.47 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 63.25 110.921 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.0 m -147.14 135.16 21.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 72.329999999999998 111.224 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.76 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.9 m -118.74 121.33 66.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.664 -0.495 . . . . 54.409999999999997 109.664 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.2 t-20 -78.81 147.24 33.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.192 0.52 . . . . 64.129999999999995 111.789 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.9 m-85 -142.12 127.58 18.91 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.49 -0.777 . . . . 61.32 110.332 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.95 17.35 51.01 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.799 -0.715 . . . . 73.219999999999999 112.671 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 56.56 47.52 18.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.854 0.359 . . . . 75.239999999999995 110.905 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.46 -37.67 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.654 -0.784 . . . . 61.539999999999999 112.926 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -106.35 155.74 19.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.802 0.334 . . . . 74.109999999999999 111.094 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.39 162.21 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.44 . . . . 55.420000000000002 110.947 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.76 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.27 150.84 21.85 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.776 -0.647 . . . . 51.109999999999999 112.114 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.3 p-10 -83.07 -9.42 59.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.769 0.319 . . . . 74.219999999999999 111.047 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.45 4.79 3.59 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.333 -0.394 . . . . 74.239999999999995 110.86 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.66 -7.89 10.48 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.497 -0.32 . . . . 60.219999999999999 110.906 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.88 9.11 2.87 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.759 -0.734 . . . . 64.129999999999995 113.262 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -106.34 146.25 30.67 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.027 0.442 . . . . 64.129999999999995 111.315 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -141.2 139.88 33.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.876 -0.602 . . . . 64.420000000000002 110.356 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -161.64 149.35 14.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.788 0.328 . . . . 54.219999999999999 111.325 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.31 129.96 42.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.272 -0.422 . . . . 65.510000000000005 110.354 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.13 165.36 27.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.079 0.466 . . . . 73.340000000000003 111.926 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.8 p -106.06 -19.62 13.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.523 -0.762 . . . . 51.030000000000001 110.332 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.92 96.84 0.5 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.009 -0.615 . . . . 63.420000000000002 112.522 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.252 -0.88 . . . . 55.329999999999998 110.95 179.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 118.963 -0.542 . . . . 54.210000000000001 111.975 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.4 p -145.17 133.32 21.53 Favored 'General case' 0 C--N 1.33 -0.283 0 O-C-N 123.854 0.721 . . . . 54.420000000000002 110.904 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.5 m -116.14 144.73 43.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.911 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.724 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -111.37 172.19 2.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.277 -0.419 . . . . 72.510000000000005 111.215 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.8 p -57.14 -62.69 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 74.349999999999994 111.002 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -148.74 131.54 16.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 52.149999999999999 111.236 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.738 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -115.53 121.35 67.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.767 -0.457 . . . . 73.219999999999999 109.767 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.1 t-20 -78.93 146.58 33.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.184 0.516 . . . . 64.219999999999999 111.734 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -141.58 128.36 20.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.466 -0.788 . . . . 74.439999999999998 110.328 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.64 16.55 51.27 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.818 -0.706 . . . . 74.319999999999993 112.687 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 57.28 49.15 13.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.812 0.339 . . . . 71.319999999999993 110.817 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.59 -36.11 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.486 -0.864 . . . . 71.530000000000001 112.876 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -106.34 155.71 19.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.351 . . . . 75.519999999999996 111.061 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.49 160.51 25.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 55.32 111.0 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.738 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.75 150.13 20.98 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.946 -0.645 . . . . 71.129999999999995 112.11 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.6 p-10 -83.39 -9.76 58.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.711 0.291 . . . . 75.409999999999997 110.969 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 76.21 4.76 3.71 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 116.326 -0.397 . . . . 72.140000000000001 110.86 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.09 -8.29 10.71 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.456 -0.338 . . . . 45.229999999999997 110.845 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.9 11.66 2.56 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.724 -0.751 . . . . 64.239999999999995 113.075 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -108.62 146.35 33.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.999 0.428 . . . . 44.450000000000003 111.309 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.17 139.58 33.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.848 -0.615 . . . . 65.140000000000001 110.303 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.2 p90 -160.91 149.46 16.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.45 -0.341 . . . . 73.140000000000001 111.43 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.09 129.75 41.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 74.230000000000004 110.251 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.16 165.39 27.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.118 0.485 . . . . 63.549999999999997 111.867 -179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.51 17.01 14.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.521 -0.763 . . . . 63.420000000000002 110.338 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.84 97.73 2.45 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.958 -0.639 . . . . 42.520000000000003 112.607 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.325 -0.845 . . . . 71.109999999999999 110.884 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . 0.646 ' H33' ' O4 ' ' A' ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 119.032 -0.508 . . . . 73.420000000000002 112.03 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.454 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 40.0 p -134.2 161.98 33.42 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.814 0.696 . . . . 63.32 110.857 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.9 m -132.18 127.52 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 71.409999999999997 110.977 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.695 ' CG2' HG13 ' A' ' 7' ' ' VAL . 28.1 m -101.47 172.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 53.340000000000003 111.353 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 37.4 t -60.64 -61.87 2.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 73.150000000000006 111.052 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 88.7 m -149.24 134.28 18.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.337 -0.392 . . . . 61.329999999999998 111.339 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.8 m -120.04 121.3 65.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.202 -0.454 . . . . 40.039999999999999 109.798 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -77.57 146.28 36.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.112 0.482 . . . . 75.409999999999997 111.762 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -140.89 128.52 21.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.557 -0.747 . . . . 60.32 110.309 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.69 50.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 74.140000000000001 112.617 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 57.55 49.19 13.08 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.866 0.365 . . . . 74.540000000000006 110.861 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.62 -36.02 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.475 -0.869 . . . . 65.219999999999999 113.013 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -106.43 155.76 19.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.912 0.387 . . . . 52.140000000000001 111.171 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -121.19 158.07 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 60.219999999999999 110.923 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.766 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -136.84 149.53 20.24 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.806 -0.634 . . . . 72.329999999999998 112.091 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.1 p-10 -85.73 -11.59 53.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.788 0.328 . . . . 74.349999999999994 110.987 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.416 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 74.34 7.33 4.62 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.375 -0.375 . . . . 52.439999999999998 110.602 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.53 -6.1 10.25 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.316 -0.402 . . . . 60.450000000000003 110.767 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.69 17.94 2.51 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.903 -0.665 . . . . 43.140000000000001 112.923 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.401 ' OD1' ' CE3' ' A' ' 22' ' ' TRP . 5.3 t-20 -116.17 145.29 43.2 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.993 0.425 . . . . 74.540000000000006 111.371 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 p -141.07 137.09 32.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.601 . . . . 54.229999999999997 110.276 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.401 ' CE3' ' OD1' ' A' ' 20' ' ' ASN . 37.4 p90 -158.61 149.28 20.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.799 0.333 . . . . 74.209999999999994 111.471 -178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.29 129.3 39.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 110.156 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.1 165.41 27.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.197 0.522 . . . . 64.209999999999994 111.934 -179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.33 16.28 14.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.486 -0.779 . . . . 62.43 110.319 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.09 96.45 2.46 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 121.036 -0.602 . . . . 75.209999999999994 112.494 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.274 -0.869 . . . . 62.140000000000001 110.923 179.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . 0.644 ' H33' ' O4 ' ' A' ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 118.97 -0.538 . . . . 74.530000000000001 112.01 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.425 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 61.6 p -149.89 160.01 43.92 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.923 0.764 . . . . 72.329999999999998 110.89 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -129.68 138.3 51.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 73.230000000000004 110.891 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.728 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -110.2 172.21 2.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 71.120000000000005 111.195 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m -56.76 -62.94 1.39 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.053 -0.521 . . . . 75.209999999999994 110.924 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 80.9 m -147.91 131.69 16.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.247 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.4 m -115.33 121.31 66.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.759 -0.46 . . . . 63.130000000000003 109.759 178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.401 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.32 146.21 33.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.09 0.471 . . . . 73.310000000000002 111.768 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.3 m-85 -141.43 128.43 20.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.563 -0.744 . . . . 74.209999999999994 110.349 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.0 51.42 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.742 -0.742 . . . . 72.319999999999993 112.644 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 56.38 47.49 18.88 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 75.150000000000006 110.93 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.72 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.572 -0.823 . . . . 74.450000000000003 112.916 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.38 155.65 19.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 111.102 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.51 160.75 24.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 54.119999999999997 110.983 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.729 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.88 150.61 20.96 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.747 -0.66 . . . . 55.219999999999999 112.108 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -84.0 -10.29 58.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.702 0.287 . . . . 73.519999999999996 111.0 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 75.25 6.2 4.16 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.368 -0.378 . . . . 72.140000000000001 110.676 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.17 -6.64 9.91 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.461 -0.336 . . . . 61.420000000000002 111.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.85 15.69 2.33 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.744 -0.741 . . . . 55.340000000000003 113.166 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -113.37 146.31 39.68 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-O 120.972 0.415 . . . . 72.430000000000007 111.375 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.7 p -141.16 138.41 33.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.837 -0.619 . . . . 55.329999999999998 110.3 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -160.67 149.46 16.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.81 0.338 . . . . 75.530000000000001 111.344 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.8 130.56 44.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.274 -0.421 . . . . 64.540000000000006 110.244 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.12 165.39 27.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.144 0.497 . . . . 64.409999999999997 111.932 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 m -117.9 15.96 14.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.51 -0.768 . . . . 65.150000000000006 110.38 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.37 98.4 2.51 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.984 -0.627 . . . . 40.340000000000003 112.559 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.225 -0.893 . . . . 72.230000000000004 110.917 179.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . 0.425 ' C5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 118.864 -0.588 . . . . 72.230000000000004 111.981 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 43.1 p -151.7 140.06 20.46 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.949 0.781 . . . . 51.409999999999997 110.898 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -116.13 145.33 43.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 54.340000000000003 110.866 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.71 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -112.33 172.19 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 71.340000000000003 111.227 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.93 -62.67 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 60.219999999999999 111.023 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.1 m -147.82 133.81 19.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.277 -0.419 . . . . 55.009999999999998 111.265 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.1 m -117.27 121.27 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.764 -0.458 . . . . 53.109999999999999 109.764 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.4 t-20 -78.56 147.4 33.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.152 0.501 . . . . 75.530000000000001 111.742 -178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.8 m-85 -142.15 127.26 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.764 . . . . 71.329999999999998 110.356 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.16 17.17 51.47 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.732 -0.747 . . . . 72.519999999999996 112.707 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 56.66 47.94 17.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 74.319999999999993 110.92 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.99 -37.43 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.545 -0.836 . . . . 42.020000000000003 112.878 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -106.41 155.7 19.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.888 0.375 . . . . 61.210000000000001 110.999 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.15 161.81 22.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 64.340000000000003 110.975 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.765 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.92 150.21 21.32 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.93 -0.653 . . . . 71.329999999999998 112.118 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -82.45 -9.56 59.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.647 0.261 . . . . 72.109999999999999 111.007 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.3 4.91 3.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.318 -0.401 . . . . 62.509999999999998 110.866 -179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.58 -8.04 10.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.427 -0.351 . . . . 72.310000000000002 110.967 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.52 10.2 2.71 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.771 -0.728 . . . . 74.409999999999997 113.19 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -107.52 146.57 31.66 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.041 0.448 . . . . 74.420000000000002 111.282 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.7 p -141.2 140.57 34.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.825 -0.625 . . . . 72.430000000000007 110.342 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.8 p90 -161.76 149.43 14.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.504 -0.317 . . . . 71.109999999999999 111.373 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 129.66 41.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.335 -0.393 . . . . 64.540000000000006 110.265 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.11 165.41 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.201 0.524 . . . . 61.130000000000003 111.887 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 p -117.24 16.39 14.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.541 -0.754 . . . . 63.210000000000001 110.313 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.01 97.99 2.47 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.061 -0.59 . . . . 65.420000000000002 112.54 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.266 -0.873 . . . . 72.150000000000006 110.933 179.88 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 119.01 -0.519 . . . . 52.030000000000001 111.99 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.8 p -148.32 138.45 22.55 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 123.902 0.751 . . . . 65.310000000000002 110.894 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -116.16 138.6 51.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 71.109999999999999 110.817 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.786 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -108.55 172.17 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 74.129999999999995 111.248 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -57.48 -62.75 1.56 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 43.240000000000002 110.944 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 72.9 m -147.52 130.07 15.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.3 -0.409 . . . . 74.219999999999999 111.232 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.786 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.7 m -113.93 121.33 65.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.738 -0.467 . . . . 65.209999999999994 109.738 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.71 146.51 32.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.081 0.467 . . . . 63.25 111.66 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -141.53 128.17 20.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.608 -0.724 . . . . 72.540000000000006 110.4 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.22 17.12 51.55 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.768 -0.73 . . . . 63.219999999999999 112.678 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.9 m120 56.39 47.36 19.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.842 0.354 . . . . 73.239999999999995 110.93 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.59 -37.42 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 64.420000000000002 112.879 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -106.44 155.69 19.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.78 0.324 . . . . 62.229999999999997 111.06 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.21 161.56 23.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 74.540000000000006 110.947 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.741 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.03 150.78 21.42 Favored Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.76 -0.654 . . . . 72.319999999999993 112.173 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -84.04 -10.49 57.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.639 0.257 . . . . 60.119999999999997 110.931 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 75.5 5.89 4.04 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.37 -0.377 . . . . 75.140000000000001 110.762 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -119.8 -6.84 10.08 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.416 -0.356 . . . . 62.450000000000003 110.873 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.08 16.06 2.22 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 120.82 -0.705 . . . . 52.219999999999999 113.07 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -113.74 145.7 40.97 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.0 0.429 . . . . 74.310000000000002 111.312 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.5 p -141.03 138.52 33.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.837 -0.619 . . . . 63.229999999999997 110.316 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.4 149.53 17.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.771 0.32 . . . . 74.420000000000002 111.376 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.75 130.19 43.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.32 -0.4 . . . . 63.340000000000003 110.31 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.9 p -140.17 165.35 27.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.168 0.508 . . . . 72.430000000000007 111.834 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -106.09 -19.83 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.474 -0.784 . . . . 73.519999999999996 110.316 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 97.56 0.53 Allowed Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.01 -0.614 . . . . 71.219999999999999 112.514 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.212 -0.899 . . . . 51.049999999999997 110.962 179.834 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 119.019 -0.515 . . . . 73.239999999999995 111.999 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.2 p -141.77 150.03 41.2 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 123.863 0.727 . . . . 65.109999999999999 110.921 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 9.4 m -132.09 147.16 52.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 33.43 110.843 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.716 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.7 m -115.95 172.2 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 63.119999999999997 111.202 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.6 -62.79 1.49 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 51.439999999999998 111.041 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.2 m -147.75 133.22 18.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.312 -0.404 . . . . 52.020000000000003 111.319 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.8 m -117.21 121.31 67.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.584 -0.525 . . . . 61.149999999999999 109.584 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.0 t-20 -78.5 147.07 34.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.165 0.507 . . . . 74.209999999999994 111.798 -178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.5 m-85 -142.03 127.24 18.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.524 -0.762 . . . . 64.430000000000007 110.301 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.39 17.18 52.36 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.712 -0.756 . . . . 20.300000000000001 112.653 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 56.53 47.81 17.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.909 0.385 . . . . 53.229999999999997 110.945 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.87 -37.6 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.515 -0.85 . . . . 41.149999999999999 112.867 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -106.44 155.64 19.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.843 0.354 . . . . 64.510000000000005 111.084 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.01 161.8 22.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.993 0.425 . . . . 73.209999999999994 110.964 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.765 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.94 150.95 21.81 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.15 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.9 p-10 -83.87 -9.83 58.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.675 0.274 . . . . 63.439999999999998 111.003 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 76.29 4.96 3.68 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.337 -0.392 . . . . 62.520000000000003 110.837 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -118.31 -7.81 10.66 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.544 -0.298 . . . . 71.409999999999997 110.912 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.75 2.78 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.73 -0.747 . . . . 72.349999999999994 113.134 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -107.95 146.04 32.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.98 0.419 . . . . 72.519999999999996 111.339 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.16 139.06 33.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 72.430000000000007 110.327 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.6 p90 -160.49 149.36 16.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.832 0.348 . . . . 73.439999999999998 111.337 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.62 129.78 41.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.247 -0.433 . . . . 54.149999999999999 110.302 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.5 p -140.18 165.3 27.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.192 0.52 . . . . 55.32 111.863 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.5 p -105.35 -21.08 13.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.522 -0.763 . . . . 73.409999999999997 110.282 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 137.32 96.4 0.42 Allowed Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.913 -0.66 . . . . 52.310000000000002 112.502 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.225 -0.893 . . . . 74.510000000000005 110.937 179.856 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 118.948 -0.549 . . . . 73.439999999999998 111.943 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.1 p -135.06 140.12 45.3 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.918 0.761 . . . . 63.409999999999997 110.889 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.97 138.34 51.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 72.239999999999995 110.897 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.729 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.4 m -109.25 172.22 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 54.310000000000002 111.197 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -62.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.939 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 75.2 m -148.81 130.02 14.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.398 . . . . 64.239999999999995 111.227 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.729 HG13 ' CG2' ' A' ' 4' ' ' VAL . 1.7 m -113.81 121.35 65.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.763 -0.458 . . . . 62.25 109.763 178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.6 t-20 -79.86 145.21 32.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.118 0.485 . . . . 65.129999999999995 111.739 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.8 m-85 -141.0 129.19 22.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.541 -0.754 . . . . 73.420000000000002 110.362 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.98 51.89 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.575 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 56.0 46.59 21.55 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.874 0.369 . . . . 54.520000000000003 110.891 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -37.72 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.609 -0.805 . . . . 24.109999999999999 112.982 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -106.48 155.67 19.35 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.869 0.366 . . . . 64.239999999999995 110.997 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.6 159.84 26.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 52.350000000000001 110.939 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.689 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -135.8 150.3 20.3 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.865 -0.684 . . . . 73.530000000000001 112.084 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.2 p-10 -84.14 -10.86 57.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.713 0.292 . . . . 52.43 111.003 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 75.25 6.12 4.16 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.352 -0.385 . . . . 74.329999999999998 110.685 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.38 -6.21 9.83 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.492 -0.322 . . . . 72.129999999999995 111.027 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.52 18.53 2.21 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.806 -0.712 . . . . 40.039999999999999 113.054 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -116.53 146.47 42.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 72.310000000000002 111.312 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.9 p -141.17 138.66 33.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.615 . . . . 71.219999999999999 110.241 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.7 p90 -160.62 149.63 16.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.439 -0.346 . . . . 74.140000000000001 111.417 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.84 130.84 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.281 -0.418 . . . . 63.219999999999999 110.207 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.13 165.38 27.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 73.439999999999998 111.966 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.5 t -118.61 16.38 13.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.519 -0.764 . . . . 62.32 110.324 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.19 97.6 2.46 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.034 -0.603 . . . . 74.319999999999993 112.529 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.177 -0.916 . . . . 74.140000000000001 111.008 179.819 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.671 0 CA-C-O 118.976 -0.535 . . . . 72.239999999999995 111.965 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.2 p -150.4 133.69 16.32 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.925 0.766 . . . . 62.32 110.939 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -115.91 138.95 50.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.261 -0.427 . . . . 62.350000000000001 110.867 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.714 ' CG2' HG13 ' A' ' 7' ' ' VAL . 32.9 m -106.6 172.15 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 65.540000000000006 111.245 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 m -57.29 -63.07 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.099 -0.501 . . . . 73.510000000000005 110.935 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 83.0 m -148.87 131.16 15.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.326 -0.397 . . . . 63.43 111.282 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.714 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.6 m -113.98 121.37 65.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.761 -0.459 . . . . 65.219999999999999 109.761 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.93 146.12 33.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.121 0.486 . . . . 45.210000000000001 111.721 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.403 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.7 m-85 -141.66 128.15 20.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.521 -0.763 . . . . 71.140000000000001 110.337 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.27 17.18 51.91 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 73.310000000000002 112.6 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.09 46.94 20.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 60.420000000000002 110.902 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.79 -38.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.583 -0.817 . . . . 44.039999999999999 112.937 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -106.46 155.69 19.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.835 0.35 . . . . 75.409999999999997 111.045 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' VAL . 6.2 m -122.5 161.27 23.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.978 0.418 . . . . 61.350000000000001 111.021 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.684 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -136.78 150.92 20.74 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.792 -0.64 . . . . 54.030000000000001 112.106 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -84.35 -11.08 56.97 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.79 0.329 . . . . 73.109999999999999 111.067 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 76.05 5.28 3.78 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.322 -0.399 . . . . 62.43 110.724 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.21 -6.97 10.35 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.445 -0.343 . . . . 43.240000000000002 110.933 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 17.75 2.15 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.758 -0.734 . . . . 74.239999999999995 112.995 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -115.3 146.6 41.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.971 0.415 . . . . 75.340000000000003 111.288 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.1 p -141.17 138.44 33.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.868 -0.605 . . . . 40.119999999999997 110.284 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -160.58 149.48 16.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.424 -0.353 . . . . 63.539999999999999 111.355 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.24 130.9 46.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.345 -0.388 . . . . 75.140000000000001 110.239 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.13 165.4 27.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.128 0.489 . . . . 73.329999999999998 111.894 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.63 16.18 14.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.537 -0.756 . . . . 44.329999999999998 110.386 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.45 97.42 2.42 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.955 -0.64 . . . . 75.409999999999997 112.569 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.253 -0.88 . . . . 74.219999999999999 110.908 179.905 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 118.938 -0.554 . . . . 53.329999999999998 111.968 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.437 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 44.9 p -151.68 149.4 29.06 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.948 0.78 . . . . 52.049999999999997 110.956 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -124.23 138.59 54.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 53.109999999999999 110.956 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.732 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.5 m -110.81 172.18 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.329999999999998 111.234 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -62.89 1.42 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 55.219999999999999 111.053 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.3 m -147.29 132.41 18.3 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.346 -0.388 . . . . 54.32 111.318 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -116.63 121.34 67.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.732 -0.47 . . . . 74.439999999999998 109.732 178.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.82 146.2 33.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.173 0.511 . . . . 74.209999999999994 111.749 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.1 m-85 -141.51 128.22 20.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.533 -0.758 . . . . 55.020000000000003 110.31 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.69 16.77 52.24 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.747 -0.74 . . . . 61.130000000000003 112.57 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 56.75 48.18 16.71 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.845 0.355 . . . . 74.319999999999993 110.843 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.87 -36.76 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.536 -0.84 . . . . 72.25 112.895 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -106.36 155.76 19.21 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.847 0.356 . . . . 63.219999999999999 111.165 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 m -121.91 160.95 23.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 110.878 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.737 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -139.06 150.63 21.34 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.917 -0.658 . . . . 44.409999999999997 112.227 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -83.83 -10.09 58.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.689 0.28 . . . . 54.009999999999998 110.989 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 74.95 6.57 4.31 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.342 -0.39 . . . . 60.329999999999998 110.765 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.4 m -120.13 -6.62 9.93 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.381 -0.372 . . . . 60.350000000000001 110.89 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.45 13.4 2.58 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 120.824 -0.703 . . . . 51.409999999999997 113.167 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -111.61 146.0 38.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.969 0.414 . . . . 62.210000000000001 111.325 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 p -141.24 139.3 33.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.783 -0.644 . . . . 71.310000000000002 110.209 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.7 p90 -160.87 149.38 16.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.786 0.326 . . . . 75.219999999999999 111.423 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.99 129.93 42.02 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.289 -0.414 . . . . 45.210000000000001 110.263 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.39 27.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.164 0.506 . . . . 63.43 111.908 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.4 t -117.19 16.85 14.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.493 -0.776 . . . . 75.310000000000002 110.388 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.56 98.0 2.46 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.978 -0.629 . . . . 53.149999999999999 112.521 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.184 -0.912 . . . . 61.310000000000002 111.017 179.803 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . 0.437 ' C5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 119.035 -0.507 . . . . 75.329999999999998 112.002 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.5 p -131.27 140.66 49.85 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.835 0.709 . . . . 61.450000000000003 110.853 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -122.56 139.0 54.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 74.239999999999995 110.866 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.775 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.6 m -108.3 172.19 2.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.307 -0.406 . . . . 71.340000000000003 111.215 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.32 -62.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.340000000000003 110.965 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 76.6 m -148.53 128.93 13.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.345 -0.389 . . . . 74.530000000000001 111.232 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.775 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.5 m -112.1 121.41 64.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.692 -0.484 . . . . 62.439999999999998 109.692 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.5 t-20 -79.43 146.43 32.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.127 0.489 . . . . 71.209999999999994 111.698 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -141.66 128.01 19.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.584 -0.735 . . . . 73.409999999999997 110.439 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.13 17.24 51.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.686 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.1 m120 56.26 47.02 20.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.816 0.341 . . . . 52.219999999999999 110.891 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.95 -37.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.525 -0.845 . . . . 63.219999999999999 112.887 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -106.36 155.63 19.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.781 0.324 . . . . 43.530000000000001 111.087 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -122.41 161.37 23.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.443 . . . . 64.310000000000002 110.987 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.734 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.33 150.22 20.9 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.743 -0.662 . . . . 54.350000000000001 112.057 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -83.61 -10.39 58.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.697 0.284 . . . . 54.020000000000003 110.983 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 75.51 5.72 4.04 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.329 -0.396 . . . . 74.329999999999998 110.815 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.67 -7.1 10.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.43 -0.35 . . . . 72.319999999999993 110.95 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.18 16.09 2.19 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.809 -0.71 . . . . 51.149999999999999 113.06 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -113.92 146.03 40.66 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.04 0.448 . . . . 74.230000000000004 111.261 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.1 138.74 33.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.848 -0.615 . . . . 53.539999999999999 110.295 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 38.5 p90 -160.77 149.56 16.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.516 -0.311 . . . . 55.439999999999998 111.419 -178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.56 130.38 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.328 -0.396 . . . . 62.32 110.199 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 14.2 p -140.17 165.47 27.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.184 0.516 . . . . 73.140000000000001 111.87 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.1 p -117.82 16.63 14.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.533 -0.758 . . . . 53.219999999999999 110.339 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 97.82 2.43 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.987 -0.625 . . . . 51.020000000000003 112.513 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.2 -0.905 . . . . 74.439999999999998 110.89 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 118.947 -0.549 . . . . 44.030000000000001 112.089 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 44.2 p -152.07 151.32 30.95 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.95 0.781 . . . . 62.310000000000002 110.888 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.8 m -125.3 138.87 54.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 64.310000000000002 110.902 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.779 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.9 m -110.11 172.24 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.274 -0.421 . . . . 44.219999999999999 111.253 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 m -56.78 -62.58 1.64 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.176 -0.465 . . . . 52.43 111.031 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.6 m -147.46 129.23 15.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.332 -0.394 . . . . 65.109999999999999 111.235 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.779 HG13 ' CG2' ' A' ' 4' ' ' VAL . 3.0 m -112.8 121.43 65.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.694 -0.484 . . . . 72.430000000000007 109.694 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -78.48 147.37 33.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 71.230000000000004 111.738 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -142.04 127.33 18.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.525 -0.761 . . . . 72.409999999999997 110.349 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.92 17.32 50.7 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.737 -0.744 . . . . 54.229999999999997 112.674 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 56.61 47.67 18.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.862 0.363 . . . . 73.129999999999995 110.911 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.48 -37.72 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.542 -0.837 . . . . 72.129999999999995 112.838 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -106.38 155.64 19.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.846 0.355 . . . . 74.310000000000002 111.099 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.96 161.96 21.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 32.530000000000001 110.918 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.36 150.24 21.46 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.931 -0.652 . . . . 61.210000000000001 112.081 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.0 p-10 -82.89 -9.36 59.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.707 0.289 . . . . 73.109999999999999 110.901 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 75.41 5.78 4.09 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.312 -0.403 . . . . 43.340000000000003 110.787 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -119.63 -6.87 10.16 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.497 -0.32 . . . . 62.119999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.84 10.25 2.91 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.648 -0.787 . . . . 14.31 113.125 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -108.51 146.03 33.84 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 117.068 0.434 . . . . 72.439999999999998 111.346 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 t -141.12 140.47 34.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 62.530000000000001 110.316 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.6 p90 -161.79 149.38 14.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 71.219999999999999 111.383 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.71 129.73 41.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.36 -0.382 . . . . 74.129999999999995 110.238 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.14 165.36 27.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.125 0.488 . . . . 65.519999999999996 111.948 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.19 16.59 14.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.557 -0.747 . . . . 71.150000000000006 110.325 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.39 97.89 2.44 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 121.035 -0.602 . . . . 75.239999999999995 112.527 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.197 -0.906 . . . . 61.240000000000002 110.968 179.877 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 118.975 -0.536 . . . . 64.239999999999995 111.972 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 54.8 p -140.31 155.09 46.95 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.897 0.748 . . . . 43.210000000000001 110.872 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -129.26 126.98 40.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 40.020000000000003 110.992 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.701 ' CG2' HG13 ' A' ' 7' ' ' VAL . 32.4 m -97.84 172.16 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 54.240000000000002 111.242 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.4 t -58.52 -62.58 1.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.086 -0.506 . . . . 45.520000000000003 110.97 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.5 m -148.02 133.14 18.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 75.230000000000004 111.244 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.742 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.3 m -116.83 121.32 67.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.755 -0.461 . . . . 71.530000000000001 109.755 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 8.6 t-20 -78.89 146.08 33.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.126 0.489 . . . . 62.109999999999999 111.721 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.0 m-85 -141.27 128.79 21.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.5 -0.773 . . . . 75.120000000000005 110.3 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.05 17.15 51.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.764 -0.731 . . . . 43.329999999999998 112.621 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.6 m120 56.53 47.53 18.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.816 0.341 . . . . 74.120000000000005 110.943 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.92 -37.29 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.485 -0.864 . . . . 74.120000000000005 112.923 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.401 ' CD1' ' HA ' ' A' ' 23' ' ' ALA . 54.9 m-85 -106.34 155.56 19.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.841 0.353 . . . . 72.409999999999997 111.192 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.49 160.42 24.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.450000000000003 110.948 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.742 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.46 150.83 21.25 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.86 -0.686 . . . . 44.25 112.16 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.5 p-10 -85.36 -10.05 56.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.312 . . . . 52.140000000000001 110.952 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 1.2 m-20 72.83 7.79 5.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.33 -0.395 . . . . 75.120000000000005 110.679 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 2.9 m -119.71 -6.8 10.13 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.413 -0.358 . . . . 72.420000000000002 110.739 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.26 15.87 2.43 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.821 -0.704 . . . . 60.43 112.953 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -114.54 145.84 41.46 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.956 0.408 . . . . 74.310000000000002 111.356 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.2 p -141.12 137.22 32.62 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.849 -0.614 . . . . 61.140000000000001 110.227 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -159.37 149.29 18.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 72.230000000000004 111.412 -179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.401 ' HA ' ' CD1' ' A' ' 13' ' ' PHE . . . -64.15 130.55 44.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.308 -0.405 . . . . 73.109999999999999 110.348 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -140.1 165.44 27.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.224 0.535 . . . . 71.430000000000007 111.885 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 p -105.78 -19.65 13.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.501 -0.772 . . . . 62.310000000000002 110.256 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.11 96.92 0.49 Allowed Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.057 -0.592 . . . . 74.319999999999993 112.5 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.3 m . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.208 -0.901 . . . . 51.119999999999997 110.977 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 119.017 -0.516 . . . . 73.439999999999998 111.981 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.423 HG21 ' O5 ' ' A' ' 28' ' ' 3HD . 30.5 p -141.72 161.68 37.34 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 123.916 0.76 . . . . 61.409999999999997 110.792 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -137.2 128.1 27.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 75.109999999999999 110.964 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.669 ' CG2' HG13 ' A' ' 7' ' ' VAL . 31.5 m -100.14 172.17 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 43.140000000000001 111.276 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.5 p -58.62 -62.7 1.66 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 72.340000000000003 110.938 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 69.7 m -146.85 137.36 23.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.451 . . . . 71.140000000000001 111.155 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -120.87 121.31 64.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.772 -0.455 . . . . 75.409999999999997 109.772 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -78.71 147.12 33.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.093 0.473 . . . . 63.509999999999998 111.801 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -142.09 128.17 19.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.56 -0.745 . . . . 73.219999999999999 110.392 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.34 17.69 47.54 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.737 -0.744 . . . . 13.25 112.65 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 56.23 46.7 20.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.794 0.33 . . . . 73.25 110.932 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.03 -38.43 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.512 -0.852 . . . . 63.240000000000002 112.908 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -106.42 155.77 19.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.834 0.35 . . . . 73.129999999999995 111.072 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 m -122.23 162.84 20.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 61.520000000000003 111.029 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.758 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.51 150.43 21.63 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.902 -0.666 . . . . 71.120000000000005 112.067 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -82.27 -9.59 59.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.744 0.307 . . . . 73.219999999999999 110.98 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 2.5 t30 75.24 6.63 4.16 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.309 -0.405 . . . . 60.409999999999997 110.723 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -119.79 -6.8 10.09 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.329 -0.396 . . . . 72.329999999999998 110.929 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.26 10.29 3.08 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.743 -0.741 . . . . 42.539999999999999 113.13 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -108.84 146.97 32.82 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.055 0.455 . . . . 74.519999999999996 111.426 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.0 p -141.2 140.77 34.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.749 -0.66 . . . . 42.409999999999997 110.249 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -162.53 148.96 12.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.486 -0.325 . . . . 73.329999999999998 111.302 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.75 130.71 46.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 64.420000000000002 110.231 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.4 p -140.1 165.36 27.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.145 0.497 . . . . 71.430000000000007 111.936 -179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.3 p -106.58 -18.37 13.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.502 -0.772 . . . . 72.239999999999995 110.234 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.84 97.63 0.56 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.0 -0.619 . . . . 60.210000000000001 112.493 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.204 -0.903 . . . . 72.319999999999993 110.9 179.827 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . 0.423 ' O5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 118.982 -0.533 . . . . 63.240000000000002 112.028 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 p -143.44 146.18 33.23 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.889 0.743 . . . . 72.209999999999994 110.936 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.8 m -120.82 127.24 51.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 74.140000000000001 110.934 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.78 ' CG2' HG13 ' A' ' 7' ' ' VAL . 34.6 m -100.17 172.18 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 73.219999999999999 111.211 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 t -55.65 -62.75 1.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.530000000000001 111.082 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.0 m -149.09 127.86 12.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 52.329999999999998 111.271 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.78 HG13 ' CG2' ' A' ' 4' ' ' VAL . 2.9 m -111.03 121.29 63.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.756 -0.461 . . . . 55.210000000000001 109.756 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -78.27 146.41 34.86 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.139 0.495 . . . . 64.340000000000003 111.73 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -141.18 128.41 20.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.563 -0.744 . . . . 71.340000000000003 110.333 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.26 16.78 50.47 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.74 -0.743 . . . . 71.510000000000005 112.703 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.4 m120 57.21 48.52 15.03 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.783 0.325 . . . . 74.420000000000002 110.818 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.44 -36.57 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.506 -0.854 . . . . 52.039999999999999 112.987 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -106.44 155.7 19.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.943 0.401 . . . . 72.329999999999998 111.11 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -120.69 159.52 25.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.06 -0.518 . . . . 64.230000000000004 110.73 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.763 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.85 149.54 20.46 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.814 -0.708 . . . . 64.140000000000001 112.285 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -86.26 -7.95 58.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.673 0.273 . . . . 74.450000000000003 111.024 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.513 ' OD1' HG21 ' A' ' 7' ' ' VAL . 2.3 m-20 68.76 10.17 7.75 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.342 -0.39 . . . . 61.25 110.745 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.0 m -121.17 -5.5 9.46 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.335 -0.393 . . . . 32.219999999999999 110.736 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.96 16.86 2.87 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 120.949 -0.643 . . . . 60.340000000000003 112.832 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -116.42 145.74 43.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.998 0.428 . . . . 75.230000000000004 111.398 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.0 p -141.14 136.93 32.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 64.109999999999999 110.145 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.21 149.17 20.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.521 -0.308 . . . . 74.340000000000003 111.53 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.15 129.96 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.35 -0.386 . . . . 73.549999999999997 110.321 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.8 p -140.14 165.34 27.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 111.843 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 72.7 m -116.56 17.67 15.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.572 -0.74 . . . . 55.329999999999998 110.327 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.14 97.23 2.4 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.923 -0.656 . . . . 64.109999999999999 112.567 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.198 -0.905 . . . . 73.340000000000003 110.978 179.85 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.695 0 CA-C-O 118.997 -0.525 . . . . 73.230000000000004 112.007 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 29.9 p -150.65 162.04 41.44 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 123.948 0.78 . . . . 71.319999999999993 110.817 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -140.49 141.43 35.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.963 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.713 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.4 m -112.22 172.17 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 74.140000000000001 111.183 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.87 -62.79 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 75.450000000000003 110.974 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.1 m -146.52 134.01 20.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 31.129999999999999 111.221 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.771 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.0 m -117.74 121.24 66.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 109.622 -0.51 . . . . 63.420000000000002 109.622 178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.402 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -77.96 147.32 34.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.18 0.515 . . . . 74.430000000000007 111.747 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.402 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 26.6 m-85 -142.22 126.84 17.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.492 -0.776 . . . . 73.150000000000006 110.319 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.06 17.38 51.69 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.735 -0.745 . . . . 31.199999999999999 112.661 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 56.41 47.19 19.43 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.896 0.379 . . . . 62.450000000000003 110.981 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.59 -38.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.587 -0.816 . . . . 55.009999999999998 112.871 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -106.43 155.71 19.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 74.519999999999996 111.02 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -122.17 162.27 21.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.467 . . . . 75.510000000000005 110.884 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -140.49 150.84 21.92 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.916 -0.659 . . . . 44.240000000000002 112.196 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 p-10 -82.5 -9.33 59.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.734 0.302 . . . . 42.520000000000003 110.874 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 3' ' ' CYS . 0.9 OUTLIER 76.25 5.07 3.7 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.298 -0.41 . . . . 73.25 110.876 -179.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.3 m -118.93 -7.56 10.4 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.479 -0.328 . . . . 71.430000000000007 111.0 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.29 7.29 3.22 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 120.669 -0.777 . . . . 72.439999999999998 113.264 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -105.22 146.28 29.49 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.998 0.428 . . . . 75.510000000000005 111.309 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -141.27 140.9 33.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 71.430000000000007 110.275 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -162.19 149.28 13.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 73.340000000000003 111.384 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.14 129.91 42.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.312 -0.404 . . . . 73.219999999999999 110.284 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.2 p -140.16 165.44 27.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.131 0.491 . . . . 62.130000000000003 111.898 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.1 p -116.89 16.22 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.543 -0.753 . . . . 71.209999999999994 110.389 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.53 97.5 2.43 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.895 -0.669 . . . . 72.340000000000003 112.484 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 m . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.252 -0.88 . . . . 62.130000000000003 110.907 179.817 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.723 0 CA-C-O 118.947 -0.549 . . . . 72.140000000000001 111.995 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.4 p -132.35 156.01 47.38 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 123.901 0.751 . . . . 65.340000000000003 110.885 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -132.61 127.47 35.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 72.140000000000001 110.938 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.731 ' CG2' HG13 ' A' ' 7' ' ' VAL . 34.4 m -102.37 172.23 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 54.409999999999997 111.106 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.9 p -55.46 -62.91 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 45.039999999999999 111.085 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.0 m -149.05 129.97 14.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.316 -0.402 . . . . 60.130000000000003 111.286 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 15' ' ' GLY . 2.6 m -113.26 121.37 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.673 -0.491 . . . . 72.109999999999999 109.673 178.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -78.36 146.13 34.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.123 0.487 . . . . 51.409999999999997 111.706 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.03 128.5 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.559 -0.746 . . . . 72.239999999999995 110.269 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.4 16.79 51.08 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.754 -0.736 . . . . 32.530000000000001 112.643 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.1 48.65 15.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 74.140000000000001 110.808 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.53 -36.58 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.48 -0.866 . . . . 42.32 113.033 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -106.39 155.64 19.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.881 0.372 . . . . 73.140000000000001 111.177 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.74 159.32 25.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.153 -0.476 . . . . 61.32 110.762 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -137.43 149.28 20.25 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.92 -0.657 . . . . 63.219999999999999 112.296 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 31.8 p-10 -85.95 -7.47 58.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.775 0.321 . . . . 32.409999999999997 111.128 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.498 ' OD1' HG21 ' A' ' 7' ' ' VAL . 4.1 m-20 68.26 10.85 8.09 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.257 -0.429 . . . . 54.43 110.634 -178.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -122.09 -5.02 8.98 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.441 -0.345 . . . . 74.439999999999998 110.79 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.47 16.74 3.05 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.827 -0.701 . . . . 74.230000000000004 112.85 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -116.53 145.98 42.94 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.992 0.425 . . . . 63.539999999999999 111.341 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.3 p -141.17 136.97 32.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.788 -0.642 . . . . 61.240000000000002 110.146 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -158.22 149.2 20.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 63.210000000000001 111.49 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.97 129.91 41.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.431 . . . . 62.350000000000001 110.317 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.7 p -140.12 165.4 27.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.232 0.539 . . . . 73.510000000000005 111.81 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 m -116.71 17.25 15.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.501 -0.772 . . . . 71.450000000000003 110.36 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.87 97.56 2.44 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.973 -0.632 . . . . 65.430000000000007 112.559 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.249 -0.882 . . . . 73.150000000000006 110.97 179.865 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 CA-C-O 118.995 -0.526 . . . . 75.310000000000002 111.988 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.459 HG21 ' C5 ' ' A' ' 28' ' ' 3HD . 61.0 p -148.82 159.89 43.74 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.866 0.729 . . . . 54.520000000000003 110.92 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 17' ' ' ASN . 6.7 m -132.86 127.01 33.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 71.340000000000003 110.961 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.75 ' CG2' HG13 ' A' ' 7' ' ' VAL . 33.9 m -101.41 172.13 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 111.221 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -56.06 -62.91 1.39 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 60.310000000000002 111.005 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 81.4 m -147.7 130.33 15.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.3 -0.409 . . . . 45.210000000000001 111.255 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.767 HG22 ' O ' ' A' ' 15' ' ' GLY . 3.0 m -113.96 121.28 65.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.709 -0.478 . . . . 61.229999999999997 109.709 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -78.73 146.34 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.184 0.516 . . . . 74.140000000000001 111.709 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.93 128.11 20.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.502 -0.772 . . . . 75.109999999999999 110.316 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.89 51.54 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.765 -0.731 . . . . 63.420000000000002 112.626 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 57.04 48.5 15.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.84 0.353 . . . . 62.450000000000003 110.91 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -171.27 -36.48 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.559 -0.829 . . . . 74.420000000000002 112.987 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.41 155.66 19.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.914 0.388 . . . . 74.340000000000003 111.149 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 m -120.82 160.15 23.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 73.219999999999999 110.83 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.767 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -138.93 150.26 21.1 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.864 -0.684 . . . . 71.540000000000006 112.21 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ASN . 31.0 p-10 -86.26 -7.19 58.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.762 0.315 . . . . 63.32 111.095 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.499 ' OD1' HG11 ' A' ' 7' ' ' VAL . 3.6 m-20 68.49 10.34 7.81 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.277 -0.42 . . . . 73.310000000000002 110.759 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.2 m -121.85 -5.63 9.08 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.387 -0.37 . . . . 72.420000000000002 110.788 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.88 15.88 2.81 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 120.862 -0.685 . . . . 53.219999999999999 112.985 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -115.12 145.38 42.41 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.948 0.404 . . . . 62.530000000000001 111.402 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -141.15 136.32 31.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.874 -0.603 . . . . 71.409999999999997 110.202 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -158.27 149.22 20.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.791 0.329 . . . . 73.209999999999994 111.383 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.96 129.97 41.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.446 . . . . 74.430000000000007 110.355 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.16 165.34 27.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.128 0.49 . . . . 60.240000000000002 111.895 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.87 -19.43 13.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.576 -0.738 . . . . 33.219999999999999 110.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.79 97.33 0.52 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.974 -0.631 . . . . 73.120000000000005 112.525 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.5 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.215 -0.897 . . . . 73.510000000000005 111.008 179.914 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . 0.459 ' C5 ' HG21 ' A' ' 2' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.644 0 CA-C-O 119.001 -0.523 . . . . 74.120000000000005 111.977 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.9 p -142.02 140.1 32.54 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.875 0.734 . . . . 73.409999999999997 110.799 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 6.9 m -127.03 128.75 46.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 52.329999999999998 110.912 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.747 ' CG2' HG13 ' A' ' 7' ' ' VAL . 31.0 m -88.58 172.19 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.147 -0.479 . . . . 72.310000000000002 111.308 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -59.41 -62.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 34.409999999999997 110.891 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 85.1 m -146.0 131.54 18.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.388 -0.369 . . . . 63.229999999999997 111.253 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.747 HG13 ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -115.85 121.29 67.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.722 -0.473 . . . . 73.430000000000007 109.722 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.404 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 7.0 t-20 -78.48 144.92 35.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.167 0.508 . . . . 64.319999999999993 111.733 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.404 ' CD1' ' O ' ' A' ' 8' ' ' ASN . 25.4 m-85 -140.84 129.28 22.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.515 -0.766 . . . . 64.409999999999997 110.27 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.2 17.04 51.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.733 -0.746 . . . . 62.329999999999998 112.678 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 56.18 46.93 20.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.843 0.354 . . . . 60.310000000000002 110.874 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.02 -37.78 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.517 -0.849 . . . . 64.140000000000001 112.939 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -106.45 155.68 19.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.885 0.374 . . . . 74.230000000000004 111.134 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.2 m -121.8 158.79 28.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.209999999999994 110.817 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.703 ' O ' HG22 ' A' ' 7' ' ' VAL . . . -135.89 151.76 20.8 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.887 -0.673 . . . . 73.219999999999999 112.21 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 p-10 -81.53 -7.9 59.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.614 0.245 . . . . 63.450000000000003 110.921 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 t30 79.26 1.63 2.33 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.303 -0.408 . . . . 60.409999999999997 111.024 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 3.1 m -113.69 -65.41 1.19 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.973 0.416 . . . . 54.229999999999997 110.084 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -168.59 25.69 0.12 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.858 -0.61 . . . . 72.140000000000001 112.476 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -118.13 145.05 45.18 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 121.04 0.448 . . . . 72.230000000000004 111.446 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 t -141.18 134.84 30.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.625 . . . . 71.439999999999998 110.15 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 34.6 p90 -158.03 149.27 21.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.812 0.339 . . . . 71.540000000000006 111.4 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 131.85 48.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.229 -0.441 . . . . 51.409999999999997 110.292 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.3 p -140.15 165.36 27.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.193 0.521 . . . . 60.229999999999997 111.885 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.7 t -117.06 16.28 15.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.467 -0.788 . . . . 73.439999999999998 110.396 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.85 96.88 2.41 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.997 -0.62 . . . . 52.240000000000002 112.505 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.2 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.242 -0.885 . . . . 44.310000000000002 110.949 179.893 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' 3HD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_